0000021076-23-000048.txt : 20231101 0000021076-23-000048.hdr.sgml : 20231101 20231101164534 ACCESSION NUMBER: 0000021076-23-000048 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 70 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] IRS NUMBER: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 231368893 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 10-Q 1 clx-20230930.htm 10-Q clx-20230930
0000021076false6/30Q12024http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpensehttp://www.clorox.com/20230930#OtherExpenseIncomeNethttp://www.clorox.com/20230930#OtherExpenseIncomeNethttp://www.clorox.com/20230930#OtherExpenseIncomeNet00000210762023-07-012023-09-3000000210762023-10-18xbrli:sharesiso4217:USD00000210762022-07-012022-09-30iso4217:USDxbrli:shares00000210762023-09-3000000210762023-06-3000000210762022-06-3000000210762022-09-300000021076clx:CyberattackMember2023-07-012023-09-300000021076clx:CostOfGoodsAndServicesSoldMemberclx:CyberattackMember2023-07-012023-09-300000021076us-gaap:SellingGeneralAndAdministrativeExpensesMemberclx:CyberattackMember2023-07-012023-09-300000021076srt:MaximumMember2023-09-3000000210762022-07-012023-06-300000021076srt:ScenarioForecastMembersrt:MinimumMember2024-06-300000021076srt:ScenarioForecastMembersrt:MaximumMember2024-06-300000021076srt:ScenarioForecastMembersrt:MinimumMemberus-gaap:EmployeeSeveranceMember2024-06-300000021076srt:ScenarioForecastMemberus-gaap:EmployeeSeveranceMembersrt:MaximumMember2024-06-300000021076clx:CostOfGoodsAndServicesSoldMember2023-07-012023-09-300000021076clx:CostOfGoodsAndServicesSoldMember2022-07-012023-09-300000021076clx:CostOfGoodsAndServicesSoldMember2022-07-012022-09-300000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300000021076us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-09-300000021076us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300000021076us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300000021076us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012023-09-300000021076clx:OtherExpenseIncomeNetMember2023-07-012023-09-300000021076clx:OtherExpenseIncomeNetMember2022-07-012023-09-300000021076clx:OtherExpenseIncomeNetMember2022-07-012022-09-3000000210762022-07-012023-09-300000021076us-gaap:EmployeeSeveranceMember2023-06-300000021076us-gaap:OtherRestructuringMember2023-06-300000021076us-gaap:EmployeeSeveranceMember2023-07-012023-09-300000021076us-gaap:OtherRestructuringMember2023-07-012023-09-300000021076us-gaap:EmployeeSeveranceMember2023-09-300000021076us-gaap:OtherRestructuringMember2023-09-300000021076clx:TotalCommodityPurchaseDerivativeContractsMember2023-07-012023-09-300000021076clx:TotalCommodityPurchaseDerivativeContractsMember2023-09-300000021076clx:TotalCommodityPurchaseDerivativeContractsMember2023-06-300000021076us-gaap:ForeignExchangeContractMemberclx:PurchasesofInventoryMember2023-09-300000021076us-gaap:ForeignExchangeContractMemberclx:PurchasesofInventoryMember2023-06-300000021076us-gaap:CommodityContractMember2023-07-012023-09-300000021076us-gaap:CommodityContractMember2022-07-012022-09-300000021076us-gaap:ForeignExchangeContractMember2023-07-012023-09-300000021076us-gaap:ForeignExchangeContractMember2022-07-012022-09-300000021076us-gaap:InterestRateContractMember2023-07-012023-09-300000021076us-gaap:InterestRateContractMember2022-07-012022-09-300000021076us-gaap:CommodityContractMember2023-09-300000021076us-gaap:CommodityContractMember2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-09-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-09-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-06-300000021076us-gaap:ForeignExchangeForwardMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Member2023-09-300000021076us-gaap:ForeignExchangeForwardMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Member2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-09-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-09-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-06-300000021076us-gaap:BankTimeDepositsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2023-09-300000021076us-gaap:BankTimeDepositsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberclx:TrustAssetsForNonqualifiedDeferredCompensationPlansMemberus-gaap:FairValueInputsLevel1Member2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberclx:TrustAssetsForNonqualifiedDeferredCompensationPlansMemberus-gaap:FairValueInputsLevel1Member2023-09-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberclx:TrustAssetsForNonqualifiedDeferredCompensationPlansMemberus-gaap:FairValueInputsLevel1Member2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberclx:TrustAssetsForNonqualifiedDeferredCompensationPlansMemberus-gaap:FairValueInputsLevel1Member2023-06-300000021076clx:NotesAndLoansPayableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberclx:NotesAndLoansPayableMemberus-gaap:FairValueInputsLevel2Member2023-09-300000021076clx:NotesAndLoansPayableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberclx:NotesAndLoansPayableMemberus-gaap:FairValueInputsLevel2Member2023-06-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongTermDebtMember2023-09-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongTermDebtMember2023-09-300000021076us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongTermDebtMember2023-06-300000021076us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LongTermDebtMember2023-06-30xbrli:pure0000021076us-gaap:CommonStockMember2022-06-300000021076us-gaap:AdditionalPaidInCapitalMember2022-06-300000021076us-gaap:RetainedEarningsMember2022-06-300000021076us-gaap:TreasuryStockCommonMember2022-06-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000021076us-gaap:NoncontrollingInterestMember2022-06-300000021076us-gaap:RetainedEarningsMember2022-07-012022-09-300000021076us-gaap:NoncontrollingInterestMember2022-07-012022-09-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000021076us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000021076us-gaap:TreasuryStockCommonMember2022-07-012022-09-300000021076us-gaap:CommonStockMember2022-09-300000021076us-gaap:AdditionalPaidInCapitalMember2022-09-300000021076us-gaap:RetainedEarningsMember2022-09-300000021076us-gaap:TreasuryStockCommonMember2022-09-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000021076us-gaap:NoncontrollingInterestMember2022-09-300000021076us-gaap:CommonStockMember2023-06-300000021076us-gaap:AdditionalPaidInCapitalMember2023-06-300000021076us-gaap:RetainedEarningsMember2023-06-300000021076us-gaap:TreasuryStockCommonMember2023-06-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000021076us-gaap:NoncontrollingInterestMember2023-06-300000021076us-gaap:RetainedEarningsMember2023-07-012023-09-300000021076us-gaap:NoncontrollingInterestMember2023-07-012023-09-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000021076us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000021076us-gaap:TreasuryStockCommonMember2023-07-012023-09-300000021076us-gaap:CommonStockMember2023-09-300000021076us-gaap:AdditionalPaidInCapitalMember2023-09-300000021076us-gaap:RetainedEarningsMember2023-09-300000021076us-gaap:TreasuryStockCommonMember2023-09-300000021076us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000021076us-gaap:NoncontrollingInterestMember2023-09-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300000021076us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000021076us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300000021076us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000021076us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberclx:RetirementIncomeMembercountry:US2023-09-300000021076us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberclx:RetirementIncomeMembercountry:US2023-07-012023-09-300000021076srt:ScenarioForecastMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberclx:RetirementIncomeMembercountry:US2023-10-012023-12-310000021076us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberclx:RetirementIncomeMembercountry:US2022-07-012022-09-300000021076us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberclx:RetirementIncomeMember2023-07-012023-09-300000021076us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberclx:RetirementIncomeMember2022-07-012022-09-300000021076clx:RetirementHealthCareMemberus-gaap:DefinedBenefitPostretirementHealthCoverageMember2023-07-012023-09-300000021076clx:RetirementHealthCareMemberus-gaap:DefinedBenefitPostretirementHealthCoverageMember2022-07-012022-09-300000021076clx:AlamedaCountyCaliforniaMatterMember2023-06-300000021076clx:AlamedaCountyCaliforniaMatterMember2023-09-300000021076clx:AlamedaCountyCaliforniaMatterMember2023-07-012023-09-300000021076clx:DickinsonCountyMichiganMatterMember2023-09-300000021076clx:DickinsonCountyMichiganMatterMember2023-06-300000021076clx:DickinsonCountyMichiganMatterMember2023-07-012023-09-30clx:reportableSegment0000021076us-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2023-07-012023-09-300000021076us-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2022-07-012022-09-300000021076clx:HouseholdMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076clx:HouseholdMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076clx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076clx:LifestyleMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076clx:InternationalMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076clx:InternationalMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:CorporateNonSegmentMember2023-07-012023-09-300000021076us-gaap:CorporateNonSegmentMember2022-07-012022-09-300000021076clx:OperatingSegmentsAndCorporateNonSegmentMember2023-07-012023-09-300000021076clx:OperatingSegmentsAndCorporateNonSegmentMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:CyberattackMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:CyberattackMemberclx:HouseholdMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:CyberattackMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:CyberattackMemberclx:InternationalMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:CyberattackMemberus-gaap:CorporateNonSegmentMember2023-07-012023-09-300000021076clx:CyberattackMemberus-gaap:ProductConcentrationRiskMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2022-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2022-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2022-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:InternationalMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMemberus-gaap:OperatingSegmentsMember2022-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMember2022-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMember2023-07-012023-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMember2022-07-012022-09-300000021076us-gaap:ProductConcentrationRiskMemberclx:RestructuringAndRelatedCostsBenchmarkMemberus-gaap:EmployeeSeveranceMember2022-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberclx:WalmartStoresIncMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberclx:WalmartStoresIncMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:CleaningMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:CleaningMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:ProfessionalProductsMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:ProfessionalProductsMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberclx:HealthAndWellnessMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:BagsAndWrapsMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:BagsAndWrapsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:CatLitterMemberclx:HouseholdMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:CatLitterMemberclx:HouseholdMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:GrillingMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberclx:GrillingMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:HouseholdMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberclx:FoodProductsMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberclx:FoodProductsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:NaturalPersonalCareMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:NaturalPersonalCareMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:WaterFiltrationMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:WaterFiltrationMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:LifestyleMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:InternationalMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberclx:InternationalMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberus-gaap:CorporateNonSegmentMember2022-07-012022-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMember2023-07-012023-09-300000021076us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMember2022-07-012022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023.
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                to
Commission File Number: 1-07151
CLX logo.jpg
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter) 
Delaware31-0595760
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
1221 Broadway, Oakland, California, 94612-1888
(Address of principal executive offices) (Zip code)
(510) 271-7000
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
___________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock - $1.00 par valueCLXNew York Stock Exchange
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.  
Large accelerated filer☑Accelerated filer☐Non-accelerated filer☐Smaller Reporting Company☐Emerging Growth Company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
 
As of October 18, 2023, there were 124,059,098 shares outstanding of the registrant’s common stock ($1.00 par value).
1

TABLE OF CONTENTS

2

PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
The Clorox Company
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)
(Dollars in millions, except per share data)
Three months ended
9/30/20239/30/2022
Net sales$1,386 $1,740 
Cost of products sold854 1,114 
Gross profit532 626 
Selling and administrative expenses276 261 
Advertising costs165 161 
Research and development costs29 32 
Interest expense21 22 
Other (income) expense, net12 34 
Earnings before income taxes29 116 
Income tax expense
4 29 
Net earnings25 87 
Less: Net earnings attributable to noncontrolling interests32 
Net earnings attributable to Clorox$22 $85 
Net earnings per share attributable to Clorox
Basic net earnings per share$0.17 $0.69 
Diluted net earnings per share$0.17 $0.68 
Weighted average shares outstanding (in thousands)
Basic123,973 123,339 
Diluted124,650 123,914 
Comprehensive income$24 $51 
Less: Total comprehensive income attributable to noncontrolling interests32 
Total comprehensive income attributable to Clorox$21 $49 

See Notes to Condensed Consolidated Financial Statements (Unaudited)
3

The Clorox Company
Condensed Consolidated Balance Sheets
(Dollars in millions, except per share data)
9/30/20236/30/2023
(Unaudited)
ASSETS
Current assets
Cash and cash equivalents$518 $367 
Receivables, net581 688 
Inventories, net710 696 
Prepaid expenses and other current assets102 77 
Total current assets1,911 1,828 
Property, plant and equipment, net of accumulated depreciation and amortization
        of $2,768 and $2,705, respectively
1,317 1,345 
Operating lease right-of-use assets328 346 
Goodwill1,246 1,252 
Trademarks, net541 543 
Other intangible assets, net162 169 
Other assets486 462 
Total assets$5,991 $5,945 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Notes and loans payable$347 $50 
Current operating lease liabilities88 87 
Accounts payable and accrued liabilities1,678 1,659 
Income taxes payable115 121 
Total current liabilities2,228 1,917 
Long-term debt2,478 2,477 
Long-term operating lease liabilities290 310 
Other liabilities837 825 
Deferred income taxes27 28 
Total liabilities5,860 5,557 
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding
— — 
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2023 and June 30, 2023; and 124,001,348 and 123,820,022 shares outstanding as of September 30, 2023 and June 30, 2023, respectively
131 131 
Additional paid-in capital1,246 1,245 
Retained earnings299 583 
Treasury stock, at cost: 6,740,113 and 6,921,439 shares as of September 30, 2023
        and June 30, 2023, respectively
(1,219)(1,246)
Accumulated other comprehensive net (loss) income(494)(493)
Total Clorox stockholders’ (deficit) equity
(37)220 
Noncontrolling interests168 168 
Total stockholders’ equity131 388 
Total liabilities and stockholders’ equity$5,991 $5,945 

See Notes to Condensed Consolidated Financial Statements (Unaudited)
4

The Clorox Company
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Dollars in millions)
Three months ended
9/30/20239/30/2022
Operating activities:
Net earnings$25 $87 
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization61 56 
Stock-based compensation13 10 
Deferred income taxes(5)(5)
Other1 16 
Changes in:
Receivables, net108 63 
Inventories, net(14)(6)
Prepaid expenses and other current assets(22)(30)
Accounts payable and accrued liabilities(138)(28)
Operating lease right-of-use assets and liabilities, net(1)1 
Income taxes payable / prepaid(8)14 
Net cash provided by operations20 178 
Investing activities:
Capital expenditures(24)(46)
Other1 1 
Net cash used for investing activities(23)(45)
Financing activities:
Notes and loans payable, net298 111 
Cash dividends paid to Clorox stockholders(149)(145)
Issuance of common stock for employee stock plans and other6 (1)
Net cash provided by (used for) financing activities
155 (35)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
— (4)
Net increase (decrease) in cash, cash equivalents and restricted cash
152 94 
Cash, cash equivalents and restricted cash:
Beginning of period368 186 
End of period$520 $280 


See Notes to Condensed Consolidated Financial Statements (Unaudited)
5

The Clorox Company
Notes to Condensed Consolidated Financial Statements (Unaudited)
(Dollars in millions, except per share data)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2023 and 2022, in the opinion of management, reflect all normal and recurring adjustments considered necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2023, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
Recently Adopted Accounting Standards
In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations. These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the standard as of July 1, 2023. The adoption relates to disclosures only and does not have an impact on the condensed consolidated financial statements, results of operations, or cash flows.
NOTE 2. CYBERATTACK
On Monday, August 14, 2023, the Company disclosed it had identified unauthorized activity on some of its Information Technology (IT) systems. That activity began on Friday, August 11, 2023 and after becoming aware of it that evening, the Company immediately began taking steps to stop and remediate the activity. The Company also took certain systems offline and engaged third-party cybersecurity experts to support its investigation and recovery efforts. The Company implemented its business continuity plans, including manual ordering and processing procedures at a reduced rate of operations in order to continue servicing its customers. However, the incident resulted in wide-scale disruptions to the Company’s business operations throughout the remainder of the quarter.
The impacts of these system disruptions included order processing delays and significant product outages, resulting in a negative impact on net sales and earnings. The Company has since transitioned back to automated order processing and the vast majority of orders are taking place in an automated manner. The Company expects to experience ongoing, but lessening, operational impacts in the second quarter as it makes progress in returning to normalized operations.
The Company also incurred incremental expenses of approximately $24 as a result of the cyberattack for the three months ended September 30, 2023. The following table summarizes the recognition of costs in the condensed consolidated statement of earnings and comprehensive income:

Three months ended
9/30/2023
Costs of products sold
$11 
Selling and administrative expenses
13 
Total
$24 

The costs incurred relate primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs incurred from the resulting disruption to the Company’s business operations. The Company expects to incur additional costs related to the
6
NOTE 2. CYBERATTACK (Continued)
cyberattack in future periods. The Company has not recognized any insurance proceeds in the three months ended September 30, 2023 related to the cyberattack. The timing of recognizing insurance recoveries, if any, may differ from the timing of recognizing the associated expenses.

NOTE 3. SUPPLY CHAIN FINANCING PROGRAM
The Company has arranged for a global financial institution to offer a voluntary supply chain finance (SCF) program for the benefit of the Company’s suppliers. The Company’s current payment terms do not exceed 120 days in keeping with industry standards. The SCF program enables suppliers to directly contract with the financial institution to receive payment from the financial institution prior to the payment terms between the Company and the supplier by selling the Company’s payables to the financial institution. Participation in the program is at the sole discretion of the supplier and the Company has no economic interest in a supplier's decision to enter into the agreement and has no direct financial relationship with the financial institution, as it relates to the SCF program. Once a supplier elects to participate in the SCF program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices to sell to the financial institution. The terms of the Company’s payment obligations are not impacted by a supplier’s participation in the program and as such, the SCF program has no direct impact on the Company’s balance sheets, cash flows or liquidity. The Company and our subsidiaries have not pledged any assets as security or provided guarantees under the SCF program.
All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets and the associated payments are included in operating activities within the condensed consolidated statements of cash flows. As of September 30, 2023 and June 30, 2023, the amount due to suppliers participating in the SCF program and included in Accounts payable and accrued liabilities was $119 and $220, respectively. The decrease in the amount due to suppliers participating in the SCF program from June 30, 2023 to September 30, 2023 was attributable to a reduction of orders due to the temporary operational disruptions of the cyberattack along with the timing of payments.
NOTE 4. RESTRUCTURING AND RELATED COSTS
In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company’s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.
The Company incurred $60 of costs in fiscal year 2023 and anticipates incurring approximately $30 to $40 of costs in fiscal year 2024 related to this initiative, of which approximately $10 to $15 are expected to be employee-related costs to reduce certain staffing levels such as severance payments, with the remainder for consulting and other costs. Costs incurred are expected to be settled primarily in cash.
The total restructuring and related implementation costs, net associated with the Company’s streamlined operating model plan as reflected in the condensed consolidated statements of earnings and comprehensive income:
Three months ended
Inception to date ended
9/30/20239/30/20229/30/2023
Costs of products sold
$— $(1)$(3)
Selling and administrative expenses
— 112 
Research and development— — (1)
Other (income) expense, net:
Employee-related costs
— 1952 
Total, net
$— $19 $60 
Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the streamlined operating model, related processes and other professional fees incurred.
The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods.
7
NOTE 4. RESTRUCTURING AND RELATED COSTS (Continued)
The following table reconciles the accrual for the streamlined operating model’s restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets:
Employee-Related CostsOtherTotal
Accrual Balance as of June 30, 2023
$23 $5 $28 
Charges
— — — 
Cash payments(16)(5)(21)
Accrual Balance as of September 30, 2023$7 $— $7 

NOTE 5. INVENTORIES, NET
Inventories, net consisted of the following as of:
9/30/20236/30/2023
Finished goods$618 $595 
Raw materials and packaging178 182 
Work in process20 8 
LIFO allowances(104)(87)
Total inventories, net$712 $698 
Less: Non-current inventories, net (1)
2 2 
Total current inventories, net$710 $696 
(1)Non-current inventories, net are recorded in Other assets.
NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
Financial Risk Management and Derivative Instruments
The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.
Commodity Price Risk Management
The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and generally have original contractual maturities of less than 2 years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.
As of September 30, 2023, and June 30, 2023, the notional amount of commodity derivatives was $36 and $41, respectively, which related primarily to exposures in soybean oil used for the Food business and jet fuel used for the Grilling business.
Foreign Currency Risk Management
The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company’s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have original contractual maturities of less than 2 years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.
The notional amounts of outstanding foreign currency forward contracts used by the Company’s subsidiaries to hedge forecasted purchases of inventory were $55 and $51 as of September 30, 2023 and June 30, 2023, respectively.
Interest Rate Risk Management
8
NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)
The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have original contractual maturities of less than 3 years. The interest rate contracts are measured at fair value using information quoted by bond dealers.
The Company held no interest rate contracts as of both September 30, 2023 and June 30, 2023.
Commodity, Foreign Exchange and Interest Rate Derivatives
The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.
The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:
Gains (losses) recognized in Other comprehensive (loss) income
Three months ended
9/30/20239/30/2022
Commodity purchase derivative contracts$(1)$(3)
Foreign exchange derivative contracts1 1 
Interest rate derivative contracts— — 
Total$— $(2)

Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earningsGains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings
Three months ended
9/30/20239/30/2022
Commodity purchase derivative contractsCost of products sold$(2)$4 
Foreign exchange derivative contractsCost of products sold— 1 
Interest rate derivative contractsInterest expense3 3 
Total$1 $8 
The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of September 30, 2023 that is expected to be reclassified into Net earnings within the next twelve months is $13.
Counterparty Risk Management and Derivative Contract Requirements
The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions, $0 and $1 contained such terms as of September 30, 2023 and June 30, 2023, respectively. As of both September 30, 2023 and June 30, 2023, neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were exceeded.
Certain terms of the agreements governing the Company’s over-the-counter derivative instruments require the Company’s credit ratings, as assigned by Standard & Poor’s and Moody’s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company’s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both September 30, 2023 and June 30, 2023, the Company and each of its counterparties had been assigned investment grade ratings by both Standard & Poor’s and Moody’s.
Certain of the Company’s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company’s broker for trades conducted on that exchange. As of September 30, 2023 and June 30, 2023, the Company maintained cash margin balances
9
NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)
related to exchange traded futures and options contracts of $2 and $0, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.
Trust Assets
The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company’s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The gains and losses on the trust assets are recorded in Other (income) expense, net in the condensed consolidated statements of earnings. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.
Fair Value of Financial Instruments
Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
As of both September 30, 2023 and June 30, 2023, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.
All of the Company’s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:
 9/30/20236/30/2023
Balance sheet
classification		Fair value
hierarchy
level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Commodity purchase options contractsPrepaid expenses and other current assets1$— $— $2 $2 
Commodity purchase swaps contractsPrepaid expenses and other current assets21 1 — — 
Foreign exchange forward contractsPrepaid expenses and other current assets22 2 — — 
 $3 $3 $2 $2 
Liabilities
Commodity purchase futures contractsAccounts payable and accrued liabilities11 1 — — 
Commodity purchase swaps contractsAccounts payable and accrued liabilities2— — 1 1 
$1 $1 $1 $1 
10
NOTE 6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)
The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:
 9/30/20236/30/2023
Balance sheet
classification		Fair value
hierarchy
level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Interest-bearing investments, including money market funds
Cash and cash
equivalents (1)
1$388 $388 $243 $243 
Time deposits
Cash and cash
equivalents (1)
216 16 9 9 
Trust assets for nonqualified deferred compensation plansOther assets1137 137 129 129 
 $541 $541 $381 $381 
Liabilities
Notes and loans payable
Notes and loans payable (2)
2$347 $347 $50 $50 
Current maturities of long-term debt and Long-term debt
Current maturities of long-
term debt and Long-term
debt (3)
22,478 2,259 2,477 2,327 
$2,825 $2,606 $2,527 $2,377 
(1)Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.
(2)Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company’s credit agreements, all of which are recorded at cost, which approximates fair value.
(3)Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.

NOTE 7. INCOME TAXES
In determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was 14.6% and 25.0% for the three months ended September 30, 2023 and 2022, respectively. The lower tax rate on earnings was primarily driven by the impact of temporary relief provided by the Internal Revenue Service relating to U.S. foreign tax credit regulations.

NOTE 8. NET EARNINGS PER SHARE (EPS)
The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:
Three months ended
9/30/20239/30/2022
Basic123,973123,339
Dilutive effect of stock options and other677575
Diluted124,650123,914
Antidilutive stock options and other2,2202,983 
Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.
11

NOTE 9. COMPREHENSIVE INCOME
The following table provides a summary of Comprehensive income for the periods indicated:
Three months ended
9/30/20239/30/2022
Net earnings
$25 $87 
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments(11)(29)
Net unrealized gains (losses) on derivatives(1)(8)
Pension and postretirement benefit adjustments11 1 
Total other comprehensive (loss) income, net of tax(1)(36)
Comprehensive income
24 51 
Less: Total comprehensive income attributable to noncontrolling interests3 2 
Total comprehensive income attributable to Clorox
$21 $49 

NOTE 10. STOCKHOLDERS’ EQUITY
Changes in the components of Stockholders’ equity were as follows for the periods indicated:
Three months ended September 30
(Dollars in millions except per share data; shares in thousands)
Common stock
Additional paid-in capital
Retained earnings
Treasury stock
Accumulated
other
comprehensive
net (loss) income
Noncontrolling interests
Total stockholders’ equity
AmountShares AmountShares
Balance as of June 30, 2022$131 130,741 $1,202 $1,048 $(1,346)(7,589)$(479)$173 $729 
Net earnings— — — 85 — — — 2 87 
Other comprehensive (loss) income— — — — — — (36)— (36)
Dividends to Clorox stockholders ($2.36 per share declared)
— — — (293)— — — — (293)
Dividends to noncontrolling interests— — — — — — — (5)(5)
Stock-based compensation— — 10 — — — — — 10 
Other employee stock plan activities— — (19)(8)31 204 — — 4 
Balance as of September 30, 2022$131 130,741 $1,193 $832 $(1,315)(7,385)$(515)$170 $496 
Balance as of June 30, 2023$131 130,741 $1,245 $583 $(1,246)(6,921)$(493)$168 $388 
Net earnings (losses)— — — 22 — — — 3 25 
Other comprehensive (loss) income— — — — — — (1)— (1)
Dividends to Clorox stockholders ($2.40 per share declared)
— — — (300)— — — — (300)
Dividends to noncontrolling interests— — — — — — — (3)(3)
Stock-based compensation— — 13 — — — — — 13 
Other employee stock plan activities— — (12)(6)27 181 — — 9 
Balance as of September 30, 2023$131 130,741 $1,246 $299 $(1,219)(6,740)$(494)$168 $131 
12
NOTE 10. STOCKHOLDERS’ EQUITY (Continued)
Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
Three months ended September 30
Foreign currency translation adjustmentsNet unrealized gains (losses) on derivativesPension and postretirement benefit adjustmentsAccumulated other comprehensive net (loss) income
Balance as of June 30, 2022$(448)$121 $(152)$(479)
Other comprehensive (loss) income before reclassifications(29)(2)— (31)
Amounts reclassified from Accumulated other comprehensive net (loss) income— (8)1 (7)
Income tax benefit (expense)— 2 — 2 
Net current period other comprehensive (loss) income(29)(8)1 (36)
Balance as of September 30, 2022$(477)$113 $(151)$(515)
Balance as of June 30, 2023$(445)$99 $(147)$(493)
Other comprehensive (loss) income before reclassifications(11)— 11 — 
Amounts reclassified from Accumulated other comprehensive net (loss) income— (1)3 2 
Income tax benefit (expense), and other— — (3)(3)
Net current period other comprehensive (loss) income(11)(1)11 (1)
Balance as of September 30, 2023$(456)$98 $(136)$(494)

NOTE 11. EMPLOYEE BENEFIT PLANS
The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.
On May 17, 2022, the Company’s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of September 30, 2023.
In anticipation of this settlement, the Company remeasured the plan’s benefit obligation as of September 30, 2023, based on a discount rate of 5.0% which resulted in a net unrealized loss balance of $126, net of tax, ($165 before taxes) in Accumulated other comprehensive net (loss) income on its condensed consolidated balance sheet related to the Plan.
In the second quarter of fiscal year 2024, a one-time non-cash settlement charge of approximately $165 (before taxes) is expected to be recognized in the Company’s condensed consolidated statement of earnings and comprehensive income, related to these net unrealized losses, as plan obligations are settled through both lump sum payouts and annuity purchases. The actual amount of the settlement charge could vary based on the final valuation of assets and liabilities. On October 10, 2023, the Company completed the annuity purchase related to the pension plan termination. On October 31, 2023, the Company paid out the lump sum amounts related to the termination.
13
NOTE 11. EMPLOYEE BENEFIT PLANS (Continued)
The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:
Three months ended
9/30/20239/30/2022
Interest cost$5 $5 
Expected return on plan assets (1)
(3)(3)
Settlement loss recognized1 — 
Amortization of unrecognized items2 2 
Total$5 $4 
(1)The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2024 net periodic benefit cost is 3.5%.
The net periodic benefit cost for the Company’s retirement health care plans was $0 for both the three months ended September 30, 2023 and 2022.
During both the three months ended September 30, 2023 and 2022, the Company made $2 in contributions to its domestic retirement income plans.
Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs. All other components are reflected in Other (income) expense, net.
NOTE 12. OTHER CONTINGENCIES AND GUARANTEES
Contingencies
The Company is involved in certain environmental matters, including response actions at various locations. The Company recorded liabilities totaling $28 as of both September 30, 2023 and June 30, 2023, respectively, for its share of aggregate future remediation costs related to these matters.
One matter, which accounted for $12 of the recorded liability as of both September 30, 2023 and June 30, 2023, respectively, relates to environmental costs associated with one of the Company’s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing groundwater at the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study related to groundwater. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators. In January 2023, the regulators issued a new order directing the Company and the current property owner to conduct a Remedial Investigation and then prepare a Feasibility Study to evaluate and remediate impacts to soil, soil vapor and indoor air. While the Company believes its latest estimates of remediation costs (including any related to soil, soil vapor and indoor air impacts) are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs in the aggregate of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs.
Another matter in Dickinson County, Michigan, at the site of one of the Company’s former operations for which the Company is jointly and severally liable, accounted for $10 of the recorded liability as of both September 30, 2023 and June 30, 2023, respectively. This amount reflects the Company’s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company’s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time.
The Company’s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. From time to time, the Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings,
14
NOTE 12: OTHER CONTINGENCIES AND GUARANTEES (continued)
claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole.
Guarantees
In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole.
The Company had not recorded any material liabilities on the aforementioned guarantees as of both September 30, 2023 and June 30, 2023.
The Company was a party to letters of credit of $15 as of September 30, 2023, primarily related to its insurance carriers, of which $0 had been drawn upon.
NOTE 13. SEGMENT RESULTS
The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. Operating segments not aggregated into a reportable segment are reflected in Corporate and Other.
Corporate and Other includes certain non-allocated administrative costs and various other non-operating income and expenses, as well as the results of the Vitamins, Minerals and Supplements (VMS) business. Assets in Corporate and Other include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes, as well as the assets related to the VMS business.
The principle measure of segment profitability used by management is segment adjusted earnings (losses) before interest and income taxes (segment adjusted EBIT). Segment adjusted EBIT is defined as earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as charges relating to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability).
The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate and Other.
15
NOTE 13. SEGMENT RESULTS (Continued)
Net sales
Three months ended
9/30/20239/30/2022
Health and Wellness$504 $657 
Household325 423 
Lifestyle229 320 
International270 285 
Corporate and Other58 55 
Total$1,386 $1,740 
Segment adjusted EBIT
Three months ended
9/30/20239/30/2022
Health and Wellness$104 $133 
Household(4)22 
Lifestyle19 60 
International34 23 
Corporate and Other(62)(63)
Total$91 $175 
Interest income
10 2 
Interest expense
(21)(22)
Cyberattack costs (1)
(24)— 
Streamlined operating model (2)
— (19)
Digital capabilities and productivity enhancements investment (3)
(27)(20)
Earnings before income taxes
$29 $116 
(1)Represents incremental costs related to the cyberattack detailed in Note 2. For informational purposes the following table provides the approximate cyberattack costs corresponding to the Company’s reportable segments as a percentage of total costs:
Three months ended
9/30/2023
Health and Wellness22 %
Household11 
Lifestyle14 
International1 
Corporate and Other
52 
Total100 %
(2)Represents restructuring and related implementation costs, net for the streamlined operating model of $0 and $19 for the three months ended September 30, 2023 and 2022, respectively. For informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company’s reportable segments as a percentage of the total costs:
Three months endedThree months ended
Inception to date ended
9/30/20239/30/20229/30/2023
Health and Wellness— %6 %6 %
Household— — 1 
Lifestyle— 5 3 
International— 19 16 
Corporate and Other— 70 74 
Total— %100 %100 %
(3)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.
All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.
16
NOTE 13. SEGMENT RESULTS (Continued)
Net sales to the Company’s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 27% for both the three months ended September 30, 2023 and 2022.
The following table provides Net sales as a percentage of the Company’s consolidated net sales, disaggregated by operating segment, for the periods indicated:
Net sales
Three months ended
9/30/20239/30/2022
Cleaning32 %33 %
Professional Products4 5 
Health and Wellness36 %38 %
Bags and Wraps11 11 
Cat Litter8 8 
Grilling5 5 
Household24 %24 %
Food9 10 
Natural Personal Care3 4 
Water Filtration5 5 
Lifestyle17 %19 %
International19 %16 %
Corporate and Other4 
%
3 
%
Total100 %100 %
17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The Clorox Company
(Dollars in millions, except per share data)
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of The Clorox Company’s (the Company or Clorox) financial statements with a narrative from the perspective of management on the Company’s financial condition, results of operations, liquidity and certain other factors that may affect future results. The following discussion of the Company’s financial condition and results of operations should be read in conjunction with MD&A and the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023, which was filed with the SEC on August 10, 2023, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q (this Report). Unless otherwise noted, MD&A compares the three month period ended September 30, 2023 (the current period) to the three month period ended September 30, 2022 (the prior period), with percentage and basis point calculations based on rounded numbers, except for per share data and the effective tax rate.
EXECUTIVE OVERVIEW
The Clorox Company is a leading multinational manufacturer and marketer of consumer and professional products with approximately 8,700 employees worldwide. The Company has operations in approximately 25 countries or territories and sells its products in more than 100 markets, primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach, cleaning and disinfecting products, Pine-Sol® and Tilex® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Glad® bags and wraps; Fresh Step® cat litter; Kingsford® grilling products; Hidden Valley® dressings, dips, seasonings and sauces; Burt’s Bees® natural personal care products; Brita® water-filtration products; and Natural Vitality®, RenewLife®, NeoCell® and Rainbow Light® vitamins, minerals and supplements. The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names.
The Company primarily markets its leading brands in midsized categories considered to be financially attractive. Most of the Company’s products, which can be found in about nine of 10 U.S. homes, compete with other nationally advertised brands within each category and with “private label” brands. About 80% of the Company’s sales are generated from brands that hold the No. 1 or No. 2 market share position in their categories.
The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. Operating segments not aggregated into a reportable segment are reflected in Corporate and Other. The four reportable segments consist of the following:
•Health and Wellness consists of cleaning, disinfecting and professional products mainly marketed and sold in the United States. Products within this segment include home care cleaning products and laundry additives primarily under the Clorox®, Clorox2®, Pine-Sol, Scentiva®, Tilex, Liquid-Plumr, and Formula 409® brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; and professional food service products under the Hidden Valley brand.
•Household consists of bags and wraps, cat litter and grilling products marketed and sold in the United States. Products within this segment include bags and wraps under the Glad brand; cat litter primarily under the Fresh Step and Scoop Away® brands; and grilling products under the Kingsford brand.
•Lifestyle consists of food, natural personal care products and water-filtration products marketed and sold in the United States. Products within this segment include dressings, dips, seasonings and sauces, primarily under the Hidden Valley brand; natural personal care products under the Burt’s Bees brand; and water-filtration products under the Brita brand.
•International consists of products sold outside the United States. Products within this segment include laundry additives; home care products; water-filtration products; digestive health products; grilling products; cat litter; food; bags and wraps; natural personal care products; and professional cleaning and disinfecting products marketed primarily under the Clorox, Ayudin®, Clorinda®, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean® and Burt’s Bees brands.
18

RECENT EVENTS AFFECTING THE COMPANY
Cyberattack
On Monday, August 14, 2023, the Company disclosed it had identified unauthorized activity on some of its Information Technology (IT) systems. That activity began on Friday, August 11, 2023 and after becoming aware of it that evening, the Company immediately began taking steps to stop and remediate the activity. The Company also took certain systems offline and engaged third-party cybersecurity experts to support its investigation and recovery efforts. The Company implemented its business continuity plans, including manual ordering and processing procedures at a reduced rate of operations in order to continue servicing its customers. However, the incident resulted in wide-scale disruptions to the Company’s business operations throughout the remainder of the quarter.
The impacts of these system disruptions included order processing delays and significant product outages, resulting in a negative impact on net sales and earnings. The Company has since transitioned back to automated order processing and the vast majority of orders are taking place in an automated manner. The Company expects to experience ongoing, but lessening, operational impacts in the second quarter as it makes progress in returning to normalized operations.
The effects of the cyberattack are expected to negatively impact fiscal year 2024 results, though some of the anticipated net sales not recognized in the first quarter as a result of the disruptions are expected to be recognized in subsequent quarters of fiscal year 2024 as customers rebuild inventories.
The Company also incurred incremental expenses of approximately $24 as a result of the cyberattack for the three months ended September 30, 2023. These costs relate to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs incurred from the resulting disruption to the Company’s business operations. The Company expects to incur additional costs related to the cyberattack in future periods.
The Company has not recognized any insurance proceeds in the three months ended September 30, 2023 related to the cyberattack. The timing of recognizing insurance recoveries, if any, may differ from the timing of recognizing the associated expenses.
Other Recent Events
For the fiscal quarter ended September 30, 2023, the Company continued to experience an inflationary environment marked by persistently unfavorable commodity costs and higher manufacturing and logistics costs. Additionally, the Company is monitoring macroeconomic conditions as a result of increased interest rates and volatility in capital markets. These evolving challenges contributed to a highly dynamic operating environment as the Company continued its efforts to drive growth, rebuild margins and drive its transformation.
The risks of future negative impacts due to transportation, logistical or supply constraints and higher commodity costs for certain raw materials remain present, and the Company continues to experience corresponding incremental costs and gross margin pressures. For fiscal year 2024, the Company anticipates the operating environment will remain volatile and challenging. Inflationary headwinds are expected to continue and consumers may feel greater pressure as continued macroeconomic uncertainty impacts spending. The Company will continue to invest in its brands, capabilities and people to deliver consistent, profitable growth over time. The Company announced and began implementing a streamlined operating model in fiscal year 2023 and will continue with its implementation in fiscal year 2024.
The impact of continued inflationary pressures, macroeconomic conditions and geopolitical instability, including ongoing conflicts in the Middle East and Ukraine, rising tensions between China and Taiwan and actual and potential shifts in U.S. and foreign trade, economic and other policies, have increased global macroeconomic and political uncertainty regarding the duration and resolution of the conflicts, the potential escalation of tensions and potential economic and global supply chain disruptions. These factors are difficult to predict considering the rapidly evolving landscape as the Company continues to expect a variable operating environment going forward.
For further discussion, refer to Item 1.A, “Risk Factors” of this report and “Risk Factors” included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023.
19

RESULTS OF OPERATIONS
CONSOLIDATED RESULTS
Three months ended
9/30/20239/30/2022% Change
Net sales$1,386 $1,740 (20)%
Three months ended September 30, 2023
Percentage change versus the year-ago period
Reported (GAAP) Net Sales Growth / (Decrease)Reported VolumeAcquisitions & DivestituresForeign Exchange Impact
Price/Mix/ Other (1)
Organic Sales Growth / (Decrease) (Non-GAAP) (2)
Organic Volume (3)
Health and Wellness(23)%(29)%— %— %6 %(23)%(29)%
Household(23)(30)— — 7 (23)(30)
Lifestyle(28)(37)— — 9 (28)(37)
International(5)(13)— (14)22 9 (13)
Total Company (4)
(20)%(26)%— %(2)%8 %(18)%(26)%
(1)This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.
(2)Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See “Non-GAAP Financial Measures” below for reconciliation of organic sales growth / (decrease) to net sales growth / (decrease), the most directly comparable GAAP financial measure.
(3)Organic volume represents volume excluding the effect of any acquisitions and divestitures.
(4)Total Company includes Corporate and Other.
Net sales and volume in the current period decreased by 20% and 26%, respectively, primarily driven by lower volume resulting from the cyberattack. The variance between volume and net sales was primarily due to the impact of favorable price mix.
Three months ended
9/30/20239/30/2022% Change
Gross profit$532 $626 (15)%
Gross margin38.4 %36.0 %
Gross margin increased by 240 basis points in the current period from 36.0% to 38.4%. The increase was primarily driven by the benefit of pricing and cost savings, partially offset by the impact of lower volume.
Expenses
Three months ended
% of Net Sales
9/30/20239/30/2022% Change9/30/20239/30/2022
Selling and administrative expenses$276 $261 6 %19.9 %15.0 %
Advertising costs165 161 2 11.9 9.3 
Research and development costs29 32 (9)2.1 1.8 
Selling and administrative expenses, as a percentage of net sales, increased by 490 basis points in the current period versus the prior period. The increase in selling and administrative expenses as a percentage of net sales was primarily due to an arbitral decision relating to a commercial dispute, incremental costs associated with the cyberattack and the Company’s digital capabilities and productivity enhancements investment, partially offset by the benefit of cost savings primarily related to implementation of the streamlined operating model.
20
RESULTS OF OPERATIONS (Continued)
For further information regarding the cyberattack and the Company’s digital capabilities and productivity enhancements investment, see Non-GAAP Financial Measures.
Advertising costs, as a percentage of net sales, increased by 260 basis points in the current period versus the prior period as a result of lower net sales from the cyberattack, while dollars were essentially flat. The Company’s U.S. retail advertising spend as a percentage of net sales increased from 11% to 14% versus the prior period.
Research and development costs, both as a percentage of net sales and dollars, were essentially flat in the current period as compared to the prior period. The Company continues to invest behind product innovation and cost savings.
Interest expense, Other (income) expense, net and the effective tax rate on earnings
Three months ended
9/30/20239/30/2022
Interest expense21 $22 
Other (income) expense, net12 34 
Effective tax rate on earnings14.6 %25.0 %
Other (income) expense, net was $12 and $34 in the current and prior period, respectively. The variance was primarily due to restructuring and related implementation costs associated with the streamlined operating model incurred in the prior period.
Restructuring and related costs
In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company’s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.
Once fully implemented, the Company expects annual cost savings to be approximately $75 to $100 annually, with benefits of $35 realized in fiscal year 2023 and benefits of approximately $45 to $50 anticipated in fiscal year 2024. The benefits of the streamlined operating model are currently expected to increase future cash flows as a result of cost savings that will be generated primarily in the areas of selling and administration, supply chain, marketing and research and development.
The Company incurred $60 of costs in fiscal year 2023 and anticipates incurring approximately $30 to $40 of costs in fiscal year 2024 related to this initiative of which approximately $10 to $15 are expected to be employee-related costs to reduce certain staffing levels such as severance payments, with the remainder for consulting and other costs. Costs incurred are expected to be settled primarily in cash.
Restructuring and related implementation costs, net were $0 for the three months ended September 30, 2023. Restructuring and related implementation costs, net were $19 for the three months ended September 30, 2022, of which $16 was related to employee-related costs and $3 was related to other costs. For further details on the streamlined operating model and restructuring, refer to the notes to condensed consolidated financial statements.
The effective tax rate on earnings was 14.6% for the current period and 25.0% for the prior period. The lower tax rate on earnings was primarily driven by the impact of temporary relief provided by the Internal Revenue Service relating to U.S. foreign tax credit regulations.
Diluted net earnings per share
Three months ended
9/30/20239/30/2022% Change
Diluted net earnings per share$0.17 $0.68 (75)%
Diluted net earnings per share (EPS) decreased by $0.51, or 75%, in the current period, primarily due to the impact of lower volume, partially offset by the benefits of pricing and cost savings.
21

SEGMENT RESULTS
The following presents the results of the Company’s reportable segments and Corporate and Other (see notes to condensed consolidated financial statements for further discussion of the principle measure of segment profitability used by management, segment adjusted earnings (losses) before interest and income taxes (segment adjusted EBIT)):
Net sales
Three months ended
9/30/20239/30/2022
Health and Wellness$504 $657 
Household325 423 
Lifestyle229 320 
International270 285 
Corporate and Other58 55 
Total$1,386 $1,740 
Segment adjusted EBIT (1)
Three months ended
9/30/20239/30/2022
Health and Wellness$104 $133 
Household(4)22
Lifestyle1960
International3423
Corporate and Other(62)(63)
Total$91 $175 
Interest income102
Interest expense(21)(22)
Cyberattack costs
(24)—
Streamlined operating model
—(19)
Digital capabilities and productivity enhancements investment(27)(20)
Earnings before income taxes
$29 $116 
(1)See “Non-GAAP Financial Measures” below for reconciliation of segment adjusted EBIT to earnings (losses) before income taxes, the most directly comparable GAAP financial measure.
Health and Wellness
Three months ended
9/30/20239/30/2022% Change
Net sales$504 $657 (23)%
Segment adjusted EBIT104 133 (22)
Volume, net sales and segment adjusted EBIT decreased by 29%, 23% and 22% respectively, during the current period. The volume and net sales decreases were primarily due to operational disruptions resulting from the cyberattack. The variance between volume and net sales was primarily due to the benefit of price increases. The decrease in segment adjusted EBIT in the current period was primarily due to lower volume partially offset by the benefits of pricing.
Household
Three months ended
9/30/20239/30/2022% Change
Net sales$325 $423 (23)%
Segment adjusted EBIT(4)22 (118)
22
SEGMENT RESULTS (Continued)
Volume, net sales and segment adjusted EBIT decreased by 30%, 23% and 118%, respectively, during the current period. The volume and net sales decreases were primarily due to operational disruptions resulting from the cyberattack. The variance between volume and net sales was primarily due to the benefit of price increases. The decrease in segment adjusted EBIT was mainly due to lower volume, partially offset by cost savings and the benefit of pricing.
Lifestyle
Three months ended
9/30/20239/30/2022% Change
Net sales$229 $320 (28)%
Segment adjusted EBIT19 60 (68)

Volume, net sales and segment adjusted EBIT decreased by 37%, 28% and 68% respectively, during the current period. The volume and net sales decreases were primarily due to operational disruptions resulting from the cyberattack. The variance between volume and net sales was mainly due to the benefit of mix and price increases. The decrease in segment adjusted EBIT was due to lower volume partially offset by lower manufacturing and logistics costs.
International
Three months ended
9/30/20239/30/2022% Change
Net sales$270 $285 (5)%
Segment adjusted EBIT34 23 48 
Volume and net sales decreased by 13% and 5% respectively, and segment adjusted EBIT increased by 48% during the current period. The volume decrease was primarily due to operational disruptions resulting from the cyberattack. The variance between volume and net sales was mainly due to the benefit of price increases, partially offset by unfavorable foreign currency exchange rates. The increase in segment adjusted EBIT was primarily due to the net impact of pricing, partially offset by unfavorable foreign currency exchange rates and lower volume.
Argentina
Effective July 1, 2018, under the requirements of U.S. GAAP, Argentina was designated as a highly inflationary economy, and as a result the U.S. dollar replaced the Argentine peso as the functional currency of the Company’s subsidiaries in Argentina. Consequently, gains and losses from non-U.S. dollar denominated monetary assets and liabilities of Clorox Argentina are recognized in Other (income) expense, net in the condensed consolidated statement of earnings, utilizing the official Argentine government exchange rate.
The business environment in Argentina continues to be challenging due to significant volatility in Argentina’s currency, high inflation, economic recession and temporary price controls. As of September 30, 2023 and June 30, 2023, the net asset position, excluding goodwill, of Clorox Argentina was $44 and $48, respectively. Of these net assets, cash balances were approximately $23 and $28 as of September 30, 2023 and June 30, 2023, respectively. Net sales from Clorox Argentina represented approximately 2% of the Company’s consolidated net sales for both the three months ended September 30, 2023 and the fiscal year ended June 30, 2023.
For additional information on the impacts of, and our response to, the business environment in Argentina, refer to “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023.
Corporate and Other
Corporate and Other includes certain non-allocated administrative costs, the VMS business and various other non-operating income and expenses.
Three months ended
9/30/20239/30/2022% Change
Net Sales
$58 $55 5 %
Segment adjusted EBIT(62)(63)(2)
23
SEGMENT RESULTS (Continued)
Net sales increased by 5% due to higher net sales in the VMS business. Segment adjusted EBIT was essentially flat for the period. 
FINANCIAL POSITION AND LIQUIDITY
The Company’s financial condition and liquidity remained strong as of September 30, 2023. The following table summarizes cash activities:
Three months ended
9/30/20239/30/2022
Net cash provided by operations$20 $178 
Net cash used for investing activities(23)(45)
Net cash provided by (used for) financing activities
155 (35)
Operating Activities
Net cash provided by operations was $20 in the current three month period, compared with $178 in the prior three month period. The decrease was primarily driven by higher employee incentive compensation paid in the current three month period and lower cash earnings in the current three month period, partially offset by lower working capital. The lower cash earnings and decrease in working capital in the current three month period, primarily due to lower Accounts Receivable, were a result of the operational disruption due to the cyberattack.
Payment Terms Extension and Supply Chain Financing
The Company initiated the extension of its payment terms with its suppliers in the second half of fiscal year 2020 in order to improve working capital as part of and to fund the IGNITE strategy and in keeping with evolving market practices. The Company’s current payment terms do not exceed 120 days in keeping with industry standards. The Company’s operating cash flows are directly impacted as a result of the extension of the payment terms with the suppliers.
As part of those ongoing efforts, the Company has arranged for a global financial institution to offer a voluntary supply chain finance (SCF) program for the benefit of the Company’s suppliers. There would not be an expected material impact to the Company’s liquidity or capital resources if the financial institution or a supplier terminated the SCF arrangement. While the Company does not have direct access to information on, or influence over, which invoices a participating supplier elects to sell to the financial institution, the Company expects that the majority of these amounts have been sold to the financial institution. Refer to the notes to the condensed consolidated financial statements for detail on the SCF program.
Investing Activities
Net cash used for investing activities was $23 in the current three month period, compared with $45 in the prior three month period. The year-over-year decrease was mainly due to the timing of payments in the current three month period as a result of the operational disruption due to the cyberattack.
Financing Activities
Net cash provided by financing activities was $155 in the current three month period, compared with net cash used for financing activities of $35 in the prior three month period. The year-over-year increase was mainly due to higher cash sourced from short term borrowings in the current three month period.
Capital Resources and Liquidity
The Company's current liabilities may periodically exceed current assets as a result of the Company's debt management policies, including the Company's use of commercial paper borrowings which fluctuates depending on the amount and timing of operating and investing cash flows and payments for shareholder transactions such as dividends. The Company continues to take actions to address some of the effects of such cost increases, which include implementing price increases, driving cost savings and optimizing the Company’s supply chain.
Notwithstanding potential unforeseen adverse market conditions and as part of the Company’s regular assessment of its cash needs, the Company believes it will have the funds necessary to support its short- and long-term liquidity and operating needs, including the costs related to the announced streamlined operating model and its digital capabilities and productivity enhancements investment, as well as the costs and impacts of the business disruption associated with the cyberattack, based on our anticipated ability to generate positive cash flows from operations in the future, access to capital markets enabled by our strong short-term and long-term credit ratings and current borrowing availability.
24
FINANCIAL POSITION AND LIQUIDITY (Continued)
Credit Arrangements
As of September 30, 2023, the Company maintained a $1,200 revolving credit agreement that matures in March 2027 (the Credit Agreement). There were no borrowings under the Credit Agreement as of September 30, 2023 and June 30, 2023, and the Company believes that borrowings under the Credit Agreement are and will continue to be available for general corporate purposes. The Credit Agreement includes certain restrictive covenants and limitations. The primary restrictive covenant is a minimum ratio of 4.0, calculated as total earnings before interest, taxes, depreciation and amortization and other similar non-cash charges and certain other items (Consolidated EBITDA) to total interest expense for the trailing four quarters (Interest Coverage ratio), as defined and described in the Credit Agreement.
The Company was in compliance with all restrictive covenants and limitations in the Credit Agreement as of September 30, 2023 and anticipates being in compliance with all restrictive covenants for the foreseeable future.
As of September 30, 2023, the Company maintained $33 of foreign and other credit lines, of which $11 was outstanding.
Stock Repurchases and Dividend Payments
As of September 30, 2023, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date. There were no share repurchases of common stock during the three months ended September 30, 2023 and 2022.
Dividends per share declared and total dividends paid to Clorox stockholders were as follows for the periods indicated:
Three months ended
9/30/20239/30/2022
Dividends per share declared$2.40 $2.36 
Total dividends paid149 145 

CONTINGENCIES
See notes to condensed consolidated financial statements for information on the Company’s contingencies.

RECENTLY ISSUED ACCOUNTING STANDARDS
See notes to condensed consolidated financial statements for a summary of recently issued accounting standards relevant to the Company.

25

NON-GAAP FINANCIAL MEASURES
The non-GAAP financial measures that are included in this MD&A and the reasons management believes they are useful to investors are described below. These measures should be considered supplemental in nature and are not intended to be a substitute for the related financial information prepared in accordance with U.S. GAAP. In addition, these measures may not be the same as similarly named measures presented by other companies.
Adjusted earnings (losses) before interest and income taxes (adjusted EBIT) represents earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as incremental costs related to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability). The Company uses this measure to assess the operating results and performance of its segments, perform analytical comparisons, identify strategies to improve performance, and allocate resources to each segment. Management believes that the presentation of adjusted EBIT is useful to investors to assess operating performance on a consistent basis by removing the impact of the items that management believes does not directly reflect the performance of each segment's underlying operations. Adjusted EBIT margin is the ratio of adjusted EBIT to net sales.
Reconciliation of earnings (losses) before income taxes to adjusted EBIT
Three months ended
9/30/20239/30/2022
Earnings (losses) before income taxes$29 $116 
Interest income(10)(2)
Interest expense21 22 
Cyberattack costs (1)
24 — 
Streamlined operating model (2)
— 19 
Digital capabilities and productivity enhancements investment (3)
27 20 
Adjusted EBIT$91 $175 
(1)Represents incremental costs incurred as a result of the cyberattack the Company experienced in the first quarter of fiscal year 2024. Due to the nature, scope and magnitude of these costs, the Company’s management believes presenting theses costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the Company’s operations and is useful for period over period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by Company management. See notes to condensed consolidated financial statements for additional information.
(2)Represents restructuring and related implementation costs, net for the streamlined operating model. Due to the nonrecurring and unusual nature of these costs, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period over period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management. See notes to condensed consolidated financial statements for additional information.
(3)Represents expenses related to the Company's digital capabilities and productivity enhancements investment. Due to the nature, scope and magnitude of this investment, these costs are considered by management to represent incremental transformational costs above the historical normal level of spending for information technology to support operations. Since these strategic investments, including incremental operating costs, will cease at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the company's underlying operating performance, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.
Of the total $500 million investment, approximately 65% is expected to represent incremental operating costs primarily recorded within selling and administrative expenses to be adjusted from reported Earnings (losses) before income taxes for purposes of disclosing adjusted EBIT over the course of the next five years. About 70% of these operating costs are expected to be related to the implementation of the ERP, with the remaining costs primarily related to the implementation of complementary technologies.
During the three months ended September 30, 2023 and 2022, the Company incurred approximately $27 and $20, respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following:
Three months ended
9/30/20239/30/2022
External consulting fees (1)
$21 $16 
IT project personnel costs (2)
2 1 
Other (3)
4 3 
Total$27 $20 
26
NON-GAAP FINANCIAL MEASURES (Continued)
(1)Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The Company relies on consultants for certain capabilities required for these programs that the Company does not maintain internally. These costs support the implementation of these programs incremental to the Company's normal IT costs and will not be incurred following implementation.
(2)Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the Company considers these costs not reflective of the ongoing costs to operate its business.
(3)Comprised of various other expenses associated with the Company’s new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses.
Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions and divestitures. Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the Company was operating and expects to continue to operate throughout the relevant periods, and the Company’s estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the Company and management.
The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:
Three months ended September 30, 2023
Percentage change versus the year-ago period
Health and WellnessHouseholdLifestyleInternational
Total Company (1)
Net sales growth / (decrease) (GAAP)(23)%(23)%(28)%(5)%(20)%
Add: Foreign Exchange— — — 14 2 
Add/(Subtract): Divestitures / Acquisitions— — — — — 
Organic sales growth / (decrease) (non-GAAP)(23)%(23)%(28)%9 %(18)%
(1)Total Company includes Corporate and Other.
Cautionary Statement
This Report, including the exhibits hereto and the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements regarding the expected or potential impact of the Company’s operational disruption stemming from a cyberattack, and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023, and in this Report, as updated from time to time in the Company’s Securities and Exchange Commission filings. These factors include, but are not limited to:
•unfavorable general economic and geopolitical conditions beyond our control, including supply chain disruptions, labor shortages, wage pressures, rising inflation, the interest rate environment, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including ongoing conflicts in the Middle East and Ukraine and rising tensions between China and Taiwan, as well as macroeconomic and geopolitical volatility and uncertainty as a result of a number of these and other factors, including actual and potential shifts between the U.S. and its trading partners, especially China;
27
CAUTIONARY STATEMENT (Continued)
•volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services;
•the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences;
•the ability of the Company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix;
•risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers;
•intense competition in the Company’s markets;
•risks related to the Company’s use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, business, service or operational disruptions, or that impact the Company’s financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings;
•the ability of the Company to implement and generate cost savings and efficiencies, and successfully implement its transformational initiatives or strategies, including achieving anticipated benefits and cost savings from the implementation of the streamlined operating model and digital capabilities and productivity enhancements;
•dependence on key customers and risks related to customer consolidation and ordering patterns;
•the Company’s ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as wage inflation and sustained labor shortages;
•the Company’s ability to maintain its business reputation and the reputation of its brands and products;
•lower revenue, increased costs or reputational harm resulting from government actions and compliance with regulations, or any material costs imposed by changes in regulation;
•changes to our processes and procedures as a result of our digital capabilities and productivity enhancements investment that may result in changes to the Company’s internal controls over financial reporting;
•the ability of the Company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity;
•risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; continued high levels of inflation in Argentina; potential operational or supply chain disruptions from wars and military conflicts, including the conflict in Ukraine; impact of the United Kingdom’s exit from the European Union; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action;
•the impact of Environmental, Social, and Governance (ESG) issues, including those related to climate change and sustainability on our sales, operating costs or reputation;
•the ability of the Company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries;
•the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls;
•the COVID-19 pandemic and related impacts, including on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the Company’s products, including any significant disruption to such systems; on the demand for and sales of the Company’s products; and on worldwide, regional and local adverse economic conditions;
28
CAUTIONARY STATEMENT (Continued)
•risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill, in particular the impairment charges related to the carrying value of the Company’s VMS business; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions;
•the accuracy of the Company’s estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based;
•risks related to increases in the estimated fair value of P&G’s interest in the Glad business;
•environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances;
•the Company’s ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the Company of third-party intellectual property rights;
•the performance of strategic alliances and other business relationships;
•the effect of the Company’s indebtedness and credit rating on its business operations and financial results and the Company’s ability to access capital markets and other funding sources, as well as the cost of capital to the Company;
•the Company’s ability to pay and declare dividends or repurchase its stock in the future;
•the impacts of potential stockholder activism; and
•risks related to any litigation associated with the exclusive forum provision in the Company’s bylaws.
The Company’s forward-looking statements in this Report are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
In this Report, unless the context requires otherwise, the terms “the Company,” “Clorox,” “we,” “us,” and “our” refer to The Clorox Company and its subsidiaries.
29

Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have not been any material changes to the Company’s market risk since June 30, 2023. For additional information, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Exhibit 99.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

Item 4. Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
On Monday, August 14, 2023, the Company disclosed it had identified unauthorized activity on some of its Information Technology (IT) systems; see Note 2 in the condensed consolidated financial statements in this Report. That activity began on Friday, August 11, 2023 and after becoming aware of it that evening, the Company immediately began taking steps to stop and remediate the activity. The Company also took certain systems offline and engaged third-party cybersecurity experts to support its investigation and recovery efforts. The Company implemented its business continuity plans, including manual ordering and processing procedures at a reduced rate of operations in order to continue servicing its customers. However, the incident resulted in wide-scale disruptions to the Company’s business operations throughout the remainder of the quarter.
During the disruptions caused by the cyberattack, we deployed additional interim controls in response to taking certain systems offline during the period to maintain our internal control over financial reporting.
Other than the additional interim controls and procedures implemented in connection with the execution of the Company’s existing business continuity plans as a result of the cyberattack discussed above, no change in the Company’s internal control over financial reporting occurred during the first fiscal quarter of the fiscal year ending June 30, 2024, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

30

PART II – OTHER INFORMATION
Item 1.A. Risk Factors
For information regarding Risk Factors, please refer to Item 1.A. in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023, as supplemented by the following revised risk factor, and the information in “Cautionary Statement” included in this Report.
Failure of key technology systems, cyberattacks, privacy breaches or data breaches could have a material adverse effect on the Company’s business, financial condition, results of operations and reputation.
To conduct its business, the Company relies extensively on information and operational technology systems, many of which are managed, hosted, provided and/or used by third parties and their vendors. These systems include, but are not limited to, programs and processes relating to communicating within the Company and with customers, consumers, vendors, investors and other parties; ordering and managing materials from suppliers; converting materials to finished products; receiving and processing purchase orders and shipping products to customers; processing transactions; storing, processing and transmitting data, including personal confidential information and payment card industry data; hosting, processing and sharing confidential and proprietary research, business and financial information; and complying with financial reporting, regulatory, legal and tax requirements. Furthermore, the Company sells certain of its natural personal care products, vitamins, minerals, supplements and other products directly to consumers online and through websites, mobile apps and connected devices, and the Company also engages in online activities, including promotions, rebates and customer loyalty and other programs, through which it may receive personal information. Through the use of any of these information and operational technology systems or processes, the Company or its vendors have in the past and could in the future again experience cyberattacks, privacy breaches, data breaches or other incidents that may result in unauthorized access, disclosure and misuse of consumer, customer, employee, vendor or Company information, especially as the Company continues operating under a hybrid working model under which employees can work and access the Company’s technology infrastructure remotely. A breach or other breakdown in the Company’s technology, including a cyberattack, privacy breach, data breach or other incident involving the Company or any of the Company's third-party service providers or vendors could adversely affect the Company’s financial condition and results of operations.
On August 14, 2023, the Company disclosed that it had identified unauthorized activity on some of its IT systems and took immediate steps to stop and remediate the activity, including taking certain systems offline. The Company implemented its business continuity plans, including manual ordering and processing procedures at a reduced rate of operations in order to continue servicing its customers, which resulted in an elevated level of consumer product availability issues.
Based on the information currently available, the Company believes the cyberattack is contained due to the steps the Company has taken to address the incident. However, due to the order processing delays and elevated level of product outages, the incident has negatively impacted the Company's fiscal first quarter financial results, and is expected to negatively impact its fiscal 2024 financial results. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. Based on its current assessment of the situation, the Company expects to experience ongoing, but lessening, operational impacts in the fiscal second quarter as it makes progress in returning to normalized operations. The cyberattack may also lead to additional regulatory scrutiny or litigation exposure.
The cyberattack also damaged portions of the Company’s IT infrastructure, which caused wide-scale disruption of the Company’s operations. The Company is repairing its infrastructure and is reintegrating the systems that it took offline. For more information regarding this incident, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Note 2. Cyberattack”.
In addition to repairing its infrastructure as a result of the cyberattack, the Company is in the process of a multi-year phased upgrade of its digital capabilities, including enhancing operating efficiencies and transitioning to a cloud-based platform, as well as replacing its enterprise resource planning system. It also uses various other hardware, software and operating systems that may need to be upgraded or replaced in the near future as such systems cease to be supported by third-party service providers, and may be vulnerable to increased risks, including the risk of further security breaches, system failures and disruptions. Any such upgrade could take time, oversight and be costly to the Company, and may include potential challenges, such as the cost of training personnel, migration of data, the potential instability of the new system and cost overruns. If such systems are not successfully upgraded or replaced in a timely manner, system outages, disruptions or delays, or other issues may arise. If a new system does not function properly or is not adequately supported by third-party service providers and processes, it could adversely affect the Company’s business and operations, which, in turn, could adversely impact the Company’s results of operations and cash flows.
Despite the security measures the Company has in place, the information and operational technology systems, including those of our customers, vendors, suppliers and other third-party service providers with whom we have contracted, have, in the past,
31
ITEM 1.A. RISK FACTORS (Continued)
and may, in the future, be vulnerable to cyber-threats such as computer viruses or other malicious codes, security breaches, unauthorized access, phishing attacks and other disruptions from employee error, unauthorized uses, system failures, including Internet outages, unintentional or malicious actions of employees or contractors or cyberattacks by hackers, criminal groups, nation-states and nation-state-sponsored organizations and social-activist organizations. The Company’s information and operational technology systems and its third-party providers’ systems, have been, and will continue to be, subject to cyber-threats such as computer viruses or other malicious codes, ransomware, unauthorized access attempts, business email compromise, cyber extortion, denial of service attacks, phishing, social engineering, hacking and other cyberattacks attempting to exploit vulnerabilities. The Company has seen and may continue to see an increase in the number of such attacks, especially as the Company continues operating under a hybrid working model under which employees can work and access the Company’s technology infrastructure remotely. In addition, while we have purchased cybersecurity insurance, costs related to a cyberattack may exceed the amount of insurance coverage or be excluded under the terms of our cybersecurity insurance policy. As cyberattacks increase in frequency and magnitude, we may be unable to obtain cybersecurity insurance in amounts and on terms we view as appropriate for our operations.
The Company’s security efforts and the efforts of its third-party providers may not prevent or timely detect future attacks and resulting breaches or breakdowns of the Company’s, or its third-party service providers’, databases or systems. In addition, if the Company or its third-party providers are unable to effectively resolve such breaches or breakdowns on a timely basis, the Company may experience interruptions in its ability to manage or conduct business, as well as reputational harm, governmental fines, penalties, regulatory proceedings, and litigation and remediation expenses. In addition, such incidents could result in unauthorized disclosure and misuse of material confidential information, including personal identifying information.
Cyber-threats are becoming more sophisticated, are constantly evolving and are being made by groups and individuals with a wide range of expertise and motives, and this increases the difficulty of detecting and successfully defending against them. We have incurred, and will continue to incur, expenses to comply with privacy and data protection standards and protocols imposed by law, regulation, industry standards and contractual obligations. Increased regulation of data collection, use, and retention practices, including self-regulation and industry standards, changes in existing laws and regulations, including reporting requirements, enactment of new laws and regulations, increased enforcement activity, and changes in interpretation of laws, could increase our cost of compliance and operation, limit our ability to grow our business or otherwise harm our business.
In addition, data breaches or theft of personal information collected by the Company and its third-party service providers as well as data breaches or theft of Company information and assets have occurred in the past and may occur in the future. The Company is subject to the laws and regulations of various countries where it operates or does business related to solicitation, collection, processing, transferring, storing or use of consumer, customer, vendor or employee information or related data. These laws and regulations change frequently, and new legislation continues to be introduced and may be interpreted and applied differently from jurisdiction to jurisdiction and may create inconsistent or conflicting requirements. The changes introduced by data privacy and protection regulations increase the complexity of regulations enacted to protect business and personal data and they subject the Company to additional costs and have required, and may in the future require, costly changes to the Company’s security systems, policies, procedures and practices. These laws and regulations also may result in the Company incurring additional expenses and liabilities in the event of unauthorized access to or disclosure of personal data.
These risks also may be present to the extent any of our partners, distributors, joint venture partners or suppliers using separate information or operational technology systems, not integrated with the systems of the Company, suffers a cyberattack and could result in increased costs related to our involvement in investigations or notifications conducted by these third parties. These risks may also be present to the extent a business we have acquired, that does not use our information or operational technology systems, experiences a system shutdown, service disruption, or cyberattack.
32

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
In May 2018, the Board of Directors authorized the Company to repurchase up to $2,000 million in shares of common stock on the open market (the 2018 Open-Market Program), which has no expiration date.
In August 1999, the Board of Directors authorized a stock repurchase program to reduce or eliminate dilution upon the issuance of common stock pursuant to the Company’s stock compensation plans (the Evergreen Program). In November 2005, the Board of Directors authorized the extension of the Evergreen Program to reduce or eliminate dilution in connection with issuances of common stock pursuant to the Company’s 2005 Stock Incentive Plan. The Evergreen Program has no expiration date and has no specified limit as to dollar amount and therefore is not included in column [d] below.
The following table sets forth the purchases of the Company’s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the first quarter of fiscal year 2024.
[a][b][c][d]
PeriodTotal Number of
Shares Purchased
Average Price Paid
per Share (1)
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs		Maximum Number (or
Approximate Dollar
Value) of Shares that
May Yet Be Purchased
Under the Plans or
Programs
July 1 to 31, 2023— $— — $993 million
August 1 to 31, 2023— — — $993 million
September 1 to 30, 2023— — — $993 million
Total— $— — 
(1)Average price paid per share in the period includes commission.

Item 5. Other Information
During the three months ended September 30, 2023, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange act or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(c) of Regulation S-K.

33

Item 6. Exhibits
See Exhibit Index below, which is incorporated by reference herein.
EXHIBIT INDEX
Exhibit Number
Exhibit Description
10.1
31.1
31.2
32
101.SCHXBRL Taxonomy Extension Schema Document.
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.
101.LABXBRL Taxonomy Extension Label Linkbase Document.
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).
34

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE CLOROX COMPANY
(Registrant)
DATE: November 1, 2023BY/s/ Laura Peck
Laura Peck
Vice President – Chief Accounting Officer and Corporate Controller

35
 EX-10.1 2 clxq1fy24ex101annualincent.htm EX-10.1 Document

Exhibit 10.1
THE CLOROX COMPANY
ANNUAL INCENTIVE PLAN

As Amended and Restated Effective
as of September 20, 2023 (the “Effective Date”)
1.Purpose.
The purpose of The Clorox Company Annual Incentive Plan (the “Plan”) is to attract and retain the best available personnel for positions of substantial responsibility and to provide an incentive for employees of The Clorox Company, a Delaware corporation (the “Company”) and its subsidiaries and to recognize and reward those employees. The Company’s executives are eligible to earn short-term cash incentive awards under this Plan.
2.Definitions. The following terms will have the following meaning for purposes of the Plan:
(a)“Award” means a bonus paid in cash under the Plan.
(b)“Board” means the Board of Directors of the Company.
(c)“Chief Executive Officer” means the chief executive officer of the Company.
(d)“Chief People Officer” means the officer of the Company responsible for the Company’s human resources matters, which position is presently held by the Executive Vice President - Chief People and Corporate Affairs Officer of the Company.
(e)“Code” means the Internal Revenue Code of 1986, as amended.
(f)“Committee” means the Management Development and Compensation Committee of the Board, or such other Committee designated by the Board to administer the Plan.
(g)“Employee” means any person employed by the Company or any Subsidiary.
(h)“Executive Committee” means the executives who are members of the Company’s management executive committee.
(i)“Mid-Year Participant” means (i) an individual who becomes an Employee on or following the date that full-year Awards are granted for a Year and who is selected by the Committee to participate in the Plan during such Year or (ii) an Employee previously selected by the Committee to participate in the Plan for the Year who is subsequently promoted during such Year. For avoidance of doubt, this shall include an Employee who is promoted to a position which is eligible for participation in the Plan.
(j)“Participant” means an Employee selected by the Committee to participate in the Plan (including, for the avoidance of doubt, a Mid-Year Participant).
(k)“Retirement” means termination of employment with the Company, other than by reason of death or disability, of a Participant after (1) attaining age 65, (2) attaining age 55 with at least ten years of vesting service, which solely for purposes of this Plan, shall be calculated under Article III of The Clorox Company 401(k) Plan (the “401(k) Plan”) entitled “Service” along with any other relevant provisions of the 401(k) Plan necessary or desirable to give full effect thereto, or any successor provisions, regardless of the status of the Participant with respect to the 401(k) Plan (“Vesting Service”) or (3) 20 or more years of Vesting Service.
(l)“Section 409A” means Section 409A of the Code and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.
(m)“Subsidiary” means any corporation in which the Company, directly or indirectly, controls 50 percent or more of the total combined voting power of all classes of stock.


(n)“Vice President” means a regular salaried Employee scheduled to work more than 20 hours per week who is in salary grade 30 or above and who is not a member of the Executive Committee, but is a Vice President.
(o)“Year” means a fiscal year of the Company.
3.Awards.
(a)Within 180 days after the beginning of each Year, the Committee will select Participants for the Year and establish in writing the method by which the Awards will be calculated for that Year; provided, that, with respect to Participants who are Mid-Year Participants, the Committee shall determine the method by which the Awards to such individuals will be calculated for the Year during which they are hired or promoted, as applicable, as soon as administratively practicable following their commencement of employment or promotion, as applicable, including whether or not the Award for such Year will be prorated. The Committee may provide for payment of all or part of the Award in the case of Retirement, death, disability or change of ownership of control of the Company or a Subsidiary during the Year in accordance with Section 409A. In addition, the Committee may provide for payment of all or part of the Award, including a prorated payment of the Award, in the event of (1) all other terminations of employment during the Year, (2) placement on medical or other leave of absence from the Company or (3) hiring or promotions during the Year in accordance with Section 409A.
(b)For the Chief Executive Officer and the Executive Committee, the Committee shall determine and certify the amount of the Award, if any, to be made. The Committee may decrease or eliminate any Award calculated under the methodology established in accordance with paragraph (a) in order to reflect additional considerations relating to performance.
(c)For Vice Presidents and all other participants, the Chief Executive Officer shall determine and certify the amount of the Award, if any, to be made. The Chief Executive Officer may increase, decrease or eliminate, any Award calculated under the methodology established in accordance with paragraph (a) in order to reflect additional considerations relating to performance.
(d)Awards will be paid to the Participants following certification and no later than ninety (90) days following the close of the Year with respect to which the Awards are made, unless all or a portion of a Participant’s Award is deferred pursuant to the Participant’s timely and validly made election made in accordance with such terms as the Company, the Board , Committee (or other committee of the Board) may determine. A timely election is one that satisfies the requirements of Section 409A and typically for performance-based compensation must be made at least six months before the end of the performance period, provided that the Participant performs services continuously from the later of the beginning of the performance period or the date the performance criteria are established through the date an election is made and provided further that in no event may a deferral be made after such compensation has become readily ascertainable as set forth in Section 409A.
(e)The Company shall withhold from the payment of any Award hereunder any amount required to be withheld for taxes.
(f)In the event of a restatement of the Company’s financial results to correct a material error resulting from fraud or intentional misconduct, as determined by the Board or the Committee, the Board, or the Committee, will review all compensation that was made pursuant to this Plan on the basis of having met or exceeded specific performance targets for performance periods beginning after June 30, 2008 which occur during the years for which financial statements are restated. If a lower payment of performance-based compensation would have been made to the Participants based upon the restated financial results, the Board or the Committee, as applicable, will, to the extent permitted by governing law and subject to the following sentence, seek to recoup for the benefit of the Company the amount by which the individual Participant’s Award(s) for the restated years exceeded the lower payment that would have been made based on the restated financial results, plus a reasonable rate of interest; provided, however, that neither the Board nor the Committee will seek to recoup Awards paid more than three years prior to the date on which the Company announces the need for the applicable financial statements to be restated. The Board, or the Committee, will only seek to recoup Awards paid to Participants whose fraud or intentional misconduct was a significant contributing factor to the need for such restatement, as determined by the Board or the Committee, as applicable. Notwithstanding the foregoing, this Section 3(f) shall not apply to Participants who are “Covered Employees” (as defined in the Company’s Policy Regarding Clawback of Incentive Compensation, the “Policy”), and Awards made to such Covered Employee shall be subject instead to the clawback provisions contained in the Policy, as provided in Section 7 hereof.


4.Termination of Employment.
Except as may be specifically provided in an Award pursuant to Section 3(a), a Participant shall have no right to an Award under the Plan for any Year in which the Participant is not actively employed by the Company or its Subsidiaries on June 30 of such Year. When establishing Awards each Year, the Committee may also provide that in the event a Participant is not employed by the Company or its Subsidiaries on the date on which the Award is paid, the Participant may forfeit such Participant’s right to the Award paid under the Plan.
5.Administration.
The Plan will be administered by the Committee. The Committee will have the authority to interpret the Plan, to prescribe rules relating to the Plan and to make all determinations necessary or advisable in administering the Plan. Decisions of the Committee with respect to the Plan will be final and conclusive. The Committee may delegate some or all of its authority as identified herein to the Chief Executive Officer or the Chief People Officer, including the power and authority to make Awards with respect to Participants who are not members of the Clorox Executive Committee or an “officer” of the Company for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to such conditions and limitations as the Committee may establish. References to the Committee in this Plan shall refer to the Chief Executive Officer or the Chief People Officer with respect to any action of such officer within the scope of the authority delegated to such officer by the Committee. The Chief Executive Officer may delegate some or all of its authority under Section 3(c) to the Chief People Officer.
6.Unfunded Plan.
Awards under the Plan will be paid from the general assets of the Company, and the rights of Participants under the Plan will be only those of general unsecured creditors of the Company.
7.Clawback.
Awards under the Plan granted to Participants who are “Covered Employees” (as defined in the Policy) are subject to clawback in accordance with the terms of the Policy, as amended from time to time, and pursuant to any other policy the Company may adopt as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. No recovery of any Award granted hereunder pursuant to such a clawback policy shall be treated as an event giving rise to a Participant’s right to terminate employment for “good reason” or “constructive termination” (or any similar term) under any agreement with the Company.
8.Amendment or Termination of the Plan. The Committee may from time to time suspend, revise, amend or terminate the Plan.
9.Applicable Law.
To the extent not preempted by federal law, the Plan shall be construed in accordance with and governed by the laws of the State of California, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction.
10.No Rights to Employment.
Nothing contained in the Plan shall give any person the right to be retained in the employment of the Company or any of its Subsidiaries. The Company reserves the right to terminate any Participant at any time for any reason notwithstanding the existence of the Plan.


11.No Assignment.
Except as otherwise required by applicable law, any interest, benefit, payment, claim or right of any Participant under the Plan shall not be sold, transferred, assigned, pledged, encumbered or hypothecated by any Participant and shall not be subject in any manner to any claims of any creditor of any Participant or beneficiary, and any attempt to take any such action shall be null and void. During the lifetime of any Participant, payment of an Award shall only be made to such Participant. Notwithstanding the foregoing, the Committee may establish such procedures as it deems necessary for a Participant to designate a beneficiary to whom any amounts would be payable in the event of any Participant’s death.
12.Number and References.
Except where otherwise indicated by the context, the plural shall include the singular and the singular shall include the plural. Any reference in the Plan to a Section of the Plan either in the Plan or to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such Section of the Plan, act, code, section, rule or regulation, as may be amended from time to time, or to any successor Section of the Plan, act, code, section, rule or regulation.
13.Severability.
If any one or more of the provisions contained in this Plan, or any application thereof, shall be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and all other applications thereof shall not in any way be affected or impaired thereby. This Plan shall be construed and enforced as if such invalid, illegal or unenforceable provision has never comprised a part hereof, and the remaining provisions hereof shall remain in full force and effect and shall not be affected by the invalid, illegal or unenforceable provision or by its severance from the Plan. In lieu of such invalid, illegal or unenforceable provisions there shall be added automatically as a part hereof a provision as similar in terms and economic effect to such invalid, illegal or unenforceable provision as may be possible and be valid, legal and enforceable.
14.Requirements of Law.
The issuance of cash under the Plan shall be subject to all applicable laws and to such approvals by any governmental agencies or national securities exchanges as may be required.
15.Non-Exclusive Plan.
The adoption of the Plan by the Board shall not be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements as it may deem desirable.
16.Section 409A Compliance.
To the extent applicable, it is intended that this Plan and any Awards granted hereunder comply with the requirements of Section 409A. Any provision that would cause the Plan or any Award granted hereunder to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A, which amendment may be retroactive to the extent permitted by Section 409A.

END OF DOCUMENT

 EX-31.1 3 clxq1fy24ex311ceocertifica.htm EX-31.1 Document
Exhibit 31.1
CERTIFICATION
I, Linda Rendle, certify that:
1.I have reviewed this quarterly report on Form 10-Q of The Clorox Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 1, 2023
 
/s/ Linda Rendle
Linda Rendle
Chief Executive Officer


 EX-31.2 4 clxq1fy24ex312cfocertifica.htm EX-31.2 Document
Exhibit 31.2
CERTIFICATION
I, Kevin B. Jacobsen, certify that:
1.I have reviewed this quarterly report on Form 10-Q of The Clorox Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 1, 2023
 
/s/ Kevin B. Jacobsen
Kevin B. Jacobsen
Executive Vice President - Chief Financial Officer


 EX-32 5 clxq1fy24ex32ceocfocertifi.htm EX-32 Document
Exhibit 32
CERTIFICATION

In connection with the periodic report of The Clorox Company (the “Company”) on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), we, Linda Rendle, Chief Executive Officer of the Company, and Kevin B. Jacobsen, Executive Vice President - Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to our knowledge:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Date: November 1, 2023

/s/ Linda Rendle
Linda Rendle
Chief Executive Officer
 
 
/s/ Kevin B. Jacobsen
Kevin B. Jacobsen
Executive Vice President - Chief Financial Officer


 EX-101.SCH 6 clx-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - CYBERATTACK link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - SUPPLY CHAIN FINANCING PROGRAM link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - RESTRUCTURING AND RELATED COSTS link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - INVENTORIES, NET link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - NET EARNINGS PER SHARE (EPS) link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - EMPLOYEE BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - SEGMENT RESULTS link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - CYBERATTACK (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - INVENTORIES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - SEGMENT RESULTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - CYBERATTACK (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - CYBERATTACK (Summary of Costs Recognized From Cyberattack) (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - SUPPLY CHAIN FINANCING PROGRAM (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - INVENTORIES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - INVENTORIES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares) (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - SEGMENT RESULTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 clx-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 clx-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 clx-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Less: Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Research and development costs Research and Development Expense Changes in: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Raw materials and packaging Inventory, Raw Materials and Supplies, Net of Reserves All Award Types Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Deferred income taxes Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Commitments and contingencies Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Unusual or Infrequent Item, or Both [Line Items] Unusual or Infrequent Item, or Both [Line Items] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] STOCKHOLDERS' EQUITY Equity [Text Block] Commodity Purchase Derivative Contracts [Axis] Commodity Purchase Derivative Contracts [Axis] Commodity Purchase Derivative Contracts [Axis] INCOME TAXES Income Tax Disclosure [Text Block] Concentration Risk [Line Items] Concentration Risk [Line Items] Total liabilities, estimated fair value Financial Liabilities Fair Value Disclosure CYBERATTACK Unusual or Infrequent Items, or Both, Disclosure [Text Block] Customer [Axis] Customer [Axis] Current liabilities Liabilities, Current [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding Preferred Stock, Value, Issued Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Cash dividends paid to Clorox stockholders Payments of Ordinary Dividends, Common Stock Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Diluted net earnings per share (in dollars per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Treasury stock, at cost: 6,740,113 and 6,921,439 shares as of September 30, 2023 and June 30, 2023, respectively Treasury Stock, Value Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Treasury stock (in shares) Beginning balance, treasury stock (in shares) Ending balance, treasury stock (in shares) Treasury Stock, Common, Shares Other employee stock plan activities (in shares) Other Employee Stock Plan Activities, Shares Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards. Schedule of Components of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Other comprehensive (loss) income before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Trading Symbol Trading Symbol Letter of credit, amount outstanding Letters of Credit Outstanding, Amount Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Interest income Investment Income, Interest and Dividend Trust assets for nonqualified deferred compensation plans, estimated fair value Investments, Fair Value Disclosure Income tax benefit (expense), and other Other Comprehensive Income (Loss), Tax Net earnings attributable to Clorox Net Income (Loss) Net Income (Loss) Insurance proceeds Unusual or Infrequent Item, or Both, Insurance Proceeds Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Notes and loans payable Commercial Paper LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Stockholders’ equity Equity, Attributable to Parent [Abstract] Professional Products Professional Products [Member] Professional Products [Member] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Gains (losses) recognized in Other comprehensive (loss) income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Receivables, net Increase (Decrease) in Receivables Cost of products sold Cost of Goods and Services Sold Executive Category: Executive Category [Axis] Foreign exchange derivative contracts Foreign Exchange Contract [Member] Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares Schedule of Weighted Average Number of Shares [Table Text Block] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Name Measure Name Name Forgone Recovery, Individual Name Household Household [Member] Household [Member] Carrying Amount Reported Value Measurement [Member] Segment adjusted EBIT Segment Adjusted EBIT Segment Adjusted EBIT Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Letter of credit Letter of credit Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding. Investment Type [Axis] Investment Type [Axis] LIFO allowances Inventory, LIFO Reserve Measurement Basis [Axis] Measurement Basis [Axis] Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Maximum duration, commodity contracts (in years) Maximum Length of Time Hedged in Cash Flow Hedge Investments [Domain] Investments [Domain] Restructuring and related implementation, incurred cost Total, net Streamlined operating model Restructuring and Related Cost, Incurred Cost COMPREHENSIVE INCOME Comprehensive Income (Loss) Note [Text Block] Local Phone Number Local Phone Number Fair Value Measurement [Domain] Fair Value Measurement [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Forecast Forecast [Member] Transaction [Domain] Transaction [Domain] Dividends declared per share (in dollars per share) Common Stock, Dividends, Per Share, Declared Notional amount Derivative, Notional Amount Selling and administrative expenses Selling, General and Administrative Expenses [Member] Total Commodity Purchase Derivative Contracts Total Commodity Purchase Derivative Contracts [Member] Total Commodity Purchase Derivative Contracts [Member] Long-term operating lease liabilities Operating Lease, Liability, Noncurrent Retirement Plan Type [Domain] Retirement Plan Type [Domain] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Retirement Benefits [Abstract] Amounts reclassified from Accumulated other comprehensive net (loss) income Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Supplier Finance Program [Table] Supplier Finance Program [Table] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Transaction Type [Axis] Transaction Type [Axis] Income Statement Location [Axis] Income Statement Location [Axis] Foreign exchange forward contracts Foreign Exchange Forward [Member] Alameda County, California Matter Alameda County, California Matter [Member] Alameda County, California Matter [Member] Cash margin balances amount Margin Deposit Assets Payables and Accruals [Abstract] Income taxes payable Accrued Income Taxes, Current Schedule of Assets and Liabilities for Fair Value Disclosure Fair Value, by Balance Sheet Grouping [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventories, net Increase (Decrease) in Inventories Domestic Plan Domestic Plan [Member] Research and development Research and Development Expense [Member] Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Beginning accrual balance Ending accrual balance Restructuring Reserve Award Type Award Type [Axis] Antidilutive stock options and other (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Total inventories, net Inventory, Current And Noncurrent, Net Inventory, Current And Noncurrent, Net Interest expense Interest expense Interest Expense Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Retirement plan contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Current operating lease liabilities Operating Lease, Liability, Current Income taxes payable / prepaid Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Entity Shell Company Entity Shell Company Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Beginning of period End of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Current maturities of long-term debt and Long-term debt, estimated fair value Debt Instrument, Fair Value Disclosure Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Gross profit Gross Profit Security Exchange Name Security Exchange Name Supplier Finance Program [Line Items] Supplier Finance Program [Line Items] Current maturities of long-term debt and Long-term debt Long-Term Debt Total assets, estimated fair value Assets, Fair Value Disclosure Selling and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive net (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Amount of derivative instruments subject to contractually defined counterparty liability position limits Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits, Amount Derivative instruments subject to contractually defined counterparty liability position limits. Incremental expenses Total Cyberattack costs Other Nonrecurring Expense Purchases of Inventory Purchases of Inventory [Member] Purchases of Inventory [Member] Settlement loss recognized Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Maximum Maximum [Member] Total comprehensive income attributable to Clorox Comprehensive Income (Loss), Net of Tax, Attributable to Parent Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Document Type Document Type One-time non-cash before tax settlement charge Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Dickinson County, Michigan Matter Dickinson County, Michigan Matter [Member] Dickinson County, Michigan Matter [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Other Other Noncash Income (Expense) SUPPLY CHAIN FINANCING PROGRAM Supplier Finance Program [Text Block] Customer Concentration Risk Customer Concentration Risk [Member] Derivative [Table] Derivative [Table] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Income Statement [Abstract] Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash and cash equivalents, estimated fair value Cash and Cash Equivalents, Fair Value Disclosure Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Liabilities Derivative Liability Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating Segments Operating Segments [Member] Class of Stock [Line Items] Class of Stock [Line Items] Commodity Purchase Derivative Contracts [Domain] Commodity Purchase Derivative Contracts [Domain] Commodity Purchase Derivative Contracts [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Postretirement Health Coverage Postretirement Health Coverage [Member] Entity Tax Identification Number Entity Tax Identification Number Cyberattack Cyberattack [Member] Cyberattack Inventories, net Total current inventories, net Inventory, Net Statistical Measurement [Axis] Statistical Measurement [Axis] Less: Non-current inventories, net Inventory, Noncurrent FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract] FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract] Financial Instruments and Fair Value Measurements [Abstract] Entity Interactive Data Current Entity Interactive Data Current Maximum undiscounted costs Maximum Exposure, Undiscounted Cost Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period. Total Shareholder Return Amount Total Shareholder Return Amount Cash, cash equivalents and restricted cash: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Segments [Domain] Segments [Domain] Trust assets for nonqualified deferred compensation plans Deferred Compensation Plan Assets Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of Stockholders Equity Schedule of Stockholders Equity [Table Text Block] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Costs of products sold Cost of Goods and Services Sold [Member] Cost of Goods and Services Sold Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets Assets, Current [Abstract] Advertising costs Advertising Expense Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Common stock, shares outstanding (in shares) Beginning balance, common stock (in shares) Ending balance, common stock (in shares) Common Stock, Shares, Outstanding Dividends to Clorox stockholders Dividends Interest cost Defined Benefit Plan, Interest Cost PEO PEO [Member] Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] Schedule of Comprehensive Income Comprehensive Income (Loss) [Table Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] EMPLOYEE BENEFIT PLANS Retirement Benefits [Text Block] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used for investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Schedule of Inventories, Net Schedule of Inventory, Current [Table Text Block] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective tax rate on earnings from continuing operations Effective Income Tax Rate Reconciliation, Percent Total liabilities Liabilities Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accumulated other comprehensive net (loss) income Accumulated other comprehensive net (loss) income AOCI Attributable to Parent [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Notes and loans payable Notes And Loans Payable [Member] Notes and Loans Payable [Member] Pension and postretirement benefit adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Plan Name [Axis] Plan Name [Axis] Number of reportable segments Number of Reportable Segments Net earnings per share attributable to Clorox Earnings Per Share [Abstract] Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2023 and June 30, 2023; and 124,001,348 and 123,820,022 shares outstanding as of September 30, 2023 and June 30, 2023, respectively Common Stock, Value, Issued Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Segment Results Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Other intangible assets, net Other Intangible Assets, Net Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Net periodic benefit cost Total Defined Benefit Plan, Net Periodic Benefit Cost (Credit) All Individuals All Individuals [Member] Operating Segments and Corporate, Non-Segment Operating Segments and Corporate, Non-Segment [Member] Operating Segments and Corporate, Non-Segment Entity Filer Category Entity Filer Category Restructuring Type [Axis] Restructuring Type [Axis] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Subsegments [Domain] Subsegments [Domain] Current Fiscal Year End Date Current Fiscal Year End Date Effects of Derivative Instruments Designated as Hedging Instruments on OCI Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Other (income) expense, net Other Expense (Income), Net [Member] Other Expense (Income), Net PEO Name PEO Name Concentration percentage Concentration Risk, Percentage Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Remediation period (in years) Remediation period Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site. Cleaning Cleaning [Member] Cleaning [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Other Postretirement Benefits Plan Other Postretirement Benefits Plan [Member] Net cash provided by operations Net Cash Provided by (Used in) Operating Activities Lifestyle Lifestyle [Member] Lifestyle [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Net unrealized loss in AOCI, before taxes Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Product Concentration Risk Product Concentration Risk [Member] Corporate and Other Corporate, Non-Segment [Member] Depreciation and amortization Depreciation, Depletion and Amortization Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total Clorox stockholders’ (deficit) equity Balance, beginning Balance, ending Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Subsegments [Axis] Subsegments [Axis] SCF payment term Supplier Finance Program, Payment Timing, Period Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Net unrealized gains (losses) on derivatives Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Grilling Grilling [Member] Grilling [Member] Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] RESTRUCTURING AND RELATED COSTS Restructuring and Related Activities Disclosure [Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Restructuring and Related Costs Restructuring and Related Costs Benchmark [Member] Restructuring and Related Costs Benchmark Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Entity Emerging Growth Company Entity Emerging Growth Company Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Trademarks, net Trademarks, net Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit. Title Trading Arrangement, Individual Title Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Common stock Common Stock [Member] Pension and postretirement benefit adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code NET EARNINGS PER SHARE (EPS) Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Total stockholders’ equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Dividends to noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Minimum Minimum [Member] Property, plant and equipment, net of accumulated depreciation and amortization of $2,768 and $2,705, respectively Property, Plant and Equipment, Net Weighted average shares outstanding (in thousands) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Receivables, net Receivables, Net, Current Exercise Price Award Exercise Price Total other comprehensive (loss) income, net of tax Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Amount due to suppliers participating in SCF Supplier Finance Program, Obligation, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Notes and loans payable, estimated fair value Short-Term Debt, Fair Value Commodity purchase derivative contracts Commodity purchase options contracts Commodity Contract [Member] Liabilities Liabilities [Abstract] Maximum duration, interest rate contracts (in years) Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge Net earnings Net earnings Net earnings Net earnings (losses) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Digital capabilities and productivity enhancements investment Digital Capabilities and Productivity Enhancements Expense Digital Capabilities and Productivity Enhancements Expense Retirement Income Plans Retirement Income Plans [Member] Retirement Income [Member] Net cash provided by (used for) financing activities Net Cash Provided by (Used in) Financing Activities Retirement Plan Type [Axis] Retirement Plan Type [Axis] OTHER CONTINGENCIES AND GUARANTEES Commitments and Contingencies Disclosure [Text Block] Other Payments for (Proceeds from) Other Investing Activities Retained earnings Retained Earnings [Member] Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net unrealized gains (losses) on derivatives Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Basic net earnings per share (in dollars per share) Earnings Per Share, Basic Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Discount rate used for benefit obligation remeasurement Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Restructuring and related implementation, expected cost Restructuring and Related Cost, Expected Cost Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Selected Financial Information Relating to the Company's Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Charges Restructuring Charges Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Operating lease right-of-use assets and liabilities, net Operating Lease, Right-of-Use Asset And Liability, Net Operating Lease, Right-of-Use Asset And Liability, Net Unusual or Infrequent Items, or Both [Abstract] Trust assets for nonqualified deferred compensation plans Trust Assets for nonqualified deferred compensation plans [Member] Trust Assets For Nonqualified Deferred Compensation Plans [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net earnings to net cash provided by operations: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Unusual or Infrequent Item, or Both [Table] Unusual or Infrequent Item, or Both [Table] All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Percentage of liability for aggregate remediation and associated costs, other than legal fees Percentage of liability for aggregate remediation and associated costs, other than legal fees The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site. Maximum duration, foreign exchange contracts (in years) Maximum Length of Time, Foreign Currency Cash Flow Hedge Less: Total comprehensive income attributable to noncontrolling interests Less: Total comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest International International [Member] International [Member] Assets Derivative Asset Summary of Costs Recognized From Cyberattack Schedule of Unusual or Infrequent Items, or Both [Table Text Block] Deferred income taxes Deferred Income Tax Expense (Benefit) Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Food Food Products [Member] Food Products [Member] Insider Trading Arrangements [Line Items] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Dilutive effect of stock options and other (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Liability for aggregate future remediation costs Accrual for Environmental Loss Contingencies Adjustment to Compensation, Amount Adjustment to Compensation Amount Employee-Related Costs Employee Severance [Member] Noncontrolling interests Equity, Attributable to Noncontrolling Interest Cash payments Payments for Restructuring Notes and loans payable, net Proceeds from (Repayments of) Short-Term Debt Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block] The entire disclosure for financial instruments and fair value measurements. Property, plant and equipment, accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Revenue from Contract with Customer Revenue from Contract with Customer Benchmark [Member] Treasury stock Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Current maturities of long-term debt and Long-term debt Long-Term Debt [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Income tax expense Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Other Other Restructuring [Member] Name Trading Arrangement, Individual Name Equity [Abstract] Equity [Abstract] Retirement Health Care Retirement Health Care [Member] Retirement Health Care INVENTORIES, NET Inventory Disclosure [Text Block] Net sales Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Interest-bearing investments, including money market funds Money Market Funds [Member] Amortization of unrecognized items Defined Benefit Plan, Amortization of Gain (Loss) Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Comprehensive income Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Weighted average long-term expected rate or return on plan assets (percentage) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Other employee stock plan activities Other Employee Stock Plan Activities, Amount Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards. Other (income) expense, net Other Expense (Income), Net The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines. Bags and Wraps Bags And Wraps [Member] Bags And Wraps [Member] Water Filtration Water Filtration [Member] Water Filtration [Member] Time deposits Bank Time Deposits [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Long-term debt Long-Term Debt, Excluding Current Maturities Natural Personal Care Natural Personal Care [Member] Natural Personal Care [Member] Diluted (in shares) Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Interest rate derivative contracts Interest Rate Contract [Member] Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid-in Capital [Member] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover page. Cover [Abstract] Health and Wellness Health and Wellness [Member] Health and Wellness Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition UNITED STATES UNITED STATES Restructuring and Related Activities [Abstract] Other liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] SEGMENT RESULTS Segment Reporting Disclosure [Text Block] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Work in process Inventory, Work in Process, Net of Reserves Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Net unrealized loss in AOCI, net of tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Scenario [Axis] Scenario [Axis] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Issuance of common stock for employee stock plans and other Issuance Of Common Stock For Employee Stock Plans And Other The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities. Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Cat Litter Cat Litter [Member] Cat Litter [Member] Walmart Stores, Inc. Walmart Stores, Inc. [Member] Walmart Stores, Inc. and its affiliates [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Concentration Risk [Table] Concentration Risk [Table] Estimated Fair Value Estimate of Fair Value Measurement [Member] Other comprehensive (loss) income, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Scenario [Domain] Scenario [Domain] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Noncontrolling interests Noncontrolling Interest [Member] EX-101.PRE 10 clx-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 clx-20230930_g1.jpg begin 644 clx-20230930_g1.jpg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htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
 3 Months Ended
Sep. 30, 2023
Oct. 18, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 1-07151  
Entity Registrant Name THE CLOROX COMPANY  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 31-0595760  
Entity Address, Address Line One 1221 Broadway  
Entity Address, City or Town Oakland  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94612-1888  
City Area Code 510  
Local Phone Number 271-7000  
Title of 12(b) Security Common Stock - $1.00 par value  
Trading Symbol CLX  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   124,059,098
Entity Central Index Key 0000021076  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Net sales $ 1,386 $ 1,740
Cost of products sold 854 1,114
Gross profit 532 626
Selling and administrative expenses 276 261
Advertising costs 165 161
Research and development costs 29 32
Interest expense 21 22
Other (income) expense, net 12 34
Earnings before income taxes 29 116
Income tax expense 4 29
Net earnings 25 87
Less: Net earnings attributable to noncontrolling interests 3 2
Net earnings attributable to Clorox $ 22 $ 85
Net earnings per share attributable to Clorox    
Basic net earnings per share (in dollars per share) $ 0.17 $ 0.69
Diluted net earnings per share (in dollars per share) $ 0.17 $ 0.68
Weighted average shares outstanding (in thousands)    
Basic (in shares) 123,973 123,339
Diluted (in shares) 124,650 123,914
Comprehensive income $ 24 $ 51
Less: Total comprehensive income attributable to noncontrolling interests 3 2
Total comprehensive income attributable to Clorox $ 21 $ 49
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Current assets    
Cash and cash equivalents $ 518 $ 367
Receivables, net 581 688
Inventories, net 710 696
Prepaid expenses and other current assets 102 77
Total current assets 1,911 1,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,768 and $2,705, respectively 1,317 1,345
Operating lease right-of-use assets 328 346
Goodwill 1,246 1,252
Trademarks, net 541 543
Other intangible assets, net 162 169
Other assets 486 462
Total assets 5,991 5,945
Current liabilities    
Notes and loans payable 347 50
Current operating lease liabilities 88 87
Accounts payable and accrued liabilities 1,678 1,659
Income taxes payable 115 121
Total current liabilities 2,228 1,917
Long-term debt 2,478 2,477
Long-term operating lease liabilities 290 310
Other liabilities 837 825
Deferred income taxes 27 28
Total liabilities 5,860 5,557
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2023 and June 30, 2023; and 124,001,348 and 123,820,022 shares outstanding as of September 30, 2023 and June 30, 2023, respectively 131 131
Additional paid-in capital 1,246 1,245
Retained earnings 299 583
Treasury stock, at cost: 6,740,113 and 6,921,439 shares as of September 30, 2023 and June 30, 2023, respectively (1,219) (1,246)
Accumulated other comprehensive net (loss) income (494) (493)
Total Clorox stockholders’ (deficit) equity (37) 220
Noncontrolling interests 168 168
Total stockholders’ equity 131 388
Total liabilities and stockholders’ equity $ 5,991 $ 5,945
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Statement of Financial Position [Abstract]    
Property, plant and equipment, accumulated depreciation and amortization $ 2,768 $ 2,705
Preferred stock, par value (in dollars per share) $ 1.00 $ 1.00
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1.00 $ 1.00
Common stock, shares authorized (in shares) 750,000,000 750,000,000
Common stock, shares issued (in shares) 130,741,461 130,741,461
Common stock, shares outstanding (in shares) 124,001,348 123,820,022
Treasury stock (in shares) 6,740,113 6,921,439
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net earnings $ 25 $ 87
Adjustments to reconcile net earnings to net cash provided by operations:    
Depreciation and amortization 61 56
Stock-based compensation 13 10
Deferred income taxes (5) (5)
Other 1 16
Changes in:    
Receivables, net 108 63
Inventories, net (14) (6)
Prepaid expenses and other current assets (22) (30)
Accounts payable and accrued liabilities (138) (28)
Operating lease right-of-use assets and liabilities, net (1) 1
Income taxes payable / prepaid (8) 14
Net cash provided by operations 20 178
Investing activities:    
Capital expenditures (24) (46)
Other 1 1
Net cash used for investing activities (23) (45)
Financing activities:    
Notes and loans payable, net 298 111
Cash dividends paid to Clorox stockholders (149) (145)
Issuance of common stock for employee stock plans and other 6 (1)
Net cash provided by (used for) financing activities 155 (35)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 (4)
Net increase (decrease) in cash, cash equivalents and restricted cash 152 94
Cash, cash equivalents and restricted cash:    
Beginning of period 368 186
End of period $ 520 $ 280
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 3 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2023 and 2022, in the opinion of management, reflect all normal and recurring adjustments considered necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2023, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
Recently Adopted Accounting Standards
In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations. These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the standard as of July 1, 2023. The adoption relates to disclosures only and does not have an impact on the condensed consolidated financial statements, results of operations, or cash flows.
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CYBERATTACK
 3 Months Ended
Sep. 30, 2023
Unusual or Infrequent Items, or Both [Abstract]  
CYBERATTACK CYBERATTACK
On Monday, August 14, 2023, the Company disclosed it had identified unauthorized activity on some of its Information Technology (IT) systems. That activity began on Friday, August 11, 2023 and after becoming aware of it that evening, the Company immediately began taking steps to stop and remediate the activity. The Company also took certain systems offline and engaged third-party cybersecurity experts to support its investigation and recovery efforts. The Company implemented its business continuity plans, including manual ordering and processing procedures at a reduced rate of operations in order to continue servicing its customers. However, the incident resulted in wide-scale disruptions to the Company’s business operations throughout the remainder of the quarter.
The impacts of these system disruptions included order processing delays and significant product outages, resulting in a negative impact on net sales and earnings. The Company has since transitioned back to automated order processing and the vast majority of orders are taking place in an automated manner. The Company expects to experience ongoing, but lessening, operational impacts in the second quarter as it makes progress in returning to normalized operations.
The Company also incurred incremental expenses of approximately $24 as a result of the cyberattack for the three months ended September 30, 2023. The following table summarizes the recognition of costs in the condensed consolidated statement of earnings and comprehensive income:

Three months ended
9/30/2023
Costs of products sold
$11 
Selling and administrative expenses
13 
Total
$24 

The costs incurred relate primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs incurred from the resulting disruption to the Company’s business operations. The Company expects to incur additional costs related to the
cyberattack in future periods. The Company has not recognized any insurance proceeds in the three months ended September 30, 2023 related to the cyberattack. The timing of recognizing insurance recoveries, if any, may differ from the timing of recognizing the associated expenses.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLY CHAIN FINANCING PROGRAM
 3 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
SUPPLY CHAIN FINANCING PROGRAM SUPPLY CHAIN FINANCING PROGRAM
The Company has arranged for a global financial institution to offer a voluntary supply chain finance (SCF) program for the benefit of the Company’s suppliers. The Company’s current payment terms do not exceed 120 days in keeping with industry standards. The SCF program enables suppliers to directly contract with the financial institution to receive payment from the financial institution prior to the payment terms between the Company and the supplier by selling the Company’s payables to the financial institution. Participation in the program is at the sole discretion of the supplier and the Company has no economic interest in a supplier's decision to enter into the agreement and has no direct financial relationship with the financial institution, as it relates to the SCF program. Once a supplier elects to participate in the SCF program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices to sell to the financial institution. The terms of the Company’s payment obligations are not impacted by a supplier’s participation in the program and as such, the SCF program has no direct impact on the Company’s balance sheets, cash flows or liquidity. The Company and our subsidiaries have not pledged any assets as security or provided guarantees under the SCF program.
All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets and the associated payments are included in operating activities within the condensed consolidated statements of cash flows. As of September 30, 2023 and June 30, 2023, the amount due to suppliers participating in the SCF program and included in Accounts payable and accrued liabilities was $119 and $220, respectively. The decrease in the amount due to suppliers participating in the SCF program from June 30, 2023 to September 30, 2023 was attributable to a reduction of orders due to the temporary operational disruptions of the cyberattack along with the timing of payments.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND RELATED COSTS
 3 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND RELATED COSTS RESTRUCTURING AND RELATED COSTS
In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company’s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.
The Company incurred $60 of costs in fiscal year 2023 and anticipates incurring approximately $30 to $40 of costs in fiscal year 2024 related to this initiative, of which approximately $10 to $15 are expected to be employee-related costs to reduce certain staffing levels such as severance payments, with the remainder for consulting and other costs. Costs incurred are expected to be settled primarily in cash.
The total restructuring and related implementation costs, net associated with the Company’s streamlined operating model plan as reflected in the condensed consolidated statements of earnings and comprehensive income:
Three months ended
Inception to date ended
9/30/20239/30/20229/30/2023
Costs of products sold
$— $(1)$(3)
Selling and administrative expenses
— 112 
Research and development— — (1)
Other (income) expense, net:
Employee-related costs
— 1952 
Total, net
$— $19 $60 
Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the streamlined operating model, related processes and other professional fees incurred.
The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods.
The following table reconciles the accrual for the streamlined operating model’s restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets:
Employee-Related CostsOtherTotal
Accrual Balance as of June 30, 2023
$23 $5 $28 
Charges
— — — 
Cash payments(16)(5)(21)
Accrual Balance as of September 30, 2023$7 $— $7 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.3
INVENTORIES, NET
 3 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
INVENTORIES, NET INVENTORIES, NET
Inventories, net consisted of the following as of:
9/30/20236/30/2023
Finished goods$618 $595 
Raw materials and packaging178 182 
Work in process20 8 
LIFO allowances(104)(87)
Total inventories, net$712 $698 
Less: Non-current inventories, net (1)
2 2 
Total current inventories, net$710 $696 
(1)Non-current inventories, net are recorded in Other assets.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
 3 Months Ended
Sep. 30, 2023
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]  
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
Financial Risk Management and Derivative Instruments
The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.
Commodity Price Risk Management
The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and generally have original contractual maturities of less than 2 years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.
As of September 30, 2023, and June 30, 2023, the notional amount of commodity derivatives was $36 and $41, respectively, which related primarily to exposures in soybean oil used for the Food business and jet fuel used for the Grilling business.
Foreign Currency Risk Management
The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company’s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have original contractual maturities of less than 2 years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.
The notional amounts of outstanding foreign currency forward contracts used by the Company’s subsidiaries to hedge forecasted purchases of inventory were $55 and $51 as of September 30, 2023 and June 30, 2023, respectively.
Interest Rate Risk Management
The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have original contractual maturities of less than 3 years. The interest rate contracts are measured at fair value using information quoted by bond dealers.
The Company held no interest rate contracts as of both September 30, 2023 and June 30, 2023.
Commodity, Foreign Exchange and Interest Rate Derivatives
The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.
The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:
Gains (losses) recognized in Other comprehensive (loss) income
Three months ended
9/30/20239/30/2022
Commodity purchase derivative contracts$(1)$(3)
Foreign exchange derivative contracts1 1 
Interest rate derivative contracts— — 
Total$— $(2)

Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earningsGains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings
Three months ended
9/30/20239/30/2022
Commodity purchase derivative contractsCost of products sold$(2)$4 
Foreign exchange derivative contractsCost of products sold— 1 
Interest rate derivative contractsInterest expense3 3 
Total$1 $8 
The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of September 30, 2023 that is expected to be reclassified into Net earnings within the next twelve months is $13.
Counterparty Risk Management and Derivative Contract Requirements
The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions, $0 and $1 contained such terms as of September 30, 2023 and June 30, 2023, respectively. As of both September 30, 2023 and June 30, 2023, neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were exceeded.
Certain terms of the agreements governing the Company’s over-the-counter derivative instruments require the Company’s credit ratings, as assigned by Standard & Poor’s and Moody’s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company’s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both September 30, 2023 and June 30, 2023, the Company and each of its counterparties had been assigned investment grade ratings by both Standard & Poor’s and Moody’s.
Certain of the Company’s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company’s broker for trades conducted on that exchange. As of September 30, 2023 and June 30, 2023, the Company maintained cash margin balances
related to exchange traded futures and options contracts of $2 and $0, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.
Trust Assets
The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company’s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The gains and losses on the trust assets are recorded in Other (income) expense, net in the condensed consolidated statements of earnings. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.
Fair Value of Financial Instruments
Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
As of both September 30, 2023 and June 30, 2023, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.
All of the Company’s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:
 9/30/20236/30/2023
Balance sheet
classification		Fair value
hierarchy
level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Commodity purchase options contractsPrepaid expenses and other current assets1$— $— $2 $2 
Commodity purchase swaps contractsPrepaid expenses and other current assets21 1 — — 
Foreign exchange forward contractsPrepaid expenses and other current assets22 2 — — 
 $3 $3 $2 $2 
Liabilities
Commodity purchase futures contractsAccounts payable and accrued liabilities11 1 — — 
Commodity purchase swaps contractsAccounts payable and accrued liabilities2— — 1 1 
$1 $1 $1 $1 
The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:
 9/30/20236/30/2023
Balance sheet
classification		Fair value
hierarchy
level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Interest-bearing investments, including money market funds
Cash and cash
equivalents (1)
1$388 $388 $243 $243 
Time deposits
Cash and cash
equivalents (1)
216 16 9 9 
Trust assets for nonqualified deferred compensation plansOther assets1137 137 129 129 
 $541 $541 $381 $381 
Liabilities
Notes and loans payable
Notes and loans payable (2)
2$347 $347 $50 $50 
Current maturities of long-term debt and Long-term debt
Current maturities of long-
term debt and Long-term
debt (3)
22,478 2,259 2,477 2,327 
$2,825 $2,606 $2,527 $2,377 
(1)Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.
(2)Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company’s credit agreements, all of which are recorded at cost, which approximates fair value.
(3)Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES
 3 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was 14.6% and 25.0% for the three months ended September 30, 2023 and 2022, respectively. The lower tax rate on earnings was primarily driven by the impact of temporary relief provided by the Internal Revenue Service relating to U.S. foreign tax credit regulations.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.3
NET EARNINGS PER SHARE (EPS)
 3 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
NET EARNINGS PER SHARE (EPS) NET EARNINGS PER SHARE (EPS)
The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:
Three months ended
9/30/20239/30/2022
Basic123,973123,339
Dilutive effect of stock options and other677575
Diluted124,650123,914
Antidilutive stock options and other2,2202,983 
Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.3
COMPREHENSIVE INCOME
 3 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
COMPREHENSIVE INCOME COMPREHENSIVE INCOME
The following table provides a summary of Comprehensive income for the periods indicated:
Three months ended
9/30/20239/30/2022
Net earnings
$25 $87 
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments(11)(29)
Net unrealized gains (losses) on derivatives(1)(8)
Pension and postretirement benefit adjustments11 1 
Total other comprehensive (loss) income, net of tax(1)(36)
Comprehensive income
24 51 
Less: Total comprehensive income attributable to noncontrolling interests3 2 
Total comprehensive income attributable to Clorox
$21 $49 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY
 3 Months Ended
Sep. 30, 2023
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Changes in the components of Stockholders’ equity were as follows for the periods indicated:
Three months ended September 30
(Dollars in millions except per share data; shares in thousands)
Common stock
Additional paid-in capital
Retained earnings
Treasury stock
Accumulated
other
comprehensive
net (loss) income
Noncontrolling interests
Total stockholders’ equity
AmountShares AmountShares
Balance as of June 30, 2022$131 130,741 $1,202 $1,048 $(1,346)(7,589)$(479)$173 $729 
Net earnings— — — 85 — — — 2 87 
Other comprehensive (loss) income— — — — — — (36)— (36)
Dividends to Clorox stockholders ($2.36 per share declared)
— — — (293)— — — — (293)
Dividends to noncontrolling interests— — — — — — — (5)(5)
Stock-based compensation— — 10 — — — — — 10 
Other employee stock plan activities— — (19)(8)31 204 — — 4 
Balance as of September 30, 2022$131 130,741 $1,193 $832 $(1,315)(7,385)$(515)$170 $496 
Balance as of June 30, 2023$131 130,741 $1,245 $583 $(1,246)(6,921)$(493)$168 $388 
Net earnings (losses)— — — 22 — — — 3 25 
Other comprehensive (loss) income— — — — — — (1)— (1)
Dividends to Clorox stockholders ($2.40 per share declared)
— — — (300)— — — — (300)
Dividends to noncontrolling interests— — — — — — — (3)(3)
Stock-based compensation— — 13 — — — — — 13 
Other employee stock plan activities— — (12)(6)27 181 — — 9 
Balance as of September 30, 2023$131 130,741 $1,246 $299 $(1,219)(6,740)$(494)$168 $131 
Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
Three months ended September 30
Foreign currency translation adjustmentsNet unrealized gains (losses) on derivativesPension and postretirement benefit adjustmentsAccumulated other comprehensive net (loss) income
Balance as of June 30, 2022$(448)$121 $(152)$(479)
Other comprehensive (loss) income before reclassifications(29)(2)— (31)
Amounts reclassified from Accumulated other comprehensive net (loss) income— (8)1 (7)
Income tax benefit (expense)— 2 — 2 
Net current period other comprehensive (loss) income(29)(8)1 (36)
Balance as of September 30, 2022$(477)$113 $(151)$(515)
Balance as of June 30, 2023$(445)$99 $(147)$(493)
Other comprehensive (loss) income before reclassifications(11)— 11 — 
Amounts reclassified from Accumulated other comprehensive net (loss) income— (1)3 2 
Income tax benefit (expense), and other— — (3)(3)
Net current period other comprehensive (loss) income(11)(1)11 (1)
Balance as of September 30, 2023$(456)$98 $(136)$(494)
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.3
EMPLOYEE BENEFIT PLANS
 3 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.
On May 17, 2022, the Company’s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of September 30, 2023.
In anticipation of this settlement, the Company remeasured the plan’s benefit obligation as of September 30, 2023, based on a discount rate of 5.0% which resulted in a net unrealized loss balance of $126, net of tax, ($165 before taxes) in Accumulated other comprehensive net (loss) income on its condensed consolidated balance sheet related to the Plan.
In the second quarter of fiscal year 2024, a one-time non-cash settlement charge of approximately $165 (before taxes) is expected to be recognized in the Company’s condensed consolidated statement of earnings and comprehensive income, related to these net unrealized losses, as plan obligations are settled through both lump sum payouts and annuity purchases. The actual amount of the settlement charge could vary based on the final valuation of assets and liabilities. On October 10, 2023, the Company completed the annuity purchase related to the pension plan termination. On October 31, 2023, the Company paid out the lump sum amounts related to the termination.
The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:
Three months ended
9/30/20239/30/2022
Interest cost$5 $5 
Expected return on plan assets (1)
(3)(3)
Settlement loss recognized1 — 
Amortization of unrecognized items2 2 
Total$5 $4 
(1)The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2024 net periodic benefit cost is 3.5%.
The net periodic benefit cost for the Company’s retirement health care plans was $0 for both the three months ended September 30, 2023 and 2022.
During both the three months ended September 30, 2023 and 2022, the Company made $2 in contributions to its domestic retirement income plans.
Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs. All other components are reflected in Other (income) expense, net.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.3
OTHER CONTINGENCIES AND GUARANTEES
 3 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
OTHER CONTINGENCIES AND GUARANTEES OTHER CONTINGENCIES AND GUARANTEES
Contingencies
The Company is involved in certain environmental matters, including response actions at various locations. The Company recorded liabilities totaling $28 as of both September 30, 2023 and June 30, 2023, respectively, for its share of aggregate future remediation costs related to these matters.
One matter, which accounted for $12 of the recorded liability as of both September 30, 2023 and June 30, 2023, respectively, relates to environmental costs associated with one of the Company’s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing groundwater at the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study related to groundwater. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators. In January 2023, the regulators issued a new order directing the Company and the current property owner to conduct a Remedial Investigation and then prepare a Feasibility Study to evaluate and remediate impacts to soil, soil vapor and indoor air. While the Company believes its latest estimates of remediation costs (including any related to soil, soil vapor and indoor air impacts) are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs in the aggregate of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs.
Another matter in Dickinson County, Michigan, at the site of one of the Company’s former operations for which the Company is jointly and severally liable, accounted for $10 of the recorded liability as of both September 30, 2023 and June 30, 2023, respectively. This amount reflects the Company’s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company’s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time.
The Company’s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. From time to time, the Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings,
claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole.
Guarantees
In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole.
The Company had not recorded any material liabilities on the aforementioned guarantees as of both September 30, 2023 and June 30, 2023.
The Company was a party to letters of credit of $15 as of September 30, 2023, primarily related to its insurance carriers, of which $0 had been drawn upon.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT RESULTS
 3 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
SEGMENT RESULTS SEGMENT RESULTS
The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. Operating segments not aggregated into a reportable segment are reflected in Corporate and Other.
Corporate and Other includes certain non-allocated administrative costs and various other non-operating income and expenses, as well as the results of the Vitamins, Minerals and Supplements (VMS) business. Assets in Corporate and Other include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes, as well as the assets related to the VMS business.
The principle measure of segment profitability used by management is segment adjusted earnings (losses) before interest and income taxes (segment adjusted EBIT). Segment adjusted EBIT is defined as earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as charges relating to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability).
The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate and Other.
Net sales
Three months ended
9/30/20239/30/2022
Health and Wellness$504 $657 
Household325 423 
Lifestyle229 320 
International270 285 
Corporate and Other58 55 
Total$1,386 $1,740 
Segment adjusted EBIT
Three months ended
9/30/20239/30/2022
Health and Wellness$104 $133 
Household(4)22 
Lifestyle19 60 
International34 23 
Corporate and Other(62)(63)
Total$91 $175 
Interest income
10 2 
Interest expense
(21)(22)
Cyberattack costs (1)
(24)— 
Streamlined operating model (2)
— (19)
Digital capabilities and productivity enhancements investment (3)
(27)(20)
Earnings before income taxes
$29 $116 
(1)Represents incremental costs related to the cyberattack detailed in Note 2. For informational purposes the following table provides the approximate cyberattack costs corresponding to the Company’s reportable segments as a percentage of total costs:
Three months ended
9/30/2023
Health and Wellness22 %
Household11 
Lifestyle14 
International1 
Corporate and Other
52 
Total100 %
(2)Represents restructuring and related implementation costs, net for the streamlined operating model of $0 and $19 for the three months ended September 30, 2023 and 2022, respectively. For informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company’s reportable segments as a percentage of the total costs:
Three months endedThree months ended
Inception to date ended
9/30/20239/30/20229/30/2023
Health and Wellness— %6 %6 %
Household— — 1 
Lifestyle— 5 3 
International— 19 16 
Corporate and Other— 70 74 
Total— %100 %100 %
(3)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.
All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.
Net sales to the Company’s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 27% for both the three months ended September 30, 2023 and 2022.
The following table provides Net sales as a percentage of the Company’s consolidated net sales, disaggregated by operating segment, for the periods indicated:
Net sales
Three months ended
9/30/20239/30/2022
Cleaning32 %33 %
Professional Products4 5 
Health and Wellness36 %38 %
Bags and Wraps11 11 
Cat Litter8 8 
Grilling5 5 
Household24 %24 %
Food9 10 
Natural Personal Care3 4 
Water Filtration5 5 
Lifestyle17 %19 %
International19 %16 %
Corporate and Other4 
%
3 
%
Total100 %100 %
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure    
Net Income (Loss) $ 22 $ 85
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 3 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2023 and 2022, in the opinion of management, reflect all normal and recurring adjustments considered necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2023, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
Recently Adopted Accounting Standards
Recently Adopted Accounting Standards
In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations. These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the standard as of July 1, 2023. The adoption relates to disclosures only and does not have an impact on the condensed consolidated financial statements, results of operations, or cash flows.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
As of both September 30, 2023 and June 30, 2023, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.
Segment Results
The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. Operating segments not aggregated into a reportable segment are reflected in Corporate and Other.
Corporate and Other includes certain non-allocated administrative costs and various other non-operating income and expenses, as well as the results of the Vitamins, Minerals and Supplements (VMS) business. Assets in Corporate and Other include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes, as well as the assets related to the VMS business.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.3
CYBERATTACK (Tables)
 3 Months Ended
Sep. 30, 2023
Unusual or Infrequent Items, or Both [Abstract]  
Summary of Costs Recognized From Cyberattack The following table summarizes the recognition of costs in the condensed consolidated statement of earnings and comprehensive income:
Three months ended
9/30/2023
Costs of products sold
$11 
Selling and administrative expenses
13 
Total
$24 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND RELATED COSTS (Tables)
 3 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs
The total restructuring and related implementation costs, net associated with the Company’s streamlined operating model plan as reflected in the condensed consolidated statements of earnings and comprehensive income:
Three months ended
Inception to date ended
9/30/20239/30/20229/30/2023
Costs of products sold
$— $(1)$(3)
Selling and administrative expenses
— 112 
Research and development— — (1)
Other (income) expense, net:
Employee-related costs
— 1952 
Total, net
$— $19 $60 
Schedule of Restructuring Reserve by Type of Cost
The following table reconciles the accrual for the streamlined operating model’s restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets:
Employee-Related CostsOtherTotal
Accrual Balance as of June 30, 2023
$23 $5 $28 
Charges
— — — 
Cash payments(16)(5)(21)
Accrual Balance as of September 30, 2023$7 $— $7 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.3
INVENTORIES, NET (Tables)
 3 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories, Net
Inventories, net consisted of the following as of:
9/30/20236/30/2023
Finished goods$618 $595 
Raw materials and packaging178 182 
Work in process20 8 
LIFO allowances(104)(87)
Total inventories, net$712 $698 
Less: Non-current inventories, net (1)
2 2 
Total current inventories, net$710 $696 
(1)Non-current inventories, net are recorded in Other assets.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)
 3 Months Ended
Sep. 30, 2023
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]  
Effects of Derivative Instruments Designated as Hedging Instruments on OCI
The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:
Gains (losses) recognized in Other comprehensive (loss) income
Three months ended
9/30/20239/30/2022
Commodity purchase derivative contracts$(1)$(3)
Foreign exchange derivative contracts1 1 
Interest rate derivative contracts— — 
Total$— $(2)
Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings
Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earningsGains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings
Three months ended
9/30/20239/30/2022
Commodity purchase derivative contractsCost of products sold$(2)$4 
Foreign exchange derivative contractsCost of products sold— 1 
Interest rate derivative contractsInterest expense3 3 
Total$1 $8 
Schedule of Assets and Liabilities for Fair Value Disclosure The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:
 9/30/20236/30/2023
Balance sheet
classification		Fair value
hierarchy
level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Commodity purchase options contractsPrepaid expenses and other current assets1$— $— $2 $2 
Commodity purchase swaps contractsPrepaid expenses and other current assets21 1 — — 
Foreign exchange forward contractsPrepaid expenses and other current assets22 2 — — 
 $3 $3 $2 $2 
Liabilities
Commodity purchase futures contractsAccounts payable and accrued liabilities11 1 — — 
Commodity purchase swaps contractsAccounts payable and accrued liabilities2— — 1 1 
$1 $1 $1 $1 
The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:
 9/30/20236/30/2023
Balance sheet
classification		Fair value
hierarchy
level		Carrying
Amount		Estimated
Fair
Value		Carrying
Amount		Estimated
Fair
Value
Assets
Interest-bearing investments, including money market funds
Cash and cash
equivalents (1)
1$388 $388 $243 $243 
Time deposits
Cash and cash
equivalents (1)
216 16 9 9 
Trust assets for nonqualified deferred compensation plansOther assets1137 137 129 129 
 $541 $541 $381 $381 
Liabilities
Notes and loans payable
Notes and loans payable (2)
2$347 $347 $50 $50 
Current maturities of long-term debt and Long-term debt
Current maturities of long-
term debt and Long-term
debt (3)
22,478 2,259 2,477 2,327 
$2,825 $2,606 $2,527 $2,377 
(1)Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.
(2)Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company’s credit agreements, all of which are recorded at cost, which approximates fair value.
(3)Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.3
NET EARNINGS PER SHARE (EPS) (Tables)
 3 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:
Three months ended
9/30/20239/30/2022
Basic123,973123,339
Dilutive effect of stock options and other677575
Diluted124,650123,914
Antidilutive stock options and other2,2202,983 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.3
COMPREHENSIVE INCOME (Tables)
 3 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Comprehensive Income
The following table provides a summary of Comprehensive income for the periods indicated:
Three months ended
9/30/20239/30/2022
Net earnings
$25 $87 
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments(11)(29)
Net unrealized gains (losses) on derivatives(1)(8)
Pension and postretirement benefit adjustments11 1 
Total other comprehensive (loss) income, net of tax(1)(36)
Comprehensive income
24 51 
Less: Total comprehensive income attributable to noncontrolling interests3 2 
Total comprehensive income attributable to Clorox
$21 $49 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY (Tables)
 3 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Stockholders Equity
Changes in the components of Stockholders’ equity were as follows for the periods indicated:
Three months ended September 30
(Dollars in millions except per share data; shares in thousands)
Common stock
Additional paid-in capital
Retained earnings
Treasury stock
Accumulated
other
comprehensive
net (loss) income
Noncontrolling interests
Total stockholders’ equity
AmountShares AmountShares
Balance as of June 30, 2022$131 130,741 $1,202 $1,048 $(1,346)(7,589)$(479)$173 $729 
Net earnings— — — 85 — — — 2 87 
Other comprehensive (loss) income— — — — — — (36)— (36)
Dividends to Clorox stockholders ($2.36 per share declared)
— — — (293)— — — — (293)
Dividends to noncontrolling interests— — — — — — — (5)(5)
Stock-based compensation— — 10 — — — — — 10 
Other employee stock plan activities— — (19)(8)31 204 — — 4 
Balance as of September 30, 2022$131 130,741 $1,193 $832 $(1,315)(7,385)$(515)$170 $496 
Balance as of June 30, 2023$131 130,741 $1,245 $583 $(1,246)(6,921)$(493)$168 $388 
Net earnings (losses)— — — 22 — — — 3 25 
Other comprehensive (loss) income— — — — — — (1)— (1)
Dividends to Clorox stockholders ($2.40 per share declared)
— — — (300)— — — — (300)
Dividends to noncontrolling interests— — — — — — — (3)(3)
Stock-based compensation— — 13 — — — — — 13 
Other employee stock plan activities— — (12)(6)27 181 — — 9 
Balance as of September 30, 2023$131 130,741 $1,246 $299 $(1,219)(6,740)$(494)$168 $131 
Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
Three months ended September 30
Foreign currency translation adjustmentsNet unrealized gains (losses) on derivativesPension and postretirement benefit adjustmentsAccumulated other comprehensive net (loss) income
Balance as of June 30, 2022$(448)$121 $(152)$(479)
Other comprehensive (loss) income before reclassifications(29)(2)— (31)
Amounts reclassified from Accumulated other comprehensive net (loss) income— (8)1 (7)
Income tax benefit (expense)— 2 — 2 
Net current period other comprehensive (loss) income(29)(8)1 (36)
Balance as of September 30, 2022$(477)$113 $(151)$(515)
Balance as of June 30, 2023$(445)$99 $(147)$(493)
Other comprehensive (loss) income before reclassifications(11)— 11 — 
Amounts reclassified from Accumulated other comprehensive net (loss) income— (1)3 2 
Income tax benefit (expense), and other— — (3)(3)
Net current period other comprehensive (loss) income(11)(1)11 (1)
Balance as of September 30, 2023$(456)$98 $(136)$(494)
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.3
EMPLOYEE BENEFIT PLANS (Tables)
 3 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Schedule of Components of Net Periodic Benefit Cost
The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:
Three months ended
9/30/20239/30/2022
Interest cost$5 $5 
Expected return on plan assets (1)
(3)(3)
Settlement loss recognized1 — 
Amortization of unrecognized items2 2 
Total$5 $4 
(1)The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2024 net periodic benefit cost is 3.5%.
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT RESULTS (Tables)
 3 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Selected Financial Information Relating to the Company's Segments
The principle measure of segment profitability used by management is segment adjusted earnings (losses) before interest and income taxes (segment adjusted EBIT). Segment adjusted EBIT is defined as earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as charges relating to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability).
The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate and Other.
Net sales
Three months ended
9/30/20239/30/2022
Health and Wellness$504 $657 
Household325 423 
Lifestyle229 320 
International270 285 
Corporate and Other58 55 
Total$1,386 $1,740 
Segment adjusted EBIT
Three months ended
9/30/20239/30/2022
Health and Wellness$104 $133 
Household(4)22 
Lifestyle19 60 
International34 23 
Corporate and Other(62)(63)
Total$91 $175 
Interest income
10 2 
Interest expense
(21)(22)
Cyberattack costs (1)
(24)— 
Streamlined operating model (2)
— (19)
Digital capabilities and productivity enhancements investment (3)
(27)(20)
Earnings before income taxes
$29 $116 
(1)Represents incremental costs related to the cyberattack detailed in Note 2. For informational purposes the following table provides the approximate cyberattack costs corresponding to the Company’s reportable segments as a percentage of total costs:
Three months ended
9/30/2023
Health and Wellness22 %
Household11 
Lifestyle14 
International1 
Corporate and Other
52 
Total100 %
(2)Represents restructuring and related implementation costs, net for the streamlined operating model of $0 and $19 for the three months ended September 30, 2023 and 2022, respectively. For informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company’s reportable segments as a percentage of the total costs:
Three months endedThree months ended
Inception to date ended
9/30/20239/30/20229/30/2023
Health and Wellness— %6 %6 %
Household— — 1 
Lifestyle— 5 3 
International— 19 16 
Corporate and Other— 70 74 
Total— %100 %100 %
(3)Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.
The following table provides Net sales as a percentage of the Company’s consolidated net sales, disaggregated by operating segment, for the periods indicated:
Net sales
Three months ended
9/30/20239/30/2022
Cleaning32 %33 %
Professional Products4 5 
Health and Wellness36 %38 %
Bags and Wraps11 11 
Cat Litter8 8 
Grilling5 5 
Household24 %24 %
Food9 10 
Natural Personal Care3 4 
Water Filtration5 5 
Lifestyle17 %19 %
International19 %16 %
Corporate and Other4 
%
3 
%
Total100 %100 %
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.3
CYBERATTACK (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Unusual or Infrequent Item, or Both [Line Items]    
Incremental expenses $ 24 $ 0
Cyberattack    
Unusual or Infrequent Item, or Both [Line Items]    
Incremental expenses 24  
Insurance proceeds $ 0  
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.3
CYBERATTACK (Summary of Costs Recognized From Cyberattack) (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Unusual or Infrequent Item, or Both [Line Items]    
Total $ 24 $ 0
Cyberattack    
Unusual or Infrequent Item, or Both [Line Items]    
Total 24  
Cyberattack | Costs of products sold    
Unusual or Infrequent Item, or Both [Line Items]    
Total 11  
Cyberattack | Selling and administrative expenses    
Unusual or Infrequent Item, or Both [Line Items]    
Total $ 13  
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLY CHAIN FINANCING PROGRAM (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Supplier Finance Program [Line Items]    
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] Accounts payable and accrued liabilities Accounts payable and accrued liabilities
Amount due to suppliers participating in SCF $ 119 $ 220
Maximum    
Supplier Finance Program [Line Items]    
SCF payment term 120 days  
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND RELATED COSTS (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended 15 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Jun. 30, 2024
Restructuring Cost and Reserve [Line Items]          
Restructuring and related implementation, incurred cost $ 0 $ 19 $ 60 $ 60  
Minimum | Forecast          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related implementation, expected cost         $ 30
Minimum | Forecast | Employee-Related Costs          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related implementation, expected cost         10
Maximum | Forecast          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related implementation, expected cost         40
Maximum | Forecast | Employee-Related Costs          
Restructuring Cost and Reserve [Line Items]          
Restructuring and related implementation, expected cost         $ 15
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended 15 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]        
Total, net $ 0 $ 19 $ 60 $ 60
Costs of products sold        
Restructuring Cost and Reserve [Line Items]        
Total, net $ 0 $ (1)   $ (3)
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of products sold Cost of products sold   Cost of products sold
Selling and administrative expenses        
Restructuring Cost and Reserve [Line Items]        
Total, net $ 0 $ 1   $ 12
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Selling and administrative expenses Selling and administrative expenses   Selling and administrative expenses
Research and development        
Restructuring Cost and Reserve [Line Items]        
Total, net $ 0 $ 0   $ (1)
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Research and development costs Research and development costs   Research and development costs
Other (income) expense, net        
Restructuring Cost and Reserve [Line Items]        
Total, net $ 0 $ 19   $ 52
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Other (income) expense, net Other (income) expense, net   Other (income) expense, net
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)
$ in Millions
 3 Months Ended
Sep. 30, 2023
USD ($)
Restructuring Reserve [Roll Forward]  
Beginning accrual balance $ 28
Charges 0
Cash payments (21)
Ending accrual balance 7
Employee-Related Costs  
Restructuring Reserve [Roll Forward]  
Beginning accrual balance 23
Charges 0
Cash payments (16)
Ending accrual balance 7
Other  
Restructuring Reserve [Roll Forward]  
Beginning accrual balance 5
Charges 0
Cash payments (5)
Ending accrual balance $ 0
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.3
INVENTORIES, NET (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Inventory Disclosure [Abstract]    
Finished goods $ 618 $ 595
Raw materials and packaging 178 182
Work in process 20 8
LIFO allowances (104) (87)
Total inventories, net 712 698
Less: Non-current inventories, net 2 2
Total current inventories, net $ 710 $ 696
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Derivative [Line Items]    
Maximum duration, foreign exchange contracts (in years) 2 years  
Maximum duration, interest rate contracts (in years) 3 years  
Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months $ 13  
Amount of derivative instruments subject to contractually defined counterparty liability position limits 0 $ 1
Commodity purchase derivative contracts    
Derivative [Line Items]    
Cash margin balances amount 2 0
Purchases of Inventory | Foreign exchange derivative contracts    
Derivative [Line Items]    
Notional amount $ 55 51
Total Commodity Purchase Derivative Contracts    
Derivative [Line Items]    
Maximum duration, commodity contracts (in years) 2 years  
Notional amount $ 36 $ 41
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]    
Gains (losses) recognized in Other comprehensive (loss) income $ 0 $ (2)
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings 1 8
Commodity purchase derivative contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gains (losses) recognized in Other comprehensive (loss) income (1) (3)
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings (2) 4
Foreign exchange derivative contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gains (losses) recognized in Other comprehensive (loss) income 1 1
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings 0 1
Interest rate derivative contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Gains (losses) recognized in Other comprehensive (loss) income 0 0
Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings $ 3 $ 3
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 3 $ 2
Liabilities 1 1
Estimated Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3 2
Liabilities 1 1
Commodity purchase options contracts | Fair Value, Inputs, Level 1 | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 2
Liabilities 1 0
Commodity purchase options contracts | Fair Value, Inputs, Level 1 | Estimated Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 2
Liabilities 1 0
Commodity purchase options contracts | Fair Value, Inputs, Level 2 | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1 0
Liabilities 0 1
Commodity purchase options contracts | Fair Value, Inputs, Level 2 | Estimated Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1 0
Liabilities 0 1
Foreign exchange forward contracts | Fair Value, Inputs, Level 2 | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 2 0
Foreign exchange forward contracts | Fair Value, Inputs, Level 2 | Estimated Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 2 $ 0
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Assets    
Cash and cash equivalents $ 518 $ 367
Total assets 5,991 5,945
Liabilities    
Notes and loans payable 347 50
Total liabilities 5,860 5,557
Carrying Amount    
Assets    
Total assets 541 381
Liabilities    
Total liabilities 2,825 2,527
Estimated Fair Value    
Assets    
Total assets, estimated fair value 541 381
Liabilities    
Total liabilities, estimated fair value 2,606 2,377
Fair Value, Inputs, Level 1 | Carrying Amount | Trust assets for nonqualified deferred compensation plans    
Assets    
Trust assets for nonqualified deferred compensation plans 137 129
Fair Value, Inputs, Level 1 | Estimated Fair Value | Trust assets for nonqualified deferred compensation plans    
Assets    
Trust assets for nonqualified deferred compensation plans, estimated fair value 137 129
Fair Value, Inputs, Level 2 | Carrying Amount | Current maturities of long-term debt and Long-term debt    
Liabilities    
Current maturities of long-term debt and Long-term debt 2,478 2,477
Fair Value, Inputs, Level 2 | Carrying Amount | Notes and loans payable    
Liabilities    
Notes and loans payable 347 50
Fair Value, Inputs, Level 2 | Estimated Fair Value | Current maturities of long-term debt and Long-term debt    
Liabilities    
Current maturities of long-term debt and Long-term debt, estimated fair value 2,259 2,327
Fair Value, Inputs, Level 2 | Estimated Fair Value | Notes and loans payable    
Liabilities    
Notes and loans payable, estimated fair value 347 50
Interest-bearing investments, including money market funds | Fair Value, Inputs, Level 1 | Carrying Amount    
Assets    
Cash and cash equivalents 388 243
Interest-bearing investments, including money market funds | Fair Value, Inputs, Level 1 | Estimated Fair Value    
Assets    
Cash and cash equivalents, estimated fair value 388 243
Time deposits | Fair Value, Inputs, Level 2 | Carrying Amount    
Assets    
Cash and cash equivalents 16 9
Time deposits | Fair Value, Inputs, Level 2 | Estimated Fair Value    
Assets    
Cash and cash equivalents, estimated fair value $ 16 $ 9
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES (Details)
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]    
Effective tax rate on earnings from continuing operations 14.60% 25.00%
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.3
NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares) (Details) - shares
shares in Thousands
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]    
Basic (in shares) 123,973 123,339
Dilutive effect of stock options and other (in shares) 677 575
Diluted (in shares) 124,650 123,914
Antidilutive stock options and other (in shares) 2,220 2,983
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.3
COMPREHENSIVE INCOME (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Stockholders' Equity Note [Abstract]    
Net earnings $ 25 $ 87
Other comprehensive (loss) income, net of tax:    
Foreign currency translation adjustments (11) (29)
Net unrealized gains (losses) on derivatives (1) (8)
Pension and postretirement benefit adjustments 11 1
Total other comprehensive (loss) income, net of tax (1) (36)
Comprehensive income 24 51
Less: Total comprehensive income attributable to noncontrolling interests 3 2
Total comprehensive income attributable to Clorox $ 21 $ 49
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance $ 388 $ 729
Beginning balance, common stock (in shares) 123,820,022  
Beginning balance, treasury stock (in shares) (6,921,439)  
Net earnings (losses) $ 25 87
Other comprehensive (loss) income (1) (36)
Dividends to Clorox stockholders (300) (293)
Dividends to noncontrolling interests (3) (5)
Stock-based compensation 13 10
Other employee stock plan activities 9 4
Ending balance $ 131 $ 496
Ending balance, common stock (in shares) 124,001,348  
Ending balance, treasury stock (in shares) (6,740,113)  
Dividends declared per share (in dollars per share) $ 2.40 $ 2.36
Common stock    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance $ 131 $ 131
Beginning balance, common stock (in shares) 130,741,000 130,741,000
Ending balance $ 131 $ 131
Ending balance, common stock (in shares) 130,741,000 130,741,000
Additional paid-in capital    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance $ 1,245 $ 1,202
Stock-based compensation 13 10
Other employee stock plan activities (12) (19)
Ending balance 1,246 1,193
Retained earnings    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance 583 1,048
Net earnings (losses) 22 85
Dividends to Clorox stockholders (300) (293)
Other employee stock plan activities (6) (8)
Ending balance 299 832
Treasury stock    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance $ (1,246) $ (1,346)
Beginning balance, treasury stock (in shares) (6,921,000) (7,589,000)
Other employee stock plan activities $ 27 $ 31
Other employee stock plan activities (in shares) 181,000 204,000
Ending balance $ (1,219) $ (1,315)
Ending balance, treasury stock (in shares) (6,740,000) (7,385,000)
Accumulated other comprehensive net (loss) income    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance $ (493) $ (479)
Other comprehensive (loss) income (1) (36)
Ending balance (494) (515)
Noncontrolling interests    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance 168 173
Net earnings (losses) 3 2
Dividends to noncontrolling interests (3) (5)
Ending balance $ 168 $ 170
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning $ 220  
Total other comprehensive (loss) income, net of tax (1) $ (36)
Balance, ending (37)  
Accumulated other comprehensive net (loss) income    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning (493) (479)
Other comprehensive (loss) income before reclassifications 0 (31)
Amounts reclassified from Accumulated other comprehensive net (loss) income 2 (7)
Income tax benefit (expense), and other (3) 2
Total other comprehensive (loss) income, net of tax (1) (36)
Balance, ending (494) (515)
Foreign currency translation adjustments    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning (445) (448)
Other comprehensive (loss) income before reclassifications (11) (29)
Amounts reclassified from Accumulated other comprehensive net (loss) income 0 0
Income tax benefit (expense), and other 0 0
Total other comprehensive (loss) income, net of tax (11) (29)
Balance, ending (456) (477)
Net unrealized gains (losses) on derivatives    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning 99 121
Other comprehensive (loss) income before reclassifications 0 (2)
Amounts reclassified from Accumulated other comprehensive net (loss) income (1) (8)
Income tax benefit (expense), and other 0 2
Total other comprehensive (loss) income, net of tax (1) (8)
Balance, ending 98 113
Pension and postretirement benefit adjustments    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Balance, beginning (147) (152)
Other comprehensive (loss) income before reclassifications 11 0
Amounts reclassified from Accumulated other comprehensive net (loss) income 3 1
Income tax benefit (expense), and other (3) 0
Total other comprehensive (loss) income, net of tax 11 1
Balance, ending $ (136) $ (151)
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.3
EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Other Postretirement Benefits Plan | Retirement Income Plans | UNITED STATES      
Defined Benefit Plan Disclosure [Line Items]      
Discount rate used for benefit obligation remeasurement   5.00%  
Net unrealized loss in AOCI, net of tax   $ 126  
Net unrealized loss in AOCI, before taxes   165  
Net periodic benefit cost   5 $ 4
Retirement plan contributions   2 2
Other Postretirement Benefits Plan | Retirement Income Plans | UNITED STATES | Forecast      
Defined Benefit Plan Disclosure [Line Items]      
One-time non-cash before tax settlement charge $ 165    
Postretirement Health Coverage | Retirement Health Care      
Defined Benefit Plan Disclosure [Line Items]      
Net periodic benefit cost   $ 0 $ 0
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.3
EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details) - Other Postretirement Benefits Plan - Retirement Income Plans - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Defined Benefit Plan Disclosure [Line Items]    
Settlement loss recognized $ 1 $ 0
UNITED STATES    
Defined Benefit Plan Disclosure [Line Items]    
Interest cost 5 5
Expected return on plan assets (3) (3)
Amortization of unrecognized items 2 2
Total $ 5 $ 4
Weighted average long-term expected rate or return on plan assets (percentage) 3.50%  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.3
OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Loss Contingencies [Line Items]    
Liability for aggregate future remediation costs $ 28 $ 28
Letter of credit 15  
Letter of credit, amount outstanding 0  
Alameda County, California Matter    
Loss Contingencies [Line Items]    
Liability for aggregate future remediation costs $ 12 12
Remediation period (in years) 30 years  
Maximum undiscounted costs $ 28  
Dickinson County, Michigan Matter    
Loss Contingencies [Line Items]    
Liability for aggregate future remediation costs $ 10 $ 10
Remediation period (in years) 30 years  
Percentage of liability for aggregate remediation and associated costs, other than legal fees 24.30%  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT RESULTS (Narrative) (Details) - reportableSegment
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Concentration Risk [Line Items]    
Number of reportable segments 4  
Revenue from Contract with Customer | Customer Concentration Risk | Walmart Stores, Inc.    
Concentration Risk [Line Items]    
Concentration percentage 27.00% 27.00%
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT RESULTS (Reportable Segment Information ) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended 15 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Net sales $ 1,386 $ 1,740    
Interest income 10 2    
Interest expense (21) (22)    
Cyberattack costs (24) 0    
Streamlined operating model 0 (19) $ (60) $ (60)
Digital capabilities and productivity enhancements investment (27) (20)    
Earnings before income taxes $ 29 $ 116    
Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 100.00%      
Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 100.00%   100.00%
Operating Segments | Health and Wellness        
Segment Reporting Information [Line Items]        
Net sales $ 504 $ 657    
Segment adjusted EBIT $ 104 $ 133    
Operating Segments | Health and Wellness | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 22.00%      
Operating Segments | Health and Wellness | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 6.00%   6.00%
Operating Segments | Household        
Segment Reporting Information [Line Items]        
Net sales $ 325 $ 423    
Segment adjusted EBIT $ (4) $ 22    
Operating Segments | Household | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 11.00%      
Operating Segments | Household | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 0.00%   1.00%
Operating Segments | Lifestyle        
Segment Reporting Information [Line Items]        
Net sales $ 229 $ 320    
Segment adjusted EBIT $ 19 $ 60    
Operating Segments | Lifestyle | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 14.00%      
Operating Segments | Lifestyle | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 5.00%   3.00%
Operating Segments | International        
Segment Reporting Information [Line Items]        
Net sales $ 270 $ 285    
Segment adjusted EBIT $ 34 $ 23    
Operating Segments | International | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 1.00%      
Operating Segments | International | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 19.00%   16.00%
Corporate and Other        
Segment Reporting Information [Line Items]        
Net sales $ 58 $ 55    
Segment adjusted EBIT $ (62) $ (63)    
Corporate and Other | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 52.00%      
Corporate and Other | Restructuring and Related Costs | Product Concentration Risk | Employee-Related Costs        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 70.00%   74.00%
Operating Segments and Corporate, Non-Segment        
Segment Reporting Information [Line Items]        
Segment adjusted EBIT $ 91 $ 175    
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT RESULTS (Net Sales Percentages) (Details) - Revenue from Contract with Customer - Product Concentration Risk
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]    
Concentration percentage 100.00% 100.00%
Corporate and Other    
Segment Reporting Information [Line Items]    
Concentration percentage 4.00% 3.00%
Health and Wellness | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 36.00% 38.00%
Health and Wellness | Cleaning | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 32.00% 33.00%
Health and Wellness | Professional Products | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 4.00% 5.00%
Household | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 24.00% 24.00%
Household | Bags and Wraps | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 11.00% 11.00%
Household | Cat Litter | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 8.00% 8.00%
Household | Grilling | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 5.00% 5.00%
Lifestyle | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 17.00% 19.00%
Lifestyle | Food | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 9.00% 10.00%
Lifestyle | Natural Personal Care | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 3.00% 4.00%
Lifestyle | Water Filtration | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 5.00% 5.00%
International | Operating Segments    
Segment Reporting Information [Line Items]    
Concentration percentage 19.00% 16.00%
XML 64 clx-20230930_htm.xml IDEA: XBRL DOCUMENT 0000021076 2023-07-01 2023-09-30 0000021076 2023-10-18 0000021076 2022-07-01 2022-09-30 0000021076 2023-09-30 0000021076 2023-06-30 0000021076 2022-06-30 0000021076 2022-09-30 0000021076 clx:CyberattackMember 2023-07-01 2023-09-30 0000021076 clx:CostOfGoodsAndServicesSoldMember clx:CyberattackMember 2023-07-01 2023-09-30 0000021076 us-gaap:SellingGeneralAndAdministrativeExpensesMember clx:CyberattackMember 2023-07-01 2023-09-30 0000021076 srt:MaximumMember 2023-09-30 0000021076 2022-07-01 2023-06-30 0000021076 srt:MinimumMember srt:ScenarioForecastMember 2024-06-30 0000021076 srt:MaximumMember srt:ScenarioForecastMember 2024-06-30 0000021076 srt:MinimumMember srt:ScenarioForecastMember us-gaap:EmployeeSeveranceMember 2024-06-30 0000021076 srt:MaximumMember srt:ScenarioForecastMember us-gaap:EmployeeSeveranceMember 2024-06-30 0000021076 clx:CostOfGoodsAndServicesSoldMember 2023-07-01 2023-09-30 0000021076 clx:CostOfGoodsAndServicesSoldMember 2022-07-01 2023-09-30 0000021076 clx:CostOfGoodsAndServicesSoldMember 2022-07-01 2022-09-30 0000021076 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0000021076 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0000021076 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2023-09-30 0000021076 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0000021076 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0000021076 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2023-09-30 0000021076 clx:OtherExpenseIncomeNetMember 2023-07-01 2023-09-30 0000021076 clx:OtherExpenseIncomeNetMember 2022-07-01 2023-09-30 0000021076 clx:OtherExpenseIncomeNetMember 2022-07-01 2022-09-30 0000021076 2022-07-01 2023-09-30 0000021076 us-gaap:EmployeeSeveranceMember 2023-06-30 0000021076 us-gaap:OtherRestructuringMember 2023-06-30 0000021076 us-gaap:EmployeeSeveranceMember 2023-07-01 2023-09-30 0000021076 us-gaap:OtherRestructuringMember 2023-07-01 2023-09-30 0000021076 us-gaap:EmployeeSeveranceMember 2023-09-30 0000021076 us-gaap:OtherRestructuringMember 2023-09-30 0000021076 clx:TotalCommodityPurchaseDerivativeContractsMember 2023-07-01 2023-09-30 0000021076 clx:TotalCommodityPurchaseDerivativeContractsMember 2023-09-30 0000021076 clx:TotalCommodityPurchaseDerivativeContractsMember 2023-06-30 0000021076 us-gaap:ForeignExchangeContractMember clx:PurchasesofInventoryMember 2023-09-30 0000021076 us-gaap:ForeignExchangeContractMember clx:PurchasesofInventoryMember 2023-06-30 0000021076 us-gaap:CommodityContractMember 2023-07-01 2023-09-30 0000021076 us-gaap:CommodityContractMember 2022-07-01 2022-09-30 0000021076 us-gaap:ForeignExchangeContractMember 2023-07-01 2023-09-30 0000021076 us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0000021076 us-gaap:InterestRateContractMember 2023-07-01 2023-09-30 0000021076 us-gaap:InterestRateContractMember 2022-07-01 2022-09-30 0000021076 us-gaap:CommodityContractMember 2023-09-30 0000021076 us-gaap:CommodityContractMember 2023-06-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000021076 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-06-30 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember 2023-09-30 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember 2023-09-30 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember 2023-06-30 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember 2023-06-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember clx:NotesAndLoansPayableMember 2023-09-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember clx:NotesAndLoansPayableMember 2023-09-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember clx:NotesAndLoansPayableMember 2023-06-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember clx:NotesAndLoansPayableMember 2023-06-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LongTermDebtMember 2023-09-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:LongTermDebtMember 2023-09-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:LongTermDebtMember 2023-06-30 0000021076 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:LongTermDebtMember 2023-06-30 0000021076 us-gaap:CommonStockMember 2022-06-30 0000021076 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000021076 us-gaap:RetainedEarningsMember 2022-06-30 0000021076 us-gaap:TreasuryStockCommonMember 2022-06-30 0000021076 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000021076 us-gaap:NoncontrollingInterestMember 2022-06-30 0000021076 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000021076 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0000021076 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000021076 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000021076 us-gaap:TreasuryStockCommonMember 2022-07-01 2022-09-30 0000021076 us-gaap:CommonStockMember 2022-09-30 0000021076 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000021076 us-gaap:RetainedEarningsMember 2022-09-30 0000021076 us-gaap:TreasuryStockCommonMember 2022-09-30 0000021076 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000021076 us-gaap:NoncontrollingInterestMember 2022-09-30 0000021076 us-gaap:CommonStockMember 2023-06-30 0000021076 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000021076 us-gaap:RetainedEarningsMember 2023-06-30 0000021076 us-gaap:TreasuryStockCommonMember 2023-06-30 0000021076 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000021076 us-gaap:NoncontrollingInterestMember 2023-06-30 0000021076 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000021076 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0000021076 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000021076 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000021076 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0000021076 us-gaap:CommonStockMember 2023-09-30 0000021076 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000021076 us-gaap:RetainedEarningsMember 2023-09-30 0000021076 us-gaap:TreasuryStockCommonMember 2023-09-30 0000021076 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000021076 us-gaap:NoncontrollingInterestMember 2023-09-30 0000021076 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0000021076 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0000021076 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-30 0000021076 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0000021076 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2022-09-30 0000021076 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 2022-09-30 0000021076 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0000021076 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0000021076 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0000021076 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0000021076 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0000021076 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0000021076 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0000021076 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2023-09-30 0000021076 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0000021076 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0000021076 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0000021076 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0000021076 clx:RetirementIncomeMember country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-09-30 0000021076 clx:RetirementIncomeMember country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-07-01 2023-09-30 0000021076 srt:ScenarioForecastMember clx:RetirementIncomeMember country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-10-01 2023-12-31 0000021076 clx:RetirementIncomeMember country:US us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-07-01 2022-09-30 0000021076 clx:RetirementIncomeMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-07-01 2023-09-30 0000021076 clx:RetirementIncomeMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-07-01 2022-09-30 0000021076 clx:RetirementHealthCareMember us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2023-07-01 2023-09-30 0000021076 clx:RetirementHealthCareMember us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2022-07-01 2022-09-30 0000021076 clx:AlamedaCountyCaliforniaMatterMember 2023-06-30 0000021076 clx:AlamedaCountyCaliforniaMatterMember 2023-09-30 0000021076 clx:AlamedaCountyCaliforniaMatterMember 2023-07-01 2023-09-30 0000021076 clx:DickinsonCountyMichiganMatterMember 2023-09-30 0000021076 clx:DickinsonCountyMichiganMatterMember 2023-06-30 0000021076 clx:DickinsonCountyMichiganMatterMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:HealthAndWellnessMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:HealthAndWellnessMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:HouseholdMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:HouseholdMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:LifestyleMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:LifestyleMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:InternationalMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:InternationalMember 2022-07-01 2022-09-30 0000021076 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0000021076 us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0000021076 clx:OperatingSegmentsAndCorporateNonSegmentMember 2023-07-01 2023-09-30 0000021076 clx:OperatingSegmentsAndCorporateNonSegmentMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:CyberattackMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:CyberattackMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:CyberattackMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:CyberattackMember us-gaap:ProductConcentrationRiskMember clx:InternationalMember 2023-07-01 2023-09-30 0000021076 us-gaap:CorporateNonSegmentMember clx:CyberattackMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0000021076 clx:CyberattackMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:HealthAndWellnessMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:HealthAndWellnessMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:HealthAndWellnessMember 2022-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:HouseholdMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:HouseholdMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:HouseholdMember 2022-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:LifestyleMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:LifestyleMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:LifestyleMember 2022-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:InternationalMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:InternationalMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember clx:InternationalMember 2022-07-01 2023-09-30 0000021076 us-gaap:CorporateNonSegmentMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember 2023-07-01 2023-09-30 0000021076 us-gaap:CorporateNonSegmentMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember 2022-07-01 2022-09-30 0000021076 us-gaap:CorporateNonSegmentMember clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember 2022-07-01 2023-09-30 0000021076 clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember 2023-07-01 2023-09-30 0000021076 clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember 2022-07-01 2022-09-30 0000021076 clx:RestructuringAndRelatedCostsBenchmarkMember us-gaap:ProductConcentrationRiskMember us-gaap:EmployeeSeveranceMember 2022-07-01 2023-09-30 0000021076 clx:WalmartStoresIncMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0000021076 clx:WalmartStoresIncMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember clx:CleaningMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember clx:CleaningMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember clx:ProfessionalProductsMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember clx:ProfessionalProductsMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HealthAndWellnessMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember clx:BagsAndWrapsMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember clx:BagsAndWrapsMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember clx:CatLitterMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember clx:CatLitterMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember clx:GrillingMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember clx:GrillingMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:HouseholdMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember clx:FoodProductsMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember clx:FoodProductsMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember clx:NaturalPersonalCareMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember clx:NaturalPersonalCareMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember clx:WaterFiltrationMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember clx:WaterFiltrationMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:LifestyleMember 2022-07-01 2022-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:InternationalMember 2023-07-01 2023-09-30 0000021076 us-gaap:OperatingSegmentsMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember clx:InternationalMember 2022-07-01 2022-09-30 0000021076 us-gaap:CorporateNonSegmentMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0000021076 us-gaap:CorporateNonSegmentMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2022-07-01 2022-09-30 0000021076 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0000021076 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2022-07-01 2022-09-30 shares iso4217:USD iso4217:USD shares pure clx:reportableSegment 0000021076 false --06-30 Q1 2024 http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://www.clorox.com/20230930#OtherExpenseIncomeNet http://www.clorox.com/20230930#OtherExpenseIncomeNet http://www.clorox.com/20230930#OtherExpenseIncomeNet 10-Q true 2023-09-30 false 1-07151 THE CLOROX COMPANY DE 31-0595760 1221 Broadway Oakland CA 94612-1888 510 271-7000 Common Stock - $1.00 par value CLX NYSE Yes Yes Large Accelerated Filer false false false 124059098 1386000000 1740000000 854000000 1114000000 532000000 626000000 276000000 261000000 165000000 161000000 29000000 32000000 21000000 22000000 12000000 34000000 29000000 116000000 4000000 29000000 25000000 87000000 3000000 2000000 22000000 85000000 0.17 0.69 0.17 0.68 123973000 123339000 124650000 123914000 24000000 51000000 3000000 2000000 21000000 49000000 518000000 367000000 581000000 688000000 710000000 696000000 102000000 77000000 1911000000 1828000000 2768000000 2705000000 1317000000 1345000000 328000000 346000000 1246000000 1252000000 541000000 543000000 162000000 169000000 486000000 462000000 5991000000 5945000000 347000000 50000000 88000000 87000000 1678000000 1659000000 115000000 121000000 2228000000 1917000000 2478000000 2477000000 290000000 310000000 837000000 825000000 27000000 28000000 5860000000 5557000000 1.00 1.00 5000000 5000000 0 0 0 0 0 0 1.00 1.00 750000000 750000000 130741461 130741461 124001348 123820022 131000000 131000000 1246000000 1245000000 299000000 583000000 6740113 6921439 1219000000 1246000000 -494000000 -493000000 -37000000 220000000 168000000 168000000 131000000 388000000 5991000000 5945000000 25000000 87000000 61000000 56000000 13000000 10000000 -5000000 -5000000 -1000000 -16000000 -108000000 -63000000 14000000 6000000 22000000 30000000 -138000000 -28000000 -1000000 1000000 -8000000 14000000 20000000 178000000 24000000 46000000 -1000000 -1000000 -23000000 -45000000 298000000 111000000 149000000 145000000 6000000 -1000000 155000000 -35000000 0 -4000000 152000000 94000000 368000000 186000000 520000000 280000000 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2023 and 2022, in the opinion of management, reflect all normal and recurring adjustments considered necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2023, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations. These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the standard as of July 1, 2023. The adoption relates to disclosures only and does not have an impact on the condensed consolidated financial statements, results of operations, or cash flows.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements for the three months ended September 30, 2023 and 2022, in the opinion of management, reflect all normal and recurring adjustments considered necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its controlled subsidiaries (the Company or Clorox) for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2023, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-04, "Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” These amendments require disclosure of the key terms of outstanding supplier finance programs and a rollforward of the related obligations. These amendments are effective for fiscal years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the standard as of July 1, 2023. The adoption relates to disclosures only and does not have an impact on the condensed consolidated financial statements, results of operations, or cash flows.</span></div> CYBERATTACK<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On Monday, August 14, 2023, the Company disclosed it had identified unauthorized activity on some of its Information Technology (IT) systems. That activity began on Friday, August 11, 2023 and after becoming aware of it that evening, the Company immediately began taking steps to stop and remediate the activity. The Company also took certain systems offline and engaged third-party cybersecurity experts to support its investigation and recovery efforts. The Company implemented its business continuity plans, including manual ordering and processing procedures at a reduced rate of operations in order to continue servicing its customers. However, the incident resulted in wide-scale disruptions to the Company’s business operations throughout the remainder of the quarter.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of these system disruptions included order processing delays and significant product outages, resulting in a negative impact on net sales and earnings. The Company has since transitioned back to automated order processing and the vast majority of orders are taking place in an automated manner. The Company expects to experience ongoing, but lessening, operational impacts in the second quarter as it makes progress in returning to normalized operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also incurred</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> incremental expenses of approxima</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tely $24 as a result of the cyberattack for the three months ended September 30, 2023. The following table summarizes the recognition of costs in the condensed consolidated statement of earnings and comprehensive income:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:127%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">11 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total</span></div></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">24 </span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><br/></span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs incurred relate primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs incurred from the resulting disruption to the Company’s business operations. The Company expects to incur additional costs related to the </span></div>cyberattack in future periods. The Company has not recognized any insurance proceeds in the three months ended September 30, 2023 related to the cyberattack. The timing of recognizing insurance recoveries, if any, may differ from the timing of recognizing the associated expenses. 24000000 The following table summarizes the recognition of costs in the condensed consolidated statement of earnings and comprehensive income:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:127%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">11 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Selling and administrative expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total</span></div></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">24 </span></td><td style="background-color:#b6b6b6;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 11000000 13000000 24000000 0 SUPPLY CHAIN FINANCING PROGRAM<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has arranged for a global financial institution to offer a voluntary supply chain finance (SCF) program for the benefit of the Company’s suppliers. The Company’s current payment terms do not exceed 120 days in keeping with industry standards. The SCF program enables suppliers to directly contract with the financial institution to receive payment from the financial institution prior to the payment terms between the Company and the supplier by selling the Company’s payables to the financial institution. Participation in the program is at the sole discretion of the supplier and the Company has no economic interest in a supplier's decision to enter into the agreement and has no direct financial relationship with the financial institution, as it relates to the SCF program. Once a supplier elects to participate in the SCF program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices to sell to the financial institution. The terms of the Company’s payment obligations are not impacted by a supplier’s participation in the program and as such, the SCF program has no direct impact on the Company’s balance sheets, cash flows or liquidity. The Company and our subsidiaries have not pledged any assets as security or provided guarantees under the SCF program.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets and the associated payments are included in operating activities within the condensed consolidated statements of cash flows. As of September 30, 2023 and June 30, 2023, the amount due to suppliers participating in the SCF program and included in <span style="-sec-ix-hidden:f-214"><span style="-sec-ix-hidden:f-215">Accounts payable and accrued liabilities</span></span> was $119 and $220, respectively. The decrease in the amount due to suppliers participating in the SCF program from June 30, 2023 to September 30, 2023 was attributable to a reduction of orders due to the temporary operational disruptions of the cyberattack along with the timing of payments.</span></div> P120D 119000000 220000000 RESTRUCTURING AND RELATED COSTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2023, the Company began recognizing costs related to a plan that involves streamlining its operating model to meet its objectives of driving growth and productivity. The streamlined operating model is expected to enhance the Company’s ability to respond more quickly to changing consumer behaviors and innovate faster. The Company anticipates the implementation of this new model will be completed in fiscal year 2024, with different phases occurring throughout the implementation period.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred $60 of costs in fiscal year 2023 and anticipates incurring approximately $30 to $40 of costs in fiscal year 2024 related to this initiative, of which approximately $10 to $15 are expected to be employee-related costs to reduce certain staffing levels such as severance payments, with the remainder for consulting and other costs. Costs incurred are expected to be settled primarily in cash.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total restructuring and related implementation costs, net associated with the Company’s streamlined operating model plan as reflected in the condensed consolidated statements of earnings and comprehensive income:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.717%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Inception to date ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-225"><span style="-sec-ix-hidden:f-226"><span style="-sec-ix-hidden:f-227">Costs of products sold</span></span></span></span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(3)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-231"><span style="-sec-ix-hidden:f-232"><span style="-sec-ix-hidden:f-233">Selling and administrative expenses</span></span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-237"><span style="-sec-ix-hidden:f-238"><span style="-sec-ix-hidden:f-239">Research and development</span></span></span></span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-243"><span style="-sec-ix-hidden:f-244"><span style="-sec-ix-hidden:f-245">Employee-related costs</span></span></span></span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">52 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">60 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee-related costs primarily include severance and other termination benefits calculated based on salary levels, prior service and statutory requirements. Other costs primarily include consulting fees incurred for the organizational design and implementation of the streamlined operating model, related processes and other professional fees incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, decide to pursue additional restructuring-related initiatives that involve costs in future periods. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the accrual for the streamlined operating model’s restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June 30, 2023</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">23 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">5 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">28 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(16)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(21)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of September 30, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 60000000 30000000 40000000 10000000 15000000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total restructuring and related implementation costs, net associated with the Company’s streamlined operating model plan as reflected in the condensed consolidated statements of earnings and comprehensive income:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.717%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Inception to date ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">9/30/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-225"><span style="-sec-ix-hidden:f-226"><span style="-sec-ix-hidden:f-227">Costs of products sold</span></span></span></span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(3)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-231"><span style="-sec-ix-hidden:f-232"><span style="-sec-ix-hidden:f-233">Selling and administrative expenses</span></span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-237"><span style="-sec-ix-hidden:f-238"><span style="-sec-ix-hidden:f-239">Research and development</span></span></span></span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Other (income) expense, net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%"><span style="-sec-ix-hidden:f-243"><span style="-sec-ix-hidden:f-244"><span style="-sec-ix-hidden:f-245">Employee-related costs</span></span></span></span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">52 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Total, net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">19 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">60 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 0 -1000000 -3000000 0 1000000 12000000 0 0 -1000000 0 19000000 52000000 0 19000000 60000000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the accrual for the streamlined operating model’s restructuring and related implementation costs discussed above, which are recorded within Accounts payable and accrued liabilities in the condensed consolidated balance sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%">Employee-Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of June 30, 2023</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">23 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">5 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">28 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Charges</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Cash payments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(16)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">(21)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:127%">Accrual Balance as of September 30, 2023</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 23000000 5000000 28000000 0 0 0 16000000 5000000 21000000 7000000 0 7000000 INVENTORIES, NET<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2023</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Non-current inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Non-current inventories, net are recorded in Other assets.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following as of:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6/30/2023</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and packaging</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFO allowances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Non-current inventories, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current inventories, net</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Non-current inventories, net are recorded in Other assets.</span></div> 618000000 595000000 178000000 182000000 20000000 8000000 104000000 87000000 712000000 698000000 2000000 2000000 710000000 696000000 FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risk Management and Derivative Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain commodity, foreign currency and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity Price Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use commodity futures, options and swap contracts to limit the impact of price volatility on a portion of its forecasted raw material requirements. These commodity derivatives may be exchange traded or over-the-counter contracts and generally have original contractual maturities of less than 2 years. Commodity purchase and options contracts are measured at fair value using market quotations obtained from the Chicago Board of Trade commodity futures exchange and commodity derivative dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, and June 30, 2023, the notional amount of commodity derivatives was $36 and $41, respectively, which related primarily to exposures in soybean oil used for the Food business and jet fuel used for the Grilling business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into certain over-the-counter derivative contracts to manage a portion of the Company’s forecasted foreign currency exposure associated with the purchase of inventory. These foreign currency contracts generally have original contractual maturities of less than 2 years. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of outstanding foreign currency forward contracts used by the Company’s subsidiaries to hedge forecasted purchases of inventory were $55 and $51 as of September 30, 2023 and June 30, 2023, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may enter into over-the-counter interest rate contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate contracts generally have original contractual maturities of less than 3 years. The interest rate contracts are measured at fair value using information quoted by bond dealers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held no interest rate contracts as of both September 30, 2023 and June 30, 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commodity, Foreign Exchange and Interest Rate Derivatives </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its commodity forward, futures and options contracts for forecasted purchases of raw materials, foreign currency forward contracts for forecasted purchases of inventory and interest rate contracts for forecasted interest payments as cash flow hedges.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amount of the existing net gain (loss) in Accumulated other comprehensive net (loss) income as of September 30, 2023 that is expected to be reclassified into Net earnings within the next twelve months is $13. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Risk Management and Derivative Contract Requirements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes a variety of financial institutions as counterparties for over-the-counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually defined counterparty liability position limits. Of the over-the-counter derivative instruments in liability positions, $0 and $1 contained such terms as of September 30, 2023 and June 30, 2023, respectively. As of both September 30, 2023 and June 30, 2023, neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were exceeded.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain terms of the agreements governing the Company’s over-the-counter derivative instruments require the Company’s credit ratings, as assigned by Standard &amp; Poor’s and Moody’s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company’s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both September 30, 2023 and June 30, 2023, the Company and each of its counterparties had been assigned investment grade ratings by both Standard &amp; Poor’s and Moody’s.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s exchange traded futures and options contracts used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account held by the Company’s broker for trades conducted on that exchange. As of September 30, 2023 and June 30, 2023, the Company maintained cash margin balances </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to exchange traded futures and options contracts of $2 and $0, respectively, which are classified as Prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in mutual funds and cash equivalents as part of trust assets related to its nonqualified deferred compensation plans. The participants in the nonqualified deferred compensation plans, who are the Company’s current and former employees, may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The gains and losses on the trust assets are recorded in Other (income) expense, net in the condensed consolidated statements of earnings. The interests in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both September 30, 2023 and June 30, 2023, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company’s derivative instruments qualify for hedge accounting. The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value<br/>hierarchy<br/>level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value<br/>hierarchy<br/>level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,377 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company’s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div> P2Y 36000000 41000000 P2Y 55000000 51000000 P3Y <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments designated as hedging instruments on Other comprehensive (loss) income and Net earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) recognized in Other comprehensive (loss) income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -1000000 -3000000 1000000 1000000 0 0 0 -2000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of gains (losses) reclassified from Accumulated other comprehensive net (loss) income into Net earnings</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> -2000000 4000000 0 1000000 3000000 3000000 1000000 8000000 13000000 0 1000000 2000000 0 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following three categories of the fair value hierarchy:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of both September 30, 2023 and June 30, 2023, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund the Company’s nonqualified deferred compensation plans, which were classified as Level 1.</span></div> The following table provides information about the balance sheet classification and the fair values of the Company’s derivative instruments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value<br/>hierarchy<br/>level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase options contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase futures contracts</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity purchase swaps contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about the balance sheet classification and the fair values of the Company’s other assets and liabilities for which disclosure of fair value is required:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6/30/2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value<br/>hierarchy<br/>level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-bearing investments, including money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time deposits</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust assets for nonqualified deferred compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes and loans payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">term debt and Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,377 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company’s credit agreements, all of which are recorded at cost, which approximates fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</span></div> 0 0 2000000 2000000 1000000 1000000 0 0 2000000 2000000 0 0 3000000 3000000 2000000 2000000 1000000 1000000 0 0 0 0 1000000 1000000 1000000 1000000 1000000 1000000 388000000 388000000 243000000 243000000 16000000 16000000 9000000 9000000 137000000 137000000 129000000 129000000 541000000 541000000 381000000 381000000 347000000 347000000 50000000 50000000 2478000000 2259000000 2477000000 2327000000 2825000000 2606000000 2527000000 2377000000 INCOME TAXESIn determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings was 14.6% and 25.0% for the three months ended September 30, 2023 and 2022, respectively. The lower tax rate on earnings was primarily driven by the impact of temporary relief provided by the Internal Revenue Service relating to U.S. foreign tax credit regulations. 0.146 0.250 NET EARNINGS PER SHARE (EPS)<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,973</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,339</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,650</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,914</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,220</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Clorox.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,973</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,339</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,650</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,914</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive stock options and other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,220</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 123973000 123339000 677000 575000 124650000 123914000 2220000 2983000 COMPREHENSIVE INCOME<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></div></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Clorox</span></div></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of Comprehensive income for the periods indicated:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></div></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></div></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Total comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Clorox</span></div></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 25000000 87000000 -11000000 -29000000 -1000000 -8000000 -11000000 -1000000 -1000000 -36000000 24000000 51000000 3000000 2000000 21000000 49000000 STOCKHOLDERS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">’</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EQUITY </span><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders’ equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common stock</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury stock</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">net (loss) income</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders’ equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,202 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,589)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($2.36 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($2.40 per share declared)</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,246 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,740)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of Stockholders’ equity were as follows for the periods indicated: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30</span></td></tr><tr style="height:29pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:103%">(Dollars in millions except per share data; shares in thousands)</span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common stock</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury stock</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">net (loss) income</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders’ equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,202 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,048 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,589)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($2.36 per share declared)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,385)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">496 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to Clorox stockholders ($2.40 per share declared)</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other employee stock plan activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,741 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,246 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,740)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 131000000 130741000 1202000000 1048000000 -1346000000 7589000 -479000000 173000000 729000000 85000000 2000000 87000000 -36000000 -36000000 2.36 293000000 293000000 5000000 5000000 10000000 10000000 -19000000 -8000000 31000000 204000 4000000 131000000 130741000 1193000000 832000000 -1315000000 7385000 -515000000 170000000 496000000 131000000 130741000 1245000000 583000000 -1246000000 6921000 -493000000 168000000 388000000 22000000 3000000 25000000 -1000000 -1000000 2.40 300000000 300000000 3000000 3000000 13000000 13000000 -12000000 -6000000 27000000 181000 9000000 131000000 130741000 1246000000 299000000 -1219000000 6740000 -494000000 168000000 131000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension and postretirement benefit adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive net (loss) income</span></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2022</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense), and other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2023</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> -448000000 121000000 -152000000 -479000000 -29000000 -2000000 0 -31000000 0 8000000 -1000000 7000000 0 -2000000 0 -2000000 -29000000 -8000000 1000000 -36000000 -477000000 113000000 -151000000 -515000000 -445000000 99000000 -147000000 -493000000 -11000000 0 11000000 0 0 1000000 -3000000 -2000000 0 0 3000000 3000000 -11000000 -1000000 11000000 -1000000 -456000000 98000000 -136000000 -494000000 EMPLOYEE BENEFIT PLANS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a domestic qualified pension plan (the Plan). The Plan is frozen for all participants. The Plan generally was frozen effective June 30, 2011 for all employees, except for certain collectively bargained employees, whose Plan freeze was effective January 1, 2019. As a result of the Plan freeze, no employees are eligible to commence participation in the Plan or accrue any additional benefits under the Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2022, the Company’s Board of Directors approved a resolution to terminate the Plan. The amendment will allow the settlement of the pension obligation with either a lump sum payout or a purchased annuity. The Plan is fully funded under specified Employee Retirement Income Security Act (ERISA) funding rules as of September 30, 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In anticipation of this settlement, the Company remeasured the plan’s benefit obligation as of September 30, 2023, based on a discount rate of 5.0% which resulted in a net unrealized loss balance of $126, net of tax, ($165 before taxes) in Accumulated other comprehensive net (loss) income on its condensed consolidated balance sheet related to the Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal year 2024, a one-time non-cash settlement charge of approximately $165 (before taxes) is expected to be recognized in the Company’s condensed consolidated statement of earnings and comprehensive income, related to these net unrealized losses, as plan obligations are settled through both lump sum payouts and annuity purchases. The actual amount of the settlement charge could vary based on the final valuation of assets and liabilities. On October 10, 2023, the Company completed the annuity purchase related to the pension plan termination. On October 31, 2023, the Company paid out the lump sum amounts related to the termination.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss recognized</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2024 net periodic benefit cost is </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.5%.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic benefit cost for the Company’s retirement health care plans was $0 for both the three months ended September 30, 2023 and 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During both the three months ended September 30, 2023 and 2022, the Company made $2 in contributions to its domestic retirement income plans.</span></div>Service cost component of the net periodic benefit cost, if any, is reflected in employee benefit costs. All other components are reflected in Other (income) expense, net. 0.050 -126000000 -165000000 165000000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plans:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss recognized</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">The weighted average long-term expected rate of return on plan assets used in computing the fiscal year 2024 net periodic benefit cost is </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.5%.</span></div> 5000000 5000000 3000000 3000000 -1000000 0 -2000000 -2000000 5000000 4000000 0.035 0 0 2000000 2000000 OTHER CONTINGENCIES AND GUARANTEES<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain environmental matters, including response actions at various locations. The Company recorded liabilities totaling $28 as of both September 30, 2023 and June 30, 2023, respectively, for its share of aggregate future remediation costs related to these matters. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One matter, which accounted for $12 of the recorded liability as of both September 30, 2023 and June 30, 2023, respectively, relates to environmental costs associated with one of the Company’s former operations at a site located in Alameda County, California. In November 2016, at the request of regulators and with the assistance of environmental consultants, the Company submitted a Feasibility Study that evaluated various options for managing groundwater at the site and included estimates of the related costs. Following further discussions with the regulators in 2017, the Company recorded an undiscounted liability for costs estimated to be incurred over a 30-year period, based on one of the options in the Feasibility Study related to groundwater. In September 2021, as a result of an additional study and further discussions with regulators, the Company submitted a Soil Vapor Intrusion Report to the regulators. In January 2023, the regulators issued a new order directing the Company and the current property owner to conduct a Remedial Investigation and then prepare a Feasibility Study to evaluate and remediate impacts to soil, soil vapor and indoor air. While the Company believes its latest estimates of remediation costs (including any related to soil, soil vapor and indoor air impacts) are reasonable, the ultimate remediation requirements are not yet finalized and the regulators could require the Company to implement remediation actions for a longer period or take additional actions, which could include estimated undiscounted costs in the aggregate of up to approximately $28 over an estimated 30-year period, or require the Company to take different actions and incur additional costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another matter in Dickinson County, Michigan, at the site of one of the Company’s former operations for which the Company is jointly and severally liable, accounted for $10 of the recorded liability as of both September 30, 2023 and June 30, 2023, respectively. This amount reflects the Company’s agreement to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing agreement with a third party. If the third party is unable to pay its share of the response and remediation obligations, the Company may be responsible for such obligations. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Although it is reasonably possible that the Company’s exposure may exceed the amount recorded for the Dickinson County matter, any amount of such additional exposures, or range of exposures, is not estimable at this time.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s estimated losses related to these matters are sensitive to a variety of uncertain factors, including the efficacy of any remediation efforts, changes in any remediation requirements and the future availability of alternative clean-up technologies. From time to time, the Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to these proceedings, </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any material payments relating to its indemnifications and believes that any reasonably possible payments would not have a material adverse effect, either individually or in the aggregate, on the Company’s condensed consolidated financial statements taken as a whole.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had not recorded any material liabilities on the aforementioned guarantees as of both September 30, 2023 and June 30, 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was a party to letters of credit of $15 as of September 30, 2023, primarily related to its insurance carriers, of which $0 had been drawn upon.</span></div> 28000000 28000000 12000000 12000000 P30Y 28000000 P30Y 10000000 10000000 0.243 P30Y 15000000 0 SEGMENT RESULTS<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. Operating segments not aggregated into a reportable segment are reflected in Corporate and Other.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and Other includes certain non-allocated administrative costs and various other non-operating income and expenses, as well as the results of the Vitamins, Minerals and Supplements (VMS) business. Assets in Corporate and Other include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes, as well as the assets related to the VMS business.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principle measure of segment profitability used by management is segment adjusted earnings (losses) before interest and income taxes (segment adjusted EBIT). Segment adjusted EBIT is defined as earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as charges relating to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate and Other. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment adjusted EBIT</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyberattack costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Streamlined operating model </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital capabilities and productivity enhancements investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Represents incremental costs related to the cyberattack detailed in Note 2. For informational purposes the following table provides the approximate cyberattack costs corresponding to the Company’s reportable segments as a percentage of total costs:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:0.1%"></td><td style="width:1.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.654%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and Other</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Represents restructuring and related implementation costs, net for the streamlined operating model of $0 and $19 for the three months ended September 30, 2023 and 2022, respectively. For informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company’s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.374%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inception to date ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales to the Company’s largest customer, Walmart Inc. and its affiliates, as a percentage of consolidated net sales, were 27% for both the three months ended September 30, 2023 and 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company’s consolidated net sales, disaggregated by operating segment, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.582%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate and Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. Operating segments not aggregated into a reportable segment are reflected in Corporate and Other.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and Other includes certain non-allocated administrative costs and various other non-operating income and expenses, as well as the results of the Vitamins, Minerals and Supplements (VMS) business. Assets in Corporate and Other include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, operating lease right-of-use assets, other long-term assets and deferred taxes, as well as the assets related to the VMS business.</span></div> 4 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principle measure of segment profitability used by management is segment adjusted earnings (losses) before interest and income taxes (segment adjusted EBIT). Segment adjusted EBIT is defined as earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as charges relating to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions and other nonrecurring or unusual items impacting comparability).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present reportable segment information and a reconciliation of the segment information to the Company’s consolidated net sales and earnings (losses) before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate and Other. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment adjusted EBIT</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Household</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cyberattack costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Streamlined operating model </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digital capabilities and productivity enhancements investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Represents incremental costs related to the cyberattack detailed in Note 2. For informational purposes the following table provides the approximate cyberattack costs corresponding to the Company’s reportable segments as a percentage of total costs:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:0.1%"></td><td style="width:1.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.654%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and Other</span></div></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Represents restructuring and related implementation costs, net for the streamlined operating model of $0 and $19 for the three months ended September 30, 2023 and 2022, respectively. For informational purposes the following table provides the approximate restructuring and related implementation costs, net corresponding to the Company’s reportable segments as a percentage of the total costs: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.374%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inception to date ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Health and Wellness</span></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Household</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Represents expenses related to the Company’s digital capabilities and productivity enhancements investment corresponding to Corporate and Other.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides Net sales as a percentage of the Company’s consolidated net sales, disaggregated by operating segment, for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.582%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9/30/2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleaning</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health and Wellness</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bags and Wraps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cat Litter</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grilling</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Household</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natural Personal Care</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Water Filtration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lifestyle</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate and Other</span></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></div></td><td colspan="3" style="background-color:#b6b6b6;padding:0 1pt"></td><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#b6b6b6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 504000000 657000000 325000000 423000000 229000000 320000000 270000000 285000000 58000000 55000000 1386000000 1740000000 104000000 133000000 -4000000 22000000 19000000 60000000 34000000 23000000 -62000000 -63000000 91000000 175000000 10000000 2000000 21000000 22000000 24000000 0 0 19000000 27000000 20000000 29000000 116000000 0.22 0.11 0.14 0.01 0.52 1 0 19000000 0 0.06 0.06 0 0 0.01 0 0.05 0.03 0 0.19 0.16 0 0.70 0.74 0 1 1 0.27 0.27 0.32 0.33 0.04 0.05 0.36 0.38 0.11 0.11 0.08 0.08 0.05 0.05 0.24 0.24 0.09 0.10 0.03 0.04 0.05 0.05 0.17 0.19 0.19 0.16 0.04 0.03 1 1 2.40 2.36 false false false false EXCEL 65 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 66 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 67 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 68 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 216 221 1 false 62 0 false 5 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.clorox.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) Sheet http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.clorox.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 6 false false R7.htm 0000007 - Disclosure - CYBERATTACK Sheet http://www.clorox.com/role/CYBERATTACK CYBERATTACK Notes 7 false false R8.htm 0000008 - Disclosure - SUPPLY CHAIN FINANCING PROGRAM Sheet http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAM SUPPLY CHAIN FINANCING PROGRAM Notes 8 false false R9.htm 0000009 - Disclosure - RESTRUCTURING AND RELATED COSTS Sheet http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS RESTRUCTURING AND RELATED COSTS Notes 9 false false R10.htm 0000010 - Disclosure - INVENTORIES, NET Sheet http://www.clorox.com/role/INVENTORIESNET INVENTORIES, NET Notes 10 false false R11.htm 0000011 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS Sheet http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS Notes 11 false false R12.htm 0000012 - Disclosure - INCOME TAXES Sheet http://www.clorox.com/role/INCOMETAXES INCOME TAXES Notes 12 false false R13.htm 0000013 - Disclosure - NET EARNINGS PER SHARE (EPS) Sheet http://www.clorox.com/role/NETEARNINGSPERSHAREEPS NET EARNINGS PER SHARE (EPS) Notes 13 false false R14.htm 0000014 - Disclosure - COMPREHENSIVE INCOME Sheet http://www.clorox.com/role/COMPREHENSIVEINCOME COMPREHENSIVE INCOME Notes 14 false false R15.htm 0000015 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.clorox.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY Notes 15 false false R16.htm 0000016 - Disclosure - EMPLOYEE BENEFIT PLANS Sheet http://www.clorox.com/role/EMPLOYEEBENEFITPLANS EMPLOYEE BENEFIT PLANS Notes 16 false false R17.htm 0000017 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES Sheet http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES OTHER CONTINGENCIES AND GUARANTEES Notes 17 false false R18.htm 0000018 - Disclosure - SEGMENT RESULTS Sheet http://www.clorox.com/role/SEGMENTRESULTS SEGMENT RESULTS Notes 18 false false R19.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 19 false false R20.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 20 false false R21.htm 9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 9954472 - Disclosure - CYBERATTACK (Tables) Sheet http://www.clorox.com/role/CYBERATTACKTables CYBERATTACK (Tables) Tables http://www.clorox.com/role/CYBERATTACK 22 false false R23.htm 9954473 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables) Sheet http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables RESTRUCTURING AND RELATED COSTS (Tables) Tables http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS 23 false false R24.htm 9954474 - Disclosure - INVENTORIES, NET (Tables) Sheet http://www.clorox.com/role/INVENTORIESNETTables INVENTORIES, NET (Tables) Tables http://www.clorox.com/role/INVENTORIESNET 24 false false R25.htm 9954475 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables) Tables http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS 25 false false R26.htm 9954476 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables) Sheet http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables NET EARNINGS PER SHARE (EPS) (Tables) Tables http://www.clorox.com/role/NETEARNINGSPERSHAREEPS 26 false false R27.htm 9954477 - Disclosure - COMPREHENSIVE INCOME (Tables) Sheet http://www.clorox.com/role/COMPREHENSIVEINCOMETables COMPREHENSIVE INCOME (Tables) Tables http://www.clorox.com/role/COMPREHENSIVEINCOME 27 false false R28.htm 9954478 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.clorox.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.clorox.com/role/STOCKHOLDERSEQUITY 28 false false R29.htm 9954479 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) Sheet http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables EMPLOYEE BENEFIT PLANS (Tables) Tables http://www.clorox.com/role/EMPLOYEEBENEFITPLANS 29 false false R30.htm 9954480 - Disclosure - SEGMENT RESULTS (Tables) Sheet http://www.clorox.com/role/SEGMENTRESULTSTables SEGMENT RESULTS (Tables) Tables http://www.clorox.com/role/SEGMENTRESULTS 30 false false R31.htm 9954481 - Disclosure - CYBERATTACK (Narrative) (Details) Sheet http://www.clorox.com/role/CYBERATTACKNarrativeDetails CYBERATTACK (Narrative) (Details) Details http://www.clorox.com/role/CYBERATTACKTables 31 false false R32.htm 9954482 - Disclosure - CYBERATTACK (Summary of Costs Recognized From Cyberattack) (Details) Sheet http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails CYBERATTACK (Summary of Costs Recognized From Cyberattack) (Details) Details http://www.clorox.com/role/CYBERATTACKTables 32 false false R33.htm 9954483 - Disclosure - SUPPLY CHAIN FINANCING PROGRAM (Details) Sheet http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails SUPPLY CHAIN FINANCING PROGRAM (Details) Details http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAM 33 false false R34.htm 9954484 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details) Sheet http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails RESTRUCTURING AND RELATED COSTS (Narrative) (Details) Details http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables 34 false false R35.htm 9954485 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details) Sheet http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details) Details http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables 35 false false R36.htm 9954486 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details) Sheet http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details) Details http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables 36 false false R37.htm 9954487 - Disclosure - INVENTORIES, NET (Details) Sheet http://www.clorox.com/role/INVENTORIESNETDetails INVENTORIES, NET (Details) Details http://www.clorox.com/role/INVENTORIESNETTables 37 false false R38.htm 9954488 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) Sheet http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) Details http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables 38 false false R39.htm 9954489 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) Sheet http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) Details http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables 39 false false R40.htm 9954490 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details) Sheet http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details) Details http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables 40 false false R41.htm 9954491 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) Sheet http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) Details http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables 41 false false R42.htm 9954492 - Disclosure - INCOME TAXES (Details) Sheet http://www.clorox.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.clorox.com/role/INCOMETAXES 42 false false R43.htm 9954493 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares) (Details) Sheet http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares) (Details) Details http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables 43 false false R44.htm 9954494 - Disclosure - COMPREHENSIVE INCOME (Details) Sheet http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails COMPREHENSIVE INCOME (Details) Details http://www.clorox.com/role/COMPREHENSIVEINCOMETables 44 false false R45.htm 9954495 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) Sheet http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails STOCKHOLDERS' EQUITY (Schedule of Equity) (Details) Details http://www.clorox.com/role/STOCKHOLDERSEQUITYTables 45 false false R46.htm 9954496 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details) Sheet http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details) Details http://www.clorox.com/role/STOCKHOLDERSEQUITYTables 46 false false R47.htm 9954497 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details) Sheet http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails EMPLOYEE BENEFIT PLANS (Narrative) (Details) Details http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables 47 false false R48.htm 9954498 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details) Sheet http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details) Details http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables 48 false false R49.htm 9954499 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details) Sheet http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails OTHER CONTINGENCIES AND GUARANTEES (Details) Details http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES 49 false false R50.htm 9954500 - Disclosure - SEGMENT RESULTS (Narrative) (Details) Sheet http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails SEGMENT RESULTS (Narrative) (Details) Details http://www.clorox.com/role/SEGMENTRESULTSTables 50 false false R51.htm 9954501 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details) Sheet http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails SEGMENT RESULTS (Reportable Segment Information ) (Details) Details http://www.clorox.com/role/SEGMENTRESULTSTables 51 false false R52.htm 9954502 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details) Sheet http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails SEGMENT RESULTS (Net Sales Percentages) (Details) Details http://www.clorox.com/role/SEGMENTRESULTSTables 52 false false All Reports Book All Reports clx-20230930.htm clx-20230930.xsd clx-20230930_cal.xml clx-20230930_def.xml clx-20230930_lab.xml clx-20230930_pre.xml clx-20230930_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 70 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "clx-20230930.htm": { "nsprefix": "clx", "nsuri": "http://www.clorox.com/20230930", "dts": { "inline": { "local": [ "clx-20230930.htm" ] }, "schema": { "local": [ "clx-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "clx-20230930_cal.xml" ] }, "definitionLink": { "local": [ "clx-20230930_def.xml" ] }, "labelLink": { "local": [ "clx-20230930_lab.xml" ] }, "presentationLink": { "local": [ "clx-20230930_pre.xml" ] } }, "keyStandard": 206, "keyCustom": 15, "axisStandard": 24, "axisCustom": 1, "memberStandard": 35, "memberCustom": 26, "hidden": { "total": 19, "http://fasb.org/us-gaap/2023": 14, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 216, "entityCount": 1, "segmentCount": 62, "elementCount": 480, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 582, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.clorox.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "longName": "0000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R3": { "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:ReceivablesNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R4": { "role": "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "longName": "0000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R6": { "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "longName": "0000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.clorox.com/role/CYBERATTACK", "longName": "0000007 - Disclosure - CYBERATTACK", "shortName": "CYBERATTACK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAM", "longName": "0000008 - Disclosure - SUPPLY CHAIN FINANCING PROGRAM", "shortName": "SUPPLY CHAIN FINANCING PROGRAM", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS", "longName": "0000009 - Disclosure - RESTRUCTURING AND RELATED COSTS", "shortName": "RESTRUCTURING AND RELATED COSTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.clorox.com/role/INVENTORIESNET", "longName": "0000010 - Disclosure - INVENTORIES, NET", "shortName": "INVENTORIES, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS", "longName": "0000011 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS", "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "clx:FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.clorox.com/role/INCOMETAXES", "longName": "0000012 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.clorox.com/role/NETEARNINGSPERSHAREEPS", "longName": "0000013 - Disclosure - NET EARNINGS PER SHARE (EPS)", "shortName": "NET EARNINGS PER SHARE (EPS)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.clorox.com/role/COMPREHENSIVEINCOME", "longName": "0000014 - Disclosure - COMPREHENSIVE INCOME", "shortName": "COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITY", "longName": "0000015 - Disclosure - STOCKHOLDERS' EQUITY", "shortName": "STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS", "longName": "0000016 - Disclosure - EMPLOYEE BENEFIT PLANS", "shortName": "EMPLOYEE BENEFIT PLANS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES", "longName": "0000017 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES", "shortName": "OTHER CONTINGENCIES AND GUARANTEES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.clorox.com/role/SEGMENTRESULTS", "longName": "0000018 - Disclosure - SEGMENT RESULTS", "shortName": "SEGMENT RESULTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": null }, "R20": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "ecd:Rule10b51ArrTrmntdFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "ecd:Rule10b51ArrTrmntdFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "longName": "9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.clorox.com/role/CYBERATTACKTables", "longName": "9954472 - Disclosure - CYBERATTACK (Tables)", "shortName": "CYBERATTACK (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfUnusualOrInfrequentItemsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfUnusualOrInfrequentItemsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables", "longName": "9954473 - Disclosure - RESTRUCTURING AND RELATED COSTS (Tables)", "shortName": "RESTRUCTURING AND RELATED COSTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.clorox.com/role/INVENTORIESNETTables", "longName": "9954474 - Disclosure - INVENTORIES, NET (Tables)", "shortName": "INVENTORIES, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables", "longName": "9954475 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)", "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables", "longName": "9954476 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)", "shortName": "NET EARNINGS PER SHARE (EPS) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMETables", "longName": "9954477 - Disclosure - COMPREHENSIVE INCOME (Tables)", "shortName": "COMPREHENSIVE INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables", "longName": "9954478 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables", "longName": "9954479 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)", "shortName": "EMPLOYEE BENEFIT PLANS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.clorox.com/role/SEGMENTRESULTSTables", "longName": "9954480 - Disclosure - SEGMENT RESULTS (Tables)", "shortName": "SEGMENT RESULTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "longName": "9954481 - Disclosure - CYBERATTACK (Narrative) (Details)", "shortName": "CYBERATTACK (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherNonrecurringExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:UnusualOrInfrequentItemInsuranceProceeds", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R32": { "role": "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "longName": "9954482 - Disclosure - CYBERATTACK (Summary of Costs Recognized From Cyberattack) (Details)", "shortName": "CYBERATTACK (Summary of Costs Recognized From Cyberattack) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherNonrecurringExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-9", "name": "us-gaap:OtherNonrecurringExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R33": { "role": "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails", "longName": "9954483 - Disclosure - SUPPLY CHAIN FINANCING PROGRAM (Details)", "shortName": "SUPPLY CHAIN FINANCING PROGRAM (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:SupplierFinanceProgramObligationCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:SupplierFinanceProgramObligationCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "longName": "9954484 - Disclosure - RESTRUCTURING AND RELATED COSTS (Narrative) (Details)", "shortName": "RESTRUCTURING AND RELATED COSTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R35": { "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails", "longName": "9954485 - Disclosure - RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)", "shortName": "RESTRUCTURING AND RELATED COSTS (Restructuring and Related Costs) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-17", "name": "us-gaap:RestructuringAndRelatedCostIncurredCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R36": { "role": "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails", "longName": "9954486 - Disclosure - RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)", "shortName": "RESTRUCTURING AND RELATED COSTS (Accrual Reconciliation) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.clorox.com/role/INVENTORIESNETDetails", "longName": "9954487 - Disclosure - INVENTORIES, NET (Details)", "shortName": "INVENTORIES, NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails", "longName": "9954488 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)", "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails", "longName": "9954489 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)", "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails", "longName": "9954490 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)", "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Values of Derivative Instruments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-61", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-61", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "longName": "9954491 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)", "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-61", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R42": { "role": "http://www.clorox.com/role/INCOMETAXESDetails", "longName": "9954492 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails", "longName": "9954493 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares) (Details)", "shortName": "NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R44": { "role": "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails", "longName": "9954494 - Disclosure - COMPREHENSIVE INCOME (Details)", "shortName": "COMPREHENSIVE INCOME (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R45": { "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails", "longName": "9954495 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)", "shortName": "STOCKHOLDERS' EQUITY (Schedule of Equity) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R46": { "role": "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails", "longName": "9954496 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)", "shortName": "STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses)) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-106", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R47": { "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "longName": "9954497 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)", "shortName": "EMPLOYEE BENEFIT PLANS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-137", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-137", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "longName": "9954498 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)", "shortName": "EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-141", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-141", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails", "longName": "9954499 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)", "shortName": "OTHER CONTINGENCIES AND GUARANTEES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AccrualForEnvironmentalLossContingencies", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "us-gaap:AccrualForEnvironmentalLossContingencies", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AccrualForEnvironmentalLossContingencies", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "us-gaap:AccrualForEnvironmentalLossContingencies", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "longName": "9954500 - Disclosure - SEGMENT RESULTS (Narrative) (Details)", "shortName": "SEGMENT RESULTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "reportablesegment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "reportablesegment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails", "longName": "9954501 - Disclosure - SEGMENT RESULTS (Reportable Segment Information ) (Details)", "shortName": "SEGMENT RESULTS (Reportable Segment Information ) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentIncomeInterestAndDividend", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "unique": true } }, "R52": { "role": "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "longName": "9954502 - Disclosure - SEGMENT RESULTS (Net Sales Percentages) (Details)", "shortName": "SEGMENT RESULTS (Net Sales Percentages) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-215", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-215", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "clx-20230930.htm", "first": true, "unique": true } } }, "tag": { "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r430", "r822" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r758" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r12", "r140", "r156", "r477", "r478", "r818" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r761" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r760" ] }, "us-gaap_SupplierFinanceProgramTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramTextBlock", "presentation": [ "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAM" ], "lang": { "en-us": { "role": { "terseLabel": "SUPPLY CHAIN FINANCING PROGRAM", "label": "Supplier Finance Program [Text Block]", "documentation": "The entire disclosure for supplier finance program." } } }, "auth_ref": [ "r289", "r290", "r291", "r682" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r794" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r460", "r461", "r462", "r587", "r819", "r820", "r821", "r871", "r891" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r596", "r599", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r614", "r615", "r616", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r645", "r646", "r651", "r653", "r709", "r711" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r759" ] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r216", "r430", "r800", "r801", "r822" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r819", "r820", "r871", "r888", "r891" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r758" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r759" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r216", "r430", "r800", "r822" ] }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostIncurredCost", "crdr": "debit", "calculation": { "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related implementation, incurred cost", "verboseLabel": "Total, net", "negatedLabel": "Streamlined operating model", "label": "Restructuring and Related Cost, Incurred Cost", "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost." } } }, "auth_ref": [ "r297", "r300", "r304", "r306" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r760" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r298", "r814" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net unrealized loss in AOCI, before taxes", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r5", "r117", "r138" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Domain]", "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r164" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r219", "r227" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type [Axis]", "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r589", "r591", "r592", "r594", "r597", "r636", "r638", "r640", "r643", "r644", "r655", "r656", "r658", "r659", "r660", "r661", "r662", "r711" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r760" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r105", "r542", "r707" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r218", "r227" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r17", "r33", "r158", "r187", "r188", "r189", "r203", "r204", "r205", "r207", "r213", "r215", "r232", "r274", "r275", "r349", "r460", "r461", "r462", "r473", "r474", "r496", "r497", "r498", "r499", "r500", "r501", "r504", "r514", "r516", "r517", "r518", "r519", "r520", "r524", "r572", "r573", "r574", "r587", "r631" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r724", "r735", "r745", "r770" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r760" ] }, "us-gaap_SupplierFinanceProgramPaymentTimingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramPaymentTimingPeriod", "presentation": [ "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SCF payment term", "label": "Supplier Finance Program, Payment Timing, Period", "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r290" ] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets, estimated fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r95" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r158", "r203", "r204", "r205", "r207", "r213", "r215", "r274", "r275", "r460", "r461", "r462", "r473", "r474", "r496", "r498", "r499", "r501", "r504", "r572", "r574", "r587", "r891" ] }, "us-gaap_SupplierFinanceProgramObligationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationCurrent", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount due to suppliers participating in SCF", "label": "Supplier Finance Program, Obligation, Current", "documentation": "Amount of obligation for supplier finance program, classified as current." } } }, "auth_ref": [ "r292", "r293", "r294" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement benefit adjustments", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r6", "r16", "r36", "r810", "r811", "r812" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r761" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r726", "r737", "r747", "r772" ] }, "us-gaap_InvestmentIncomeInterestAndDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterestAndDividend", "crdr": "credit", "calculation": { "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest and Dividend", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r123" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r780" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted net earnings per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r195", "r208", "r209", "r210", "r211", "r212", "r220", "r225", "r226", "r227", "r231", "r505", "r506", "r536", "r558", "r676" ] }, "us-gaap_InventoryNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNoncurrent", "crdr": "debit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails": { "parentTag": "clx_InventoryCurrentAndNoncurrentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Non-current inventories, net", "label": "Inventory, Noncurrent", "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle." } } }, "auth_ref": [ "r806" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r725", "r736", "r746", "r771" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r722" ] }, "us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program, classified as current." } } }, "auth_ref": [ "r293" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r761" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r16", "r36", "r188", "r189", "r516", "r517", "r518", "r519", "r520", "r810" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity Note [Abstract]", "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS' EQUITY", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r134", "r199", "r333", "r335", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r347", "r349", "r503", "r634", "r635", "r664" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r17", "r158", "r187", "r188", "r189", "r203", "r204", "r205", "r207", "r213", "r215", "r232", "r274", "r275", "r349", "r460", "r461", "r462", "r473", "r474", "r496", "r497", "r498", "r499", "r500", "r501", "r504", "r514", "r516", "r517", "r518", "r519", "r520", "r524", "r572", "r573", "r574", "r587", "r631" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 }, "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r27", "r200", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r486", "r490", "r491", "r512", "r600", "r677", "r718", "r835", "r875", "r876" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r144", "r168", "r200", "r238", "r259", "r265", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r485", "r490", "r512", "r539", "r612", "r707", "r718", "r835", "r836", "r875" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive net (loss) income", "verboseLabel": "Accumulated other comprehensive net (loss) income", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r16", "r36", "r497", "r500", "r524", "r572", "r573", "r810", "r811", "r812", "r819", "r820", "r821" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r755" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r761" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operations:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramLineItems", "presentation": [ "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Line Items]", "label": "Supplier Finance Program [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r290", "r292", "r293" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r154", "r157", "r214", "r215", "r246", "r468", "r476", "r559" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments [Domain]", "label": "Investments [Domain]", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r589", "r591", "r592", "r594", "r597", "r636", "r638", "r640", "r643", "r644", "r655", "r656", "r658", "r659", "r660", "r661", "r662", "r711" ] }, "us-gaap_SupplierFinanceProgramTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierFinanceProgramTable", "presentation": [ "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Table]", "label": "Supplier Finance Program [Table]", "documentation": "Disclosure of information about supplier finance program." } } }, "auth_ref": [ "r290", "r292", "r293" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r12", "r243" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r761" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r761" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r187", "r188", "r514", "r516", "r517", "r518", "r519", "r520" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r42", "r45", "r98", "r99", "r272", "r665" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEES" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER CONTINGENCIES AND GUARANTEES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r133", "r308", "r309", "r666", "r831" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive net (loss) income", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r35", "r36", "r117", "r173", "r544", "r576", "r577" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r507", "r508", "r509" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r732", "r743", "r753", "r778" ] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfShortTermDebt", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Notes and loans payable, net", "label": "Proceeds from (Repayments of) Short-Term Debt", "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r51", "r165", "r548" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r719" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities, estimated fair value", "label": "Financial Liabilities Fair Value Disclosure", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r42", "r45", "r98", "r99", "r272", "r578", "r665" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r24" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r297", "r298", "r304", "r305" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BankTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankTimeDepositsMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Time deposits", "label": "Bank Time Deposits [Member]", "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest." } } }, "auth_ref": [ "r153" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r721" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Basic net earnings per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r195", "r208", "r209", "r210", "r211", "r212", "r218", "r220", "r225", "r226", "r227", "r231", "r505", "r506", "r536", "r558", "r676" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r43", "r272" ] }, "clx_RetirementIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "RetirementIncomeMember", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Income Plans", "label": "Retirement Income Plans [Member]", "documentation": "Retirement Income [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r106" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r297", "r298", "r304", "r305" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee-Related Costs", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r25" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r84", "r86", "r87", "r89", "r596", "r599", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r613", "r614", "r615", "r616", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r645", "r646", "r651", "r653", "r674", "r709", "r711" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September\u00a030, 2023 and June\u00a030, 2023; and 124,001,348 and 123,820,022 shares outstanding as of September\u00a030, 2023 and June\u00a030, 2023, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r106", "r543", "r707" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Inventory Disclosure [Abstract]", "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r297", "r298", "r299", "r300", "r304", "r305", "r306" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r507", "r508", "r509" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r106", "r602" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Beginning balance, common stock (in shares)", "periodEndLabel": "Ending balance, common stock (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r17", "r106", "r602", "r617", "r891", "r892" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r71", "r72", "r432" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, cash equivalents and restricted cash:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "clx_OtherEmployeeStockPlanActivitiesShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "OtherEmployeeStockPlanActivitiesShares", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other employee stock plan activities (in shares)", "label": "Other Employee Stock Plan Activities, Shares", "documentation": "Number of shares issued during the period as a result of exercises of employee stock options or the vesting of other share-based awards." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Costs", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r52", "r54", "r55" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r297", "r298", "r299", "r300", "r304", "r305", "r306" ] }, "us-gaap_OtherIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets, net", "label": "Other Intangible Assets, Net", "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Advertising costs", "label": "Advertising Expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r463" ] }, "us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes incurred restructuring and related costs." } } }, "auth_ref": [ "r798", "r799" ] }, "us-gaap_Dividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Dividends", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends to Clorox stockholders", "label": "Dividends", "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock." } } }, "auth_ref": [ "r9", "r137" ] }, "clx_NotesAndLoansPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "NotesAndLoansPayableMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes and loans payable", "label": "Notes And Loans Payable [Member]", "documentation": "Notes and Loans Payable [Member]" } } }, "auth_ref": [] }, "clx_CatLitterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "CatLitterMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cat Litter", "label": "Cat Litter [Member]", "documentation": "Cat Litter [Member]" } } }, "auth_ref": [] }, "clx_PurchasesofInventoryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "PurchasesofInventoryMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases of Inventory", "label": "Purchases of Inventory [Member]", "documentation": "Purchases of Inventory [Member]" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r823" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling and administrative expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories, net", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development costs", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r102", "r464", "r883" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of products sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r121", "r530" ] }, "clx_LifestyleMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "LifestyleMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lifestyle", "label": "Lifestyle [Member]", "documentation": "Lifestyle [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r731", "r742", "r752", "r777" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails", "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive income", "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r78", "r141", "r184", "r186", "r192", "r533", "r555" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities for Fair Value Disclosure", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r95", "r96" ] }, "clx_InternationalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "InternationalMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International", "label": "International [Member]", "documentation": "International [Member]" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends to noncontrolling interests", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r137" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration percentage", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r42", "r45", "r98", "r99", "r272" ] }, "clx_HealthAndWellnessMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "HealthAndWellnessMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Health and Wellness", "label": "Health and Wellness [Member]", "documentation": "Health and Wellness" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails", "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Total comprehensive income attributable to noncontrolling interests", "verboseLabel": "Less: Total comprehensive income attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r10", "r75", "r78", "r184", "r186", "r193", "r534", "r556" ] }, "clx_SiteContingencyAgreedPercentageOfCostSharing": { "xbrltype": "percentItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "SiteContingencyAgreedPercentageOfCostSharing", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of liability for aggregate remediation and associated costs, other than legal fees", "label": "Percentage of liability for aggregate remediation and associated costs, other than legal fees", "documentation": "The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r331", "r380", "r381", "r382", "r383", "r384", "r385", "r508", "r525", "r526", "r527", "r688", "r689", "r692", "r693", "r694" ] }, "us-gaap_MarginDepositAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarginDepositAssets", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash margin balances amount", "label": "Margin Deposit Assets", "documentation": "The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer." } } }, "auth_ref": [ "r598", "r806" ] }, "clx_RemediationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "RemediationPeriod", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remediation period (in years)", "label": "Remediation period", "documentation": "Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site." } } }, "auth_ref": [] }, "clx_FoodProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "FoodProductsMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Food", "label": "Food Products [Member]", "documentation": "Food Products [Member]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average long-term expected rate or return on plan assets (percentage)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets", "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r401", "r423" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r731", "r742", "r752", "r777" ] }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMETables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Comprehensive Income", "label": "Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r116" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r763" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r162", "r175", "r200", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r485", "r490", "r512", "r707", "r835", "r836", "r875" ] }, "clx_NaturalPersonalCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "NaturalPersonalCareMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Natural Personal Care", "label": "Natural Personal Care [Member]", "documentation": "Natural Personal Care [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "verboseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r762" ] }, "us-gaap_UnusualOrInfrequentItemAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemAxis", "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual or Infrequent Item, or Both [Axis]", "label": "Unusual or Infrequent Item, or Both [Axis]", "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r125" ] }, "clx_OtherEmployeeStockPlanActivitiesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "OtherEmployeeStockPlanActivitiesAmount", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other employee stock plan activities", "label": "Other Employee Stock Plan Activities, Amount", "documentation": "Amount includes the value of stock granted during the period as a result of exercises of employee stock options or vesting of other share-based awards." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_UnusualOrInfrequentItemDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemDomain", "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual or Infrequent Item, or Both [Domain]", "label": "Unusual or Infrequent Item, or Both [Domain]", "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r125" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interests", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r73", "r349", "r819", "r820", "r821", "r891" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest-bearing investments, including money market funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r839" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive stock options and other (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r228" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r732", "r743", "r753", "r778" ] }, "us-gaap_UnusualOrInfrequentItemLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemLineItems", "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]", "label": "Unusual or Infrequent Item, or Both [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r523" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings attributable to Clorox", "terseLabel": "Net Income (Loss)", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r119", "r129", "r151", "r161", "r182", "r185", "r189", "r200", "r206", "r208", "r209", "r210", "r211", "r214", "r215", "r224", "r238", "r258", "r264", "r267", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r506", "r512", "r553", "r618", "r629", "r630", "r678", "r716", "r835" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r167" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings per share attributable to Clorox", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r762" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r272", "r691", "r838", "r886", "r887" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r73", "r74", "r76", "r158", "r159", "r188", "r203", "r204", "r205", "r207", "r213", "r274", "r275", "r349", "r460", "r461", "r462", "r473", "r474", "r496", "r497", "r498", "r499", "r500", "r501", "r504", "r514", "r516", "r520", "r524", "r573", "r574", "r585", "r604", "r617", "r632", "r633", "r663", "r717", "r817", "r825", "r872", "r891" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate and Other", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r19", "r258", "r259", "r260", "r261", "r267", "r824" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r311", "r312", "r314", "r315", "r377", "r429", "r456", "r457", "r458", "r528", "r529", "r571", "r598", "r599", "r637", "r639", "r641", "r642", "r657", "r667", "r668", "r680", "r690", "r702", "r708", "r711", "r828", "r837", "r878", "r879", "r880", "r881", "r882" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Net Periodic Benefit Cost", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r139" ] }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum duration, foreign exchange contracts (in years)", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments." } } }, "auth_ref": [ "r15" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTS" ], "lang": { "en-us": { "role": { "terseLabel": "SEGMENT RESULTS", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r250", "r261", "r265", "r266", "r267", "r268", "r269", "r270", "r272" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r331", "r380", "r385", "r508", "r526", "r688", "r689", "r692", "r693", "r694" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r762" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r11" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r331", "r380", "r385", "r508", "r525", "r692", "r693", "r694" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r311", "r312", "r314", "r315", "r429", "r529", "r571", "r598", "r599", "r637", "r639", "r641", "r642", "r657", "r667", "r668", "r680", "r690", "r702", "r708", "r837", "r877", "r878", "r879", "r880", "r881", "r882" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails", "http://www.clorox.com/role/SUPPLYCHAINFINANCINGPROGRAMDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r311", "r312", "r314", "r315", "r377", "r429", "r456", "r457", "r458", "r528", "r529", "r571", "r598", "r599", "r637", "r639", "r641", "r642", "r657", "r667", "r668", "r680", "r690", "r702", "r708", "r711", "r828", "r837", "r878", "r879", "r880", "r881", "r882" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Selected Financial Information Relating to the Company's Segments", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r47", "r48", "r49", "r50" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r523" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r757" ] }, "us-gaap_IncreaseDecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReceivables", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Receivables, net", "label": "Increase (Decrease) in Receivables", "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r11" ] }, "us-gaap_UnusualOrInfrequentItemTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemTable", "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual or Infrequent Item, or Both [Table]", "label": "Unusual or Infrequent Item, or Both [Table]", "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r125" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r130" ] }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/CYBERATTACK" ], "lang": { "en-us": { "role": { "terseLabel": "CYBERATTACK", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]", "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r124" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r311", "r312", "r314", "r315", "r429", "r529", "r571", "r598", "r599", "r637", "r639", "r641", "r642", "r657", "r667", "r668", "r680", "r690", "r702", "r708", "r837", "r877", "r878", "r879", "r880", "r881", "r882" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r47", "r48", "r49", "r50" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r757" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r731", "r742", "r752", "r777" ] }, "us-gaap_UnusualOrInfrequentItemInsuranceProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemInsuranceProceeds", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance proceeds", "label": "Unusual or Infrequent Item, or Both, Insurance Proceeds", "documentation": "Amount of insurance proceeds for an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r125" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.clorox.com/role/INVENTORIESNETTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Inventories, Net", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r23", "r112", "r113", "r114" ] }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "presentation": [ "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares", "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)." } } }, "auth_ref": [ "r40" ] }, "clx_OtherExpenseIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "OtherExpenseIncomeNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other (income) expense, net", "label": "Other Expense (Income), Net", "documentation": "The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines." } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityTableTextBlock", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stockholders Equity", "label": "Schedule of Stockholders Equity [Table Text Block]", "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented." } } }, "auth_ref": [ "r17" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r299", "r619" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related implementation, expected cost", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r297", "r300", "r304", "r306" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r120", "r200", "r238", "r258", "r264", "r267", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r512", "r678", "r835" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r105", "r334" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r720" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r105", "r602", "r617", "r891", "r892" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r126" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r14", "r67", "r68", "r69", "r70" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r111", "r149", "r547", "r707", "r817", "r825", "r872" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r107" ] }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r83" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r720" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r105", "r334" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash dividends paid to Clorox stockholders", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r38" ] }, "clx_OperatingLeaseRightofUseAssetAndLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "OperatingLeaseRightofUseAssetAndLiabilityNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets and liabilities, net", "label": "Operating Lease, Right-of-Use Asset And Liability, Net", "documentation": "Operating Lease, Right-of-Use Asset And Liability, Net" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r160", "r235", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r272", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r288", "r300", "r306", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r681", "r805", "r886" ] }, "us-gaap_LongTermDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current maturities of long-term debt and Long-term debt", "label": "Long-Term Debt [Member]", "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.clorox.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective tax rate on earnings from continuing operations", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current maturities of long-term debt and Long-term debt", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r22", "r147", "r330", "r332", "r688", "r689", "r885" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r720" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r720" ] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Effects of Derivative Instruments Designated as Hedging Instruments on OCI", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r88" ] }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccrualForEnvironmentalLossContingencies", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for aggregate future remediation costs", "label": "Accrual for Environmental Loss Contingencies", "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies." } } }, "auth_ref": [ "r313", "r683", "r796", "r797", "r829", "r832" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r729", "r740", "r750", "r775" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r720" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "clx_DickinsonCountyMichiganMatterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "DickinsonCountyMichiganMatterMember", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dickinson County, Michigan Matter", "label": "Dickinson County, Michigan Matter [Member]", "documentation": "Dickinson County, Michigan Matter [Member]" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r734", "r742", "r752", "r769", "r777", "r781", "r789" ] }, "us-gaap_ShorttermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShorttermDebtFairValue", "crdr": "credit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes and loans payable, estimated fair value", "label": "Short-Term Debt, Fair Value", "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863", "r864", "r865", "r866", "r867", "r868" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r720" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r28", "r163", "r200", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r486", "r490", "r491", "r512", "r707", "r835", "r875", "r876" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r310", "r311", "r312", "r316", "r833", "r834" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r734", "r742", "r752", "r769", "r777", "r781", "r789" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Nature [Axis]", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r310", "r311", "r312", "r316", "r833", "r834" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r720" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r18", "r84", "r87", "r89", "r92", "r93", "r494" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r310", "r311", "r312", "r316", "r833", "r834" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of credit, amount outstanding", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Axis]", "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r164" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Postretirement Benefits Plan", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r353", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r410", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r427", "r428", "r694", "r695", "r696", "r697", "r698" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r724", "r735", "r745", "r770" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANS" ], "lang": { "en-us": { "role": { "terseLabel": "EMPLOYEE BENEFIT PLANS", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r352", "r377", "r379", "r385", "r403", "r405", "r406", "r407", "r408", "r409", "r424", "r425", "r426", "r694" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r494" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r756" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r287", "r299", "r619" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r802", "r813" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current maturities of long-term debt and Long-term debt, estimated fair value", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r331", "r511", "r688", "r689" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate used for benefit obligation remeasurement", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan." } } }, "auth_ref": [ "r399" ] }, "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum duration, commodity contracts (in years)", "label": "Maximum Length of Time Hedged in Cash Flow Hedge", "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange forward contracts", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r606", "r610", "r615", "r623", "r627", "r649", "r650", "r651", "r711" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r202", "r240", "r257", "r258", "r259", "r260", "r261", "r263", "r267", "r317", "r318", "r319", "r320", "r322", "r323", "r325", "r327", "r328", "r835", "r836" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Pension and postretirement benefit adjustments", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r7", "r117" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3" ] }, "us-gaap_MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum duration, interest rate contracts (in years)", "label": "Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge", "documentation": "Maximum period the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r15" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive (loss) income, net of tax", "terseLabel": "Other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r17", "r21", "r183", "r186", "r191", "r514", "r515", "r520", "r532", "r554", "r810", "r811" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Selling and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r122" ] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trust assets for nonqualified deferred compensation plans, estimated fair value", "label": "Investments, Fair Value Disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r507" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r355", "r392", "r417", "r694", "r695" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r202", "r240", "r257", "r258", "r259", "r260", "r261", "r263", "r267", "r317", "r318", "r319", "r320", "r322", "r323", "r325", "r327", "r328", "r835", "r836" ] }, "clx_InventoryCurrentAndNoncurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "InventoryCurrentAndNoncurrentNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.clorox.com/role/INVENTORIESNETDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total inventories, net", "label": "Inventory, Current And Noncurrent, Net", "documentation": "Inventory, Current And Noncurrent, Net" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r176", "r177", "r511", "r588", "r589", "r590", "r592", "r593", "r594", "r595", "r596", "r598", "r599", "r606", "r607", "r645", "r648", "r651", "r652", "r653", "r654", "r674", "r711", "r889" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r733", "r744", "r754", "r779" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r355", "r359", "r391", "r416", "r694", "r695" ] }, "us-gaap_DeferredCompensationPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationPlanAssets", "crdr": "debit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trust assets for nonqualified deferred compensation plans", "label": "Deferred Compensation Plan Assets", "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements." } } }, "auth_ref": [ "r806" ] }, "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanSettlementsBenefitObligation", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One-time non-cash before tax settlement charge", "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement", "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement." } } }, "auth_ref": [ "r358" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared per share (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r137" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net periodic benefit cost", "totalLabel": "Total", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r389", "r414", "r694", "r695" ] }, "us-gaap_InventoryLIFOReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryLIFOReserve", "crdr": "credit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails_1": { "parentTag": "clx_InventoryCurrentAndNoncurrentNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "LIFO allowances", "label": "Inventory, LIFO Reserve", "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods." } } }, "auth_ref": [ "r807" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r166", "r277", "r531", "r681", "r707", "r826", "r827" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement plan contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r370", "r380", "r422", "r692", "r693", "r694", "r695" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r731", "r742", "r752", "r777" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of unrecognized items", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r355", "r393", "r418", "r694", "r695" ] }, "clx_GrillingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "GrillingMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grilling", "label": "Grilling [Member]", "documentation": "Grilling [Member]" } } }, "auth_ref": [] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables, net", "label": "Receivables, Net, Current", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r707" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r757" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r20", "r95", "r331", "r688", "r689" ] }, "us-gaap_OtherRestructuringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestructuringMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Restructuring [Member]", "documentation": "Restructuring and related activities classified as other." } } }, "auth_ref": [ "r684", "r685", "r686", "r687" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails": { "parentTag": "clx_InventoryCurrentAndNoncurrentNet", "weight": 1.0, "order": 2.0 }, "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories, net", "verboseLabel": "Total current inventories, net", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r174", "r671", "r707" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interests", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r34", "r148", "r200", "r273", "r317", "r320", "r321", "r322", "r328", "r329", "r512", "r546", "r604" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r169" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange derivative contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r674", "r692", "r705" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateContractMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest rate derivative contracts", "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r669", "r674", "r692" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock (in shares)", "negatedPeriodStartLabel": "Beginning balance, treasury stock (in shares)", "negatedPeriodEndLabel": "Ending balance, treasury stock (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r65" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r353", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r410", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r427", "r428", "r431", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r18", "r79", "r80", "r81", "r82", "r85", "r87", "r90", "r91", "r93", "r502" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 }, "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "negatedTerseLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r100", "r152", "r190", "r242", "r521", "r620", "r716", "r890" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r235", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r272", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r300", "r306", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r681", "r805", "r886" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r176", "r177", "r511", "r588", "r589", "r590", "r592", "r594", "r595", "r596", "r598", "r599", "r613", "r615", "r616", "r646", "r647", "r648", "r651", "r652", "r653", "r654", "r674", "r889" ] }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes payable / prepaid", "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable", "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes." } } }, "auth_ref": [ "r815" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r353", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r401", "r402", "r404", "r407", "r410", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r427", "r428", "r431", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r780" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r790" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r65" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r791" ] }, "clx_MaximumExposureUndiscountedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "MaximumExposureUndiscountedCost", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum undiscounted costs", "label": "Maximum Exposure, Undiscounted Cost", "documentation": "Maximum potential amount of future payments (undiscounted) that the Company could incur over an estimated remediation period." } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r129" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r502" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r522" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r257", "r258", "r259", "r260", "r261", "r267" ] }, "clx_FinancialInstrumentsAndFairValueMeasurementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "FinancialInstrumentsAndFairValueMeasurementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]", "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]", "documentation": "Financial Instruments and Fair Value Measurements [Abstract]" } } }, "auth_ref": [] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r762" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r790" ] }, "clx_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTextBlock", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS", "label": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Text Block]", "documentation": "The entire disclosure for financial instruments and fair value measurements." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r731", "r742", "r752", "r777" ] }, "clx_TotalCommodityPurchaseDerivativeContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "TotalCommodityPurchaseDerivativeContractsMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Commodity Purchase Derivative Contracts", "label": "Total Commodity Purchase Derivative Contracts [Member]", "documentation": "Total Commodity Purchase Derivative Contracts [Member]" } } }, "auth_ref": [] }, "clx_OperatingSegmentsAndCorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "OperatingSegmentsAndCorporateNonSegmentMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments and Corporate, Non-Segment", "label": "Operating Segments and Corporate, Non-Segment [Member]", "documentation": "Operating Segments and Corporate, Non-Segment" } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r44" ] }, "clx_CommodityPurchaseDerivativeContractsDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "CommodityPurchaseDerivativeContractsDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commodity Purchase Derivative Contracts [Domain]", "label": "Commodity Purchase Derivative Contracts [Domain]", "documentation": "Commodity Purchase Derivative Contracts [Domain]" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r762" ] }, "clx_DigitalCapabilitiesAndProductivityEnhancementsExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "DigitalCapabilitiesAndProductivityEnhancementsExpense", "crdr": "debit", "calculation": { "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Digital capabilities and productivity enhancements investment", "label": "Digital Capabilities and Productivity Enhancements Expense", "documentation": "Digital Capabilities and Productivity Enhancements Expense" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r331", "r688", "r689" ] }, "clx_LetterOfCreditBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "LetterOfCreditBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of credit", "label": "Letter of credit", "documentation": "Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding." } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r762" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r792" ] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Amount", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r96", "r97" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r728", "r739", "r749", "r774" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r782" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r510" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r723", "r793" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r762" ] }, "clx_TrademarksNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "TrademarksNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks, net", "label": "Trademarks, net", "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "crdr": "credit", "calculation": { "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlement loss recognized", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement." } } }, "auth_ref": [ "r354", "r396", "r421" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r108", "r137", "r545", "r575", "r577", "r583", "r603", "r707" ] }, "clx_HouseholdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "HouseholdMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Household", "label": "Household [Member]", "documentation": "Household [Member]" } } }, "auth_ref": [] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Fair Value", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r331", "r511", "r688", "r689" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r780" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents, estimated fair value", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "clx_WalmartStoresIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "WalmartStoresIncMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Walmart Stores, Inc.", "label": "Walmart Stores, Inc. [Member]", "documentation": "Walmart Stores, Inc. and its affiliates [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r723", "r793" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/NETEARNINGSPERSHAREEPSScheduleofWeightedAverageNumberofSharesOutstandingandAntidilutiveSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of stock options and other (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r221", "r222", "r223", "r227", "r433" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "UNITED STATES", "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r780" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r239", "r240", "r257", "r262", "r263", "r269", "r271", "r272", "r350", "r351", "r530" ] }, "clx_WaterFiltrationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "WaterFiltrationMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Water Filtration", "label": "Water Filtration [Member]", "documentation": "Water Filtration [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r723", "r793" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails", "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited", "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings", "verboseLabel": "Net earnings", "terseLabel": "Net earnings", "netLabel": "Net earnings (losses)", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r161", "r182", "r185", "r196", "r200", "r206", "r214", "r215", "r238", "r258", "r264", "r267", "r273", "r317", "r318", "r320", "r321", "r322", "r324", "r326", "r328", "r329", "r484", "r487", "r488", "r506", "r512", "r537", "r551", "r586", "r618", "r629", "r630", "r678", "r703", "r704", "r717", "r812", "r835" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.clorox.com/role/NETEARNINGSPERSHAREEPS" ], "lang": { "en-us": { "role": { "terseLabel": "NET EARNINGS PER SHARE (EPS)", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r217", "r228", "r229", "r230" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r106" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r780" ] }, "clx_CostOfGoodsAndServicesSoldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "CostOfGoodsAndServicesSoldMember", "presentation": [ "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Costs of products sold", "label": "Cost of Goods and Services Sold [Member]", "documentation": "Cost of Goods and Services Sold" } } }, "auth_ref": [] }, "clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "TrustAssetsForNonqualifiedDeferredCompensationPlansMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trust assets for nonqualified deferred compensation plans", "label": "Trust Assets for nonqualified deferred compensation plans [Member]", "documentation": "Trust Assets For Nonqualified Deferred Compensation Plans [Member]" } } }, "auth_ref": [] }, "clx_AlamedaCountyCaliforniaMatterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "AlamedaCountyCaliforniaMatterMember", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alameda County, California Matter", "label": "Alameda County, California Matter [Member]", "documentation": "Alameda County, California Matter [Member]" } } }, "auth_ref": [] }, "clx_CyberattackMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "CyberattackMember", "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cyberattack", "label": "Cyberattack [Member]", "documentation": "Cyberattack" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income, net of tax:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r781" ] }, "clx_CleaningMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "CleaningMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cleaning", "label": "Cleaning [Member]", "documentation": "Cleaning [Member]" } } }, "auth_ref": [] }, "clx_SegmentAdjustedEBIT": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "SegmentAdjustedEBIT", "crdr": "credit", "calculation": { "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment adjusted EBIT", "label": "Segment Adjusted EBIT", "documentation": "Segment Adjusted EBIT" } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r727", "r738", "r748", "r773" ] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTS" ], "lang": { "en-us": { "role": { "terseLabel": "RESTRUCTURING AND RELATED COSTS", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r295", "r296", "r298", "r301", "r307" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r104", "r146" ] }, "us-gaap_RetirementPlanSponsorLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationAxis", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Axis]", "label": "Retirement Plan Sponsor Location [Axis]", "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r407", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r840", "r841", "r842" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r780" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charges", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r12", "r302", "r304", "r830" ] }, "us-gaap_RetirementPlanSponsorLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationDomain", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Domain]", "label": "Retirement Plan Sponsor Location [Domain]", "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r407", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r840", "r841", "r842" ] }, "us-gaap_DomesticPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticPlanMember", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSComponentsoftheNetCostofRetirementIncomeDetails", "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Plan", "label": "Domestic Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r840", "r841", "r842" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net unrealized loss in AOCI, net of tax", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax", "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r5", "r117", "r397" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r781" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r727", "r738", "r748", "r773" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net earnings attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r77", "r142", "r182", "r185", "r214", "r215", "r552", "r812" ] }, "clx_RetirementHealthCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "RetirementHealthCareMember", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Health Care", "label": "Retirement Health Care [Member]", "documentation": "Retirement Health Care" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r272", "r691", "r838", "r886", "r887" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding (in thousands)", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer", "label": "Revenue from Contract with Customer Benchmark [Member]", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r272", "r803" ] }, "clx_CommodityPurchaseDerivativeContractsAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "CommodityPurchaseDerivativeContractsAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commodity Purchase Derivative Contracts [Axis]", "label": "Commodity Purchase Derivative Contracts [Axis]", "documentation": "Commodity Purchase Derivative Contracts [Axis]" } } }, "auth_ref": [] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r730", "r741", "r751", "r776" ] }, "clx_OtherExpenseIncomeNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "OtherExpenseIncomeNetMember", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other (income) expense, net", "label": "Other Expense (Income), Net [Member]", "documentation": "Other Expense (Income), Net" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r783" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "calculation": { "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit (expense), and other", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r8", "r187", "r191", "r468", "r480", "r481", "r514", "r518", "r520", "r532", "r554" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSAccrualReconciliationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning accrual balance", "periodEndLabel": "Ending accrual balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r298", "r303" ] }, "clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of derivative instruments subject to contractually defined counterparty liability position limits", "label": "Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits, Amount", "documentation": "Derivative instruments subject to contractually defined counterparty liability position limits." } } }, "auth_ref": [] }, "us-gaap_TransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransactionDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction [Domain]", "label": "Transaction [Domain]", "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r674" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Results", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r251", "r252", "r253", "r254", "r255", "r256", "r271", "r679" ] }, "clx_RestructuringAndRelatedCostsBenchmarkMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "RestructuringAndRelatedCostsBenchmarkMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Costs", "label": "Restructuring and Related Costs Benchmark [Member]", "documentation": "Restructuring and Related Costs Benchmark" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost: 6,740,113 and 6,921,439 shares as of September\u00a030, 2023 and June\u00a030, 2023, respectively", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r32", "r65", "r66" ] }, "clx_IssuanceOfCommonStockForEmployeeStockPlansAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "IssuanceOfCommonStockForEmployeeStockPlansAndOther", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for employee stock plans and other", "label": "Issuance Of Common Stock For Employee Stock Plans And Other", "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities." } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "crdr": "debit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails_1": { "parentTag": "clx_InventoryCurrentAndNoncurrentNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials and packaging", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments." } } }, "auth_ref": [ "r132", "r808" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_TransactionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransactionTypeAxis", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction Type [Axis]", "label": "Transaction Type [Axis]", "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r674" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r135", "r136", "r137", "r170", "r171", "r172", "r233", "r334", "r335", "r336", "r338", "r341", "r346", "r348", "r579", "r580", "r581", "r582", "r690", "r795", "r816" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r170", "r171", "r172", "r233", "r334", "r335", "r336", "r338", "r341", "r346", "r348", "r579", "r580", "r581", "r582", "r690", "r795", "r816" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails_1": { "parentTag": "clx_InventoryCurrentAndNoncurrentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r132", "r672" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r39", "r164", "r670" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.clorox.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Adopted Accounting Standards", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.clorox.com/role/INVENTORIESNETDetails_1": { "parentTag": "clx_InventoryCurrentAndNoncurrentNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/INVENTORIESNETDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work in process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r132", "r673" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.clorox.com/role/RESTRUCTURINGANDRELATEDCOSTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring Reserve by Type of Cost", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r53", "r56" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r513" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r36", "r873", "r874" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r127" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of period", "periodEndLabel": "End of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r39", "r127", "r198" ] }, "clx_ProfessionalProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "ProfessionalProductsMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional Products", "label": "Professional Products [Member]", "documentation": "Professional Products [Member]" } } }, "auth_ref": [] }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r94" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.clorox.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "clx_BagsAndWrapsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.clorox.com/20230930", "localname": "BagsAndWrapsMember", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bags and Wraps", "label": "Bags And Wraps [Member]", "documentation": "Bags And Wraps [Member]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used for) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r197" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Clorox stockholders\u2019 (deficit) equity", "periodStartLabel": "Balance, beginning", "periodEndLabel": "Balance, ending", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r106", "r109", "r110", "r131", "r604", "r617", "r632", "r633", "r707", "r718", "r817", "r825", "r872", "r891" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used for investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r197" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/INCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r201", "r465", "r470", "r471", "r472", "r475", "r479", "r482", "r483", "r584" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtraordinaryAndUnusualItemsAbstract", "lang": { "en-us": { "role": { "label": "Unusual or Infrequent Items, or Both [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operations", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r127", "r128", "r129" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.clorox.com/role/INVENTORIESNET" ], "lang": { "en-us": { "role": { "terseLabel": "INVENTORIES, NET", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r276" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r31", "r101", "r541", "r601" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r869", "r870" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails", "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income attributable to Clorox", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r37", "r184", "r186", "r194", "r535", "r557" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r11" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r787" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r665" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r784" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r788" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gains (losses) recognized in Other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r178", "r179", "r492", "r493", "r495" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net of accumulated depreciation and amortization of $2,768 and $2,705, respectively", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r13", "r538", "r549", "r707" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "COMPREHENSIVE INCOME", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r115", "r191", "r532", "r554" ] }, "us-gaap_CommodityContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommodityContractMember", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commodity purchase derivative contracts", "verboseLabel": "Commodity purchase options contracts", "label": "Commodity Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices." } } }, "auth_ref": [ "r692", "r706" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r187", "r188", "r514", "r516", "r517", "r518", "r519", "r520" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r42", "r45", "r98", "r99", "r272", "r665" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r785" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/COMPREHENSIVEINCOMEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gains (losses) on derivatives", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r178", "r179" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails", "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r42", "r45", "r98", "r99", "r272", "r665", "r804" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r786" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r26" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValuesofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r331", "r380", "r381", "r382", "r383", "r384", "r385", "r525", "r526", "r527", "r688", "r689", "r692", "r693", "r694" ] }, "us-gaap_OtherNonrecurringExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonrecurringExpense", "crdr": "debit", "calculation": { "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CYBERATTACKNarrativeDetails", "http://www.clorox.com/role/CYBERATTACKSummaryofCostsRecognizedFromCyberattackDetails", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Incremental expenses", "terseLabel": "Total", "negatedTerseLabel": "Cyberattack costs", "label": "Other Nonrecurring Expense", "documentation": "Amount of other expense that is infrequent in occurrence or unusual in nature." } } }, "auth_ref": [ "r125" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gains (losses) on derivatives", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r180", "r188", "r189", "r489", "r675", "r810" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r41", "r42", "r45", "r46", "r98", "r143", "r665" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r787" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "calculation": { "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income before reclassifications", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r36", "r188", "r514", "r517", "r520", "r554", "r810" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleoftheEffectsofDerivativeInstrumentsDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gains (losses) reclassified from Accumulated other comprehensive net (loss) income and recognized in Net earnings", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r155", "r179", "r181" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "calculation": { "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts reclassified from Accumulated other comprehensive net (loss) income", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r36", "r188", "r514", "r519", "r520", "r554", "r810" ] }, "us-gaap_DefinedBenefitPostretirementHealthCoverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPostretirementHealthCoverageMember", "presentation": [ "http://www.clorox.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postretirement Health Coverage", "label": "Postretirement Health Coverage [Member]", "documentation": "Plan designed to provide postretirement health benefits to retiree or beneficiary. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r767" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r767" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r780" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r766" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.clorox.com/role/STOCKHOLDERSEQUITYScheduleofChangesinAccumulatedOtherComprehensiveNetLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r787" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r789" ] }, "us-gaap_SubsegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsAxis", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Axis]", "label": "Subsegments [Axis]", "documentation": "Information by business subsegments." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r764" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r788" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r466", "r467", "r540" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r788" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.clorox.com/role/OTHERCONTINGENCIESANDGUARANTEESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature [Domain]", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r310", "r311", "r312", "r316", "r833", "r834" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r765" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 }, "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedStatementsofEarningsandComprehensiveIncomeUnaudited", "http://www.clorox.com/role/SEGMENTRESULTSReportableSegmentInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r118", "r150", "r238", "r258", "r264", "r267", "r537", "r550", "r678" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r788" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r57" ] }, "us-gaap_SubsegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsDomain", "presentation": [ "http://www.clorox.com/role/SEGMENTRESULTSNetSalesPercentagesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Domain]", "label": "Subsegments [Domain]", "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r731", "r742", "r752", "r769", "r777" ] }, "us-gaap_CommercialPaper": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommercialPaper", "crdr": "credit", "calculation": { "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 }, "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets", "http://www.clorox.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofAssetsandLiabilitiesforFairValueDisclosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes and loans payable", "label": "Commercial Paper", "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days." } } }, "auth_ref": [ "r103", "r145", "r884" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r769" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r809" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r788" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r768" ] }, "us-gaap_ScheduleOfUnusualOrInfrequentItemsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfUnusualOrInfrequentItemsTextBlock", "presentation": [ "http://www.clorox.com/role/CYBERATTACKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Costs Recognized From Cyberattack", "label": "Schedule of Unusual or Infrequent Items, or Both [Table Text Block]", "documentation": "Tabular disclosure of the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r125" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r789" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r769" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r769" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r789" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.clorox.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r105", "r602" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r769" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220-20/tableOfContent" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "b.", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479468/405-50-50-4" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477128/405-50-55-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-16" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r795": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r796": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r797": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r798": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r800": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r801": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-7" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 71 0000021076-23-000048-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000021076-23-000048-xbrl.zip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

V0[KM7^OIU^'KR3R=1:\R M=TN_VJ8_I1N+4K'H*TRHA<&;;+?AS[*RE+2ZLA0NU]#_LV;TAJHRU#1%&G5I M:]17>E3NJ)JJC-JMCMSLMO^OVZP-]EV.:O ?0P<>+6L-J)PL_'SWVQ]W#R\D M+'I5PE#&QM#^R#:!+9''9IBR@+5Z> 0;0]91CL9R:I%#9[83A#'HF)>I0AZ] MM1V,&WF4_16D)V+-JFVBC2S"%44^#5?S73=6>0YD SPQ@R5,>;TIGJ[!5H/Q M*I A80:4'T@Q@!C0$+TW9=ZGX"283!*Q!VP:U(GA&% MN988S8+]7"0FN?MR__+IT]5.I%"9\%"[UVBW,M=NR#RMU&MT>\H>8BY*K[6? MQ6:>MCH&5B'U*P+B#4 MGV:\K&)(*"185DBHIZ* .\DR)B<1E/F=JF9P!^ ?U#0MZB:N4F[MY3IKYW65 M/-?MYOJKU*6JS2!*BPCZ7=IUIUUT"%'4%JEF;9'?;=^E$]M<;257N^2%+'IK M[P.N+7G_375/1!J1(A^G;D<)),]96BS!)28, M]JKF:5HMAOJ4.X.@\.8A()HSX=HNZT- M9^RR$6U)=5@B ;Y">8-=J2')VQ556)N*)S=:_7WTO=I+WB NMB?R!L\Z;_ Y M+7UX/_6'.HUVAB6EW)= 87NI-%)DPE!U*4Y0&UQ(RWV=14:AR"@L*1)$1J'( M*#Q1+Z7(*!0960-)9!0*^JTR_2KK$X)*1;\GH.=&[+]JZ;F-J8:[;;A\3''1 M2E3 V&:O6:S5DX"7,%)+R[R;$P!WVW#YB%'J[[6+UJF!J],\#]ZMH.+-EC%W M:LI$:0G=FT?W9O&LG0#_5E#WYDEC.S6U MF_VU:H/GZ1S+M_ER\V1?RND;R[7Y??MV-UA$@GQ/G7RE;MX:>]LS%,IB]=#&*?1(5-8IF5GX* =^=FXB2YD201I\@$LTXF\2A#9RH,/7!'7$?0VS7ZL&&".OSFKERZ&FH[PMYRX#VN=H[K/2VG#@W MG297[VCU'(VKG]?T8]Z!P:NHV[/3J["'(J$H]4_2'CH)O\178XR-(8BFSGA; M 8/RG@.G0:H-5$M+>A?8%BO< ["W\_&BW$A=X5>SP>PYIGP?%65 M^EW8%R1J!S+O )*NU#,ZL\_XHOL^(5-N?L]=!; XR%0CNB>XX@RY0I(VE#*I M#%N45%'GZ)<8P.82^>9*ZH7,9&#?+N_J4MI#O[)V0]Y$)O+JR^ERHY?QZ:4X %9;EX_V-;E;S5 M$F'KFG=F"]JL-TEHS-[6KA&(YPJERHWM :B?&5J.XPFF6!DFQM4J.AT*J@\2W?9[@RY*> M(\"7[/).;B>J-&"O*[$77YD'LA)Z\#'A.OQX#!K\(PRW=X MK(*X3JW">IKM@#;5AA/M@/93LTS M;@; GL':?F$;1G"@H>*Y*RB!PD+QO]E MF_Z4UHD5'IE9""<]"*93S:&J"W\./XC<_[5.9.57-EZ6?R4.=6<4L_:H^5$G MNN]@IBY&PS3?<7"R&:S0UAOD!3Y[9:]ES\[?',[ODC?J4#)S# 1;!DFHQB! M"Q* L5(. 00X_@S_./>7OG-\&"%X(,V$>(1E2[XU2*WT%;ZJ; M?"W.-Z06'1D>!@CA>XT%_?A:^?3ATN'S%<"#+Y+ 2'^A:%B*Z)<('HK@H0@>'GVD"!Z*F,O)QUP4>PV"O5?%,_W-KGQ79W)Q"X\8ED_UY M%($BB38(L'%(8O_ZET== $&:HBZ2PF[LMDR"A3HRL_+\\II*6'&F-5/9C!CR M=#LLO90FG-R$DYMP\LI;J4TX>07V>B,#>DTXN0DG-^'DE7FR"2::#OPDGK[02U823FW"RJIF3342QB2BN1$BLB2@V$<4FHOCL3S81Q280L_&!F.[AA@=B M&D)^(81\M.&5UB\ZHKC?!!0;O:P)**YQB&:WP;9]E&NO@;9]%+B+HV?:UM43 MMT\75'S^(,X"<<,9 3P*$'94X>%^-30X.\"HXVGT^[VCORP8131QM]K*P!6( M&E:BA?5UA$7<%]<)M[/$]I? )&K1_L23MS[YHSR8G@XWZO'FAQMK*R5Q[N%H M+'RW0O'>TU+A21O7K(M-AL%?7X5'/;';\_W=3O]0[O6/=X]D]T#X8K>_OW?0 MW3G<_W^'NZ]6D1?JPY>GZ4!BB;%8P4CL7"8^[_>9+;V_%W#HG9;7W>D#, MP5H@0DGE'T682J0M D3^K7W9IF:K+<^LFJ/:,@/*$$AZ\"_A#>$U,&08]R-F MOA2HQ4_B9*0D #W%/$AOHI$##.MB\U@0DK[D4EK]'@FLGR7X._RT7\2^8FI# MC3 __.H,V\+&$^Q)VSD\R;RLZ&5A$ (3P,X!KYB)M^'1.(,5PC]1, V AS41 M8R-:%@P@JK?=R042%A'R4D<@QG-6G,#+(77%M3LY2. VCNF')19>Q2+EN12, 3N M'M:S=G>0$;N[]-N_%[$L?]PR(IRHSM,X%"T\RZA 70P.. ENPBAJU9(@,NSK MO3T:__7>41D6H.U](3[*G'< 3?DB&WH]$>%UJ!)TQ'@,X\+UDL//O-=JPJ^[ M1\BD2RRK/ OCC6-XGN-/XMS+Y['V'H)#6MQ7%\]?4G$8L!B3US ML!_@! K+<*#K'+<#-FOD=7:V_T'$M#!1+*T?':R6?G3'A*^S)$6!F+,F3???NG%' MS1(TU8"< 5L7E G2'>"J27Q6C +0&\(L3PE@B-/WF$?^^>G2\@F.AX9'4@!Q MTK@XC#)C0+:SGD"/*54A:Z]?TMQ^>Z_[&,E=^X?=M4E$6Z^Y'C1)[4:#&6YP->89$ YC9BE8Z+S*HVTHN_? M-0I_O%I1^+G$\_'B\^GGLXO37[VO7RXOKBZ^?/9./W_P?KWXG]\N/EQ<_6?9 M33CJKN0FS,X7J^9R]$V"B%]*$(G"/XHPP"RP5&)Z+^7;I0G"\,Q+;^+DW'X2 M1!Q2+X881KNGY@<@)E4 O.<*$GPW=K%[@]WV[N=_0>/,7"74$7RSA-KL. ]2A3^M(@6KS0 M8,6F(XLW=/PRZ+ASN*JAY0TJP#=W2(%V.%K*87PM,THZMO;*9E;DS^GZWI2- M+]N$>R90R1,PWF8E5TVI=EN:1]]H_T4]DY;RL.X2VE]#@NLLFYJQ0@K-AA_1 MUN[=P8L>3%BL+L9"O_CEV*9>B=G=,G;-">7"*,)6K MO@6L,1J+%$:X">'3UZ 2ZE^-X8&TYC<56/8*'$(:7LL8IZ."#'(TCI*))& % M#!I0B=8("ZRXZ'$LPN#'\W1 $&C=NBI[D17.AH&_2=+O2 B^&&.1'2^L[BWX M=A>'OO+#A69118S@]YSZ/C!GGGG?I"_#:V2EEJH#UG7\JNJV'G'#Q9]P@396 MD*)IQ,6K&;^*"86?KF0ZRKSSVQQ(1@<1+HOQ&';R;(CE@!_-3;V"BUXT;@(D M!)*("AKQ**59+IQ^".0Q5KN1TVX0K^+'&6Y$*%/#"!D6RP?>4$1]_*E;+MO= M88E MAO23#A"\2&GJ!D96J1$>%2+G2 N!,_KXI?/%U?G'E5;RL&$OHD Z-NH7QF#BY@7)*,0+ZF,QNB (FYC /3+F89]XF'\GO:W+LX]O\%8; MI&)DPLH.Z$\]%(G>=CS[% FZB *BGQY6]%)!+YTM0AFD-#N&Z5&"LSJ@C5$F MJ>$*((FD2!&F(>RK4O2ZM=)NZ!D1@2A4$_P)K$YO'-)/V_O7,(QD:6^#!-Z M4Q^*:TV>8((@\ 7Q; DOH.61.Z$?%1)W#_%'X/88ACYRQG6"3 >SH0O0#\?, M &9N,I((,X P'3**]%[4KJI\_+R=B!@C&&5F)'Y/4MHNC7$A1GRKT2)ZB/&4 M)5$P]QUMN (58 $A<20Y(XO, 6JQXQC(%H:="&0NPD@#*N"N*Y):8<:@]O()-MT(994V&FHL3P7(V>#7#=- MSLH6H_?S+18P_D\V1*05O*6\7I*FE%NS )DOC;!RM+]::4UWM$G.E"[PS>@" MJ #_JM6%=:-[1U/^;ZN(NU!K(S%11XY.H&BB%7+]K$9HFY9Z=MQ ]G+LN*;0 MA;PQW-]^B("-C.RB$=7L+PI40/O(0".9TOT^%C +ET19R0'%Q\\+0DD,Y%C& M-):Z]5D%80O&2')K![#EHJ\AURK 1G1:X".?9D/@XB&H+ZB<@.Z6"9^]+%D! M4T"4OA"%1ERQ/TF4' @20#:&B$LG'Q+;5B M1W XJ,)&M*$X_RDL3/3#T,)PC$Q<&S=&,L;=^+.RZ65=6FGE*WP7S9#C28ZR MEFQ!VA70(2E/%?$V$\0U T54!" Q,ZFM4Y.=F&D 16L(36]/*@<%PA4BW6>9 MQ@A$2YPH* ;>J-A*/0G*]C5:#;F'V'&L$BNPQ0!4?<*T0X,(%7'8?13(9-JC M:-Y6CJ]XL$U"VEHF?)::FM6+RPQ%4$@>Y:=+HWN+. :^\#GM4HI11"F8=J11 M$LB(N2-'TAZ0P ,CR H%;M68! 5?6R 4XB%:;UI'0J;"OUNXFS=H6RAX29X0 MC6TPSLIH9HY^!%N<^.P1,0:VHRBUO!XE-J,=5,"!Q,K$00N^QS"#L.(!6(X$ M)\6Y]^A\M)Q.-Z#C-5777K_(BU2V'*-+FX!,,IAVAWXZ=KH6J9!'"WNPBA#MH'D=&\]B8RH4?)9^O M12G#754P9J93ZT59.W-C+CQI^?9 -3[G+'D!AD>KN[,# ET[6)5@$0/0S]D? MB1Z9D4#Y1>+LDTA!8X!A#[TM&E9MGO[!&^,QP_\7)ZZ&9>&*J[]:$HA4XWI. MW8PTZP7?G#)$']VD6L%2^+-*@C*BMI+\^)!&%!P7\)=I*SPU]!3,(.QA#FJ5 M"EE=@]"/#1CQ".B5+@T>C(,[D]J?>"$JQXA1."I&= F@-]3;:^\@_&OD%Y'& M=\X3O&1,T*DG46>!>8%@@G&!,,0MJ78(T8HWHXZ&@*:;YN&?]@/&-\Q@EJBK M(,XAW7J@U*4#=7_K1?*C(1QD1M+".M>PVN?#Z1O2&Q(.T_Z#)A3BY'8K$U9@ VM5H3DQ#"7=YB( 5UEW9EYB[2C MM3N0Y63NZ]U=BJ(IA'[+6TKRXGLR0H-FV^QUIT/'G12Y-D)6<:?N>.5>YHG_ M'5%Y"[A-J),\;L0'9?5Z*E"[R=?P4,#5=0/V&>U$:G9"AQ6R=QAF E,BWM9! MS\H3BM6 AHH<[ 0"J1<#8.6!NIKX:>6T@'D58Y2\K[LMV 1M^F/<#2YID+\A MVRP>BFJ%_&_>Q-$V3'1@>\\:1K8Y11!&'*YRK$-:W#9;5>(&8ZFL-)R#\$:9 M$WM?^0UO*O/12^(ID>323AB%[N_X8J;G7]5!R-_B;'*F?4%)K [ :6!R1UQQ MK&)918Z<2ZB:TS)TQ:GM":0?D7.9(_0YQ1;,8YA3 R>JT-UIT]B!I3'F,U5* MF55*=_&R05=MT@A1.V$ST:4P\Y31)I:V)=90_A3>(M\\#'EX*97Q&'^3?;_ M^JK(@J\RO40B>46N.E@%?>%O=UXAV80C$654DA&+D<0?; ^$&+\[(U6?C$Y# M<'JD#XK:@*]@_?"CG5?D_^]O'^SOOGK?;>_M_/2V/*/W*UKBV-3J-GSVR'RV M^RA\MH=\MGNPWGRV>@K$@RO?Z\#.5S6>B\TLA>[L'3=MM!]E7^>7IS8B9'&H M2S[!]S_UTK?OE\WP/-Y;K0S/^TT?Q!B.5R(6)Z).KZ=GYU_OOKU/][%Y>5OYQ^\T[.S M+[\1P7B75Z>?/YQ^^_"RB$8HP$4J],%FO#%5SF59@8$(KF2E$B-=C(?A)7F- M21#E2JN:MJWSR>DEI[_M/T3Z6V?']GY_M/RWNM-;6>[^_.7S-O9<]VP6W:?S MT\O?OJW?37!%]7(Q+\=R[TB*C#+!*,%*4"Z1VX WS+Q/'_Y+C,8GIR8Y"_/' M,>?$R==W\K3DA(8I,MDO(BY'Q&3?)%7%M":/!WZ3W%!@%S.M]3RR(15F]JB@ M+P.5'P.8E'%.;^)"^IC2USBF30'AG#*/*+2K$KVH^3S5#=HD)!W(=FL+[14W M3B77XL +4%"E@S5N),WG;#MXLD+]O36?(N8$C@7[M(BI9P&H.8B+C)L@[VEZTNHK$,Q2&U.?RDMGMO78ZI'F-+5W3*) M?Y6?S2D F/F;>Q8$N-O F_QV:R#"&/;:>9'P_RC"S*G*, V;:S>*]Y.36[CF M!0OO5"[]FW)13I&1( /1IQB5WD?5'&ZQ)HR2JD[FM#B9DBRA(FNN]\@8'1UV M5WT)#XIH0D:DFD&(DA2H(L BE#YB%!!J0LC*ET9?<,96F3RJM;53<0Z/2P'$ MH%[:]C[5BF=5CJT(6BGW_0J >YC5RF^[#78+2LL&TX^,:7N!H0AE7TL2M<)*>Z>N^O_;Y4C'$V($DP%1]L[+2V5 M12>NF&X(G7I;W@]8N '"OY=<7ILTF8/]=O=P[^'!NY=O/C[_N]VC1YKLPDD] MZ^/3>9#T%T6\BAS+;ODU2RKXAG@X/MP$1AHN=LM3B>:LSET/OM/3T8\UV^;- M3$%:LT-XD/RC!TD^6M.-:S*/5C5.>+Z(T'ZPT/.+SHM8IZ2([OR8ZCT7OZZ9 M/0WYK@GY=CH'ZT._&W#QS>F3>;CB#')1]C7>IY'P/>3&ZK'05F?GSGU25T/Z M/V![V\TZT;LWOFW$X0/: >LE#E6D92EYN+Z _]U.TY)AQ4^HNVHGM'8":_4F MO"Y//I!B?) M;==$^A!_ 0= U;8*VK6$:KB.HG/OCJ)SCEFW!LK[&IX0I0AW3U;MF#9 $-^_ MF]J*">++.2"C:RB2N_<1R>NKS2['\(W1\=3^Y"7#(8U(?DFZ\8?[I'"NG\SV MMG9?J!Y]N&H*6J-'W[./?*-";V1VR^G,3,/%8\$J6;-;CG\T.0+WW)G5%B#' M2\8!'F!GUB,YIN&*%\@5G<,E.Y:O'%NLZ'6\=,OODY()U#G2O!5B'7K^;KOS M"!6.^^WN H6 LXR+;OMH01_]@T[Z:*$IES:STS[>P]W[9@L:IPL'X1/L/%/; MI]"I(IQJ]YF&DGH&Z18Y89KE&NF_IL_P7MO[8-L;1>R+* M$JK]N\G*97G7(1#+=+V;4Z*H>S]C23)L5HR==IUR;1R RY MQ+W>T;9W/T2( MVLVK@7=XN1*BN\H2@OH^8 ^]5/?$TV6XIKTM5TMQ4<;_3L_,^ M/N*[7?YA&2&@Q-!I"2FDYY(PCF^P&TJ:#O7H-%1I5!_@8]5X$5X)7$:%^C$^ M%GD1B)6(^F[J)J)5C*Q<^L,83F]0ZM/HEIY?AEBISM/7E?Z^L[12>T9WOI:S ME0#DYE;4RE=5]&.;%5U3;P8TC88U3(II;V_L^/! M.R(\O5+[T#&<]6T(YRJCB7>P_Q<\H3*5UPF "D.I[FPAX4L@](_J* HG .(Z MTEJ)"+!'&W$NDKZ1D0IS2+MHJ6DHO!?8'QVV"Q63$S6I[G/:"J/IPYR]6>:HN&HG(W:J>K$K[BH:GWG7^ M[6O+-ER%/15A7+^5/QB,VHSQ1]C<5LO/1="/5HQ8/]RKW5"YDY0UP$NT_;I[ M2#]XW86? TGCN<%Y1Y-6N6MUW[2X':_*#ID*'1X\SV#,+ M,!:,(ZYV?'FQX]PP8(;%%KUL>>4F94XTQ+NFQ-M@BJQ9>OBS4,G%%;H&?D>P MU;%,LR2.I7:4K]]-?;^RG!7,'U[PFEJU[.$7D]^]H"1>M?/9 '&[IE;1%P(P M7T/)>J_:F16LI%OLN.Y:@=Y4.C[M^>RNVOEL@&2]IR+[#%1 S2.7Q JKQS9_ MD;;O V[,2@N-9>LA'V!CGEG-;GBBX8F'K4!=.9Y8T0MX9J7,B^QD>#"[D^&C M]21\O$7>N:V@MW668-YC(8.J576_A.G=@_5/F%Z]0BI,V4I#S(KG/.4TV!Z+ M-)]4(YLVIXM[:(69R5W5+E8G#58W6AS#]H1 Q9@4X3B85ACK>0F=IN_#9@N822DI+)5_%"%.5I5Q9#3+02I&3@TK9VM74$UE&&X"&ZU>M5&)C2+10\)4"=]9XH>4Q4CYIIJT/";[2^%V M32QRH.@_F>DP;3:34N7*WGC9),OEJ$(66=O[!;:1&=/6(! _ECFM5)=4'<6# MBSZ.9=!2;_-EEKD\[,S8)N+6$+Q3A$#5!YDI/W IWHN2>"#3$MUC\U-@8E4# M4:%][[1:V F2! ?9ALT=U18FE!-4=3% 5DK.1]Y3S?F@XRI#G"0+ M2.EX6 4M."-C6M7M\IT)O4&M.+]D@Y$#"Q-+2P]L-=N8 ??>EN!]+&= MLWP2C4#VJ4I49+;59MT\G=ZZ5/74[TMN)HHE%'Y$ S_P9#*I[B_MKP6INHL:QE-MBHK)I'^IUXG5QB:4JD5Y.X?MG*WBBT72=B"-RI@*K>S M_#&-;ND*NC>E7K?US])SK!&,X%;W="]EF 99M:IKLBD&69NFM[N[[:.]Y8HJ MYI9&=-J[W8/'J./87:Z5;C/99K(+3'9WL7*>^Q9O= \7J9-9%$#UZ1V9BU;1 MV"I 3Q< UN1-/,UNKF"#U:\RQ5FA=TO=_&BQ%]R7'6M:M\4@49K%@W9:7J ( MIB8NL>*[^3=#^/R\!#_GS C;J?3K^ M+V;>=0^6R--XCCWXRR(2]#&S:!NB:HBJ(:H?$M510U0- M43TP4>TW--70U$,+JCOTE7\11+6@*VX=[(O3('CG?53!R',5C%S H%A#.EZD M<]_C967?0;(T>]OL;;.W3],?97YY:[.M2W9S>_1=?0F^/[B;WVY=%KT\%7[^ MYIWWP4F+\MYZIT[:U'U<@&M(7TT3WN:8FF-JCJDYIN:8FF.ZFVJT3AK0#]/Y MG8S>152@.:7:._.JM=?6\I./>ECK.WCS9'-8+_;)YK#6 MZ,GFL-;HR>:PUNC)^5B3&]=/9/= ^&*WO[]WT-TYW/]_G9V#5S6'NY(X)DQ@ M 79;IOK&=]P*FT[O3!14\IA.O,L\U.=->N,L5<>PVP+?#Q*<#I(_EG+F3LL? "K MLENGVE5CN^PDQQ[QV-K=P ?5@0V9#N[P)$C&M!C3I!&I;$0 G82WY/F3'CZ7 M"_][R^!%984_]&;O+.(Y)=&U]-(P^XYX1UE6C,86L*F(%< F;D@;=T2.-A2I;,%V(6IP4/M=Y5V3,F03#)B+6_VG+S+8QBBY M@;\1'!$7T/N=D0+QU72J&BQ.A3/QA-.D'^8,3,H][^<J OD)7)"+@%O^F'L0#6 ,:#1XCS4*HR M!&?.2"T(U(:*3]C_H030$+=S"!.')A VM3=,Y5G1^UW-GH3'M+Q04LC/"YBK MAGDC&B3P,^!$/!78V<@"O"49(J-E?I$!,[2]"X1#1+1?KP_C)*G:6!Y$,'9> M:1?@A0Q+I]\'TYOQLCHV*_$QH;3)S$_#'NRING@RQ6(>;F^.8(Z*<+[!)G@? M>98N[:BO/TV_[0.O$V4Y/G@*1SW)0@))_6C.^"R) ](?Z9EO:E7PR!=-(.9M M:H;5Z^,TCO$ ^"I'^OT(N^5U=K;_H?&1@:0R%.2(4J.P?OY>Q)*C,AKKAT^3 MWN$H!B!>*Q2'--0O/C4+>CSY(3!#7ACC5X2NE M$X1@P2B8B-F*$-.,OOEN:1WK.4"2%]3#Z'0/3A[%&EA,T2V; WN(Z/#J?1'W MQ77"J'D#&0,M1F4Q-9#).$% ;I\;)0<*![(G)PFA'*8:WM!5+Q%C&Q@4* *( MQRH[P(T,JYP-41XPE")"+9'$93A)D$($E!WW(Z6+L$X*7 \W .,PRO@Z3).8 M(8'[A8P8)1*F/YAH16.^7@!:0($23?%ANW,,,Y=I"MI5-FHIL9KE:J=K-]7= M00M8#!N!-YEFPT]A$, 0YS K&O2W[REL,LM,M7=P?63JD/(;Q*P] WU;T!-7 M(KP1,3'\C8PB_.](^&DR^\Q!XQ.YTGQ*5\.$=&@'P%EX<4&X8@9&G6Y VEC% M^NX*U8U".H]1H;-AV,_MQ''!O[4OVRRT[IHJ*D$$+-,KT/X8K8$ M:$[ZH4^ZC)I,9XN7+(KH5,(U$97OZK(#2EO8<'5$"F ,?1C\.QPGQF8#>.P: M+MH;)8&,E$EBWD3=1$8(PF[<4PT1/#$1:.](!>,:[;843[7L(-(2 4X,.59! M8:??$4V+W3KX)-WXXS0)0%7S$)M_ ,J4>1H-,<]JK_HYI< ,4C$>@CXS"F\; M4G@Z4F ? FE4[, H60)@%A:HX^NS,F: @I4W=H+NP:#YOE75-34!!1530V); M$G8Y>@&CQ M$<2']CL:IPV1NB"F7_C"& M=8#ISGU;2E:B-0T=+V3&KJ>)AS:+/R37O@V;D( )KX5OOT?U,!"YL!\HSR[) M$T5312R*'"02]6I"[V649*J[DM8PX#U%!@2$?\G1.$HF4N+8-ISJQ%"L\%*: M*3Y9'P6B2 K/26E3=9MI7<;:+0H_D4R-ED6R_+N<&*F8:3=D^6;07Y,,EK^H.:<$[2)NKU)*\;#-CW3=!^DD:!F?*8O4T_[!#AG!%3S*)+4_TK= MM.S/89W-^LTI$F#\_DIP9?A:&*<2-VBH9&6HQ#9<=5HIHC)2Y/8@N2^7^0@M M.'P:+I^@),F;@WW"@XV2&Y#)*0:]"EFK#=HC@]MW*-*1HU+2G3[ AJ8Q*R6^ M36)!BTUI^RI'8E!$PFJZJ-%HOZ]Z&TB,)#,"0TL+^\.&,)Z.,/0!8(^](F5K M@'KU*4[U94 @5Q6G##Y[=U7-Z>_*%A!>)]8R<^92)XA,*UX5ABO(85G=!.%;C,9ZP_)5*C0_1*C_7+JH,DV+"4M.'DI4WYBDT:B M@I+D3@33$DG3B3Z48I08EB29)?SO0KU/!2G5;U1,4HDH&0"IA7YVHJG9 M3)#2A'5&14AI(,0<)]-I*N7$%*T;!_):1.93RA^&)RQSVME:LYE?L M>K7A\)]K,+UAUN%H% [X@'!7\]0D#F*?9>(PWGD\+0%$TU?3HVTBAQ=%;.UT M5%_U2(0CI2L 2T9>$>/P)\:."+PA$);3<-P:!K"0TW2 7L%8G#@.0M>UAK;" MC!PD5EQNA#)61W@0&$HVF3;5,*7^ E^LLFU.*D'/WV+*7?L'_"1(1DXB8IA; MW\=YD<(4@2OA:=!GG)G'(.I(0*E1B9I">W^:(8I,8FYVDJ+(-/W@3:2<7)5# MX'5," IM+*/,5ZUW*.(FS$I\.7:_ M42%BTBUUS8'Q$-;8*0U5K(J6%\9Q3R[HL+Z^NB;JFF]-7_HLTY6* M7U)+, X&*K\3@7*%!UQ.6O'YO0#54AP?5W''-&LFK5>ABL)'+B7UB3!T08PDNQK,6IYV/[=JC' M/=&SAA4JM9UO.,J'FE$J:)RAS"LQEBE% >I>+31P68UCDP,-"A%@CV+IU=A# M339T*1OZJ,F&;K*AG]$#0OHOZ#!.:P"VI+'NA%VJ))]L(P%5?9=EJ&3GVC?O MRB*2*&@LD<@,4S*10)=.T>BW:G:UMAF#-O$@Q(00-K6F_ !H)_*$!DD24)4E M7K%8>A'Z!99*ZNM_YDO9?A9I.L%1T84A9\F\?WZZ--$C:S8Z<2:**4C2)^,$ MRU"4]>O$'6!^??,<%7:#BJB\%VPKE*M-V-F KH22N5V:/QHK[GL:]?*)#0S? M+U+A5RV,Z9IJS2BFFAKO38I/8ZC1*;>U!=935SI?RJDM-!\48U=%<*3O1I ):&(@L*XZ^_I<8C4]^*<>4 ML-A0_>Z72-@2A.9(G^Y(I>MH0A]\+LLUA$JHV]N1C#Y.-AB!]6@3$.#N"Q'I M@L%&QE@]2<@EH,8I#R1?#>BEC&29=O@ME']FT5S"N(^$R$F8VB]"GG?G6&*J6Z54+8TUGZ^BJ8EVI)CF_,F@ES M)T3G%- 7,2,K4#U25JK@UR6U%/Y3(Y3391KZ6IG;9"PFZM8 L8_0-"%:$9@& MJ>)8*9C18',BB65YXG_76BB#"S4G^1S1#?+4.B@5>"[#) J ,3FG*!N1SZ(Y MG.)!(W67MY9?S94!]K MJL?FP0>Z<%#6?3$#QJX$@C8'RL[%X7( %*=1TK*Q%-\9G$R8H C"42FU5\^, M@*2,2DQ(G;GX#ML6)U[2B_31HY0MX)\^*NQC'H?RG$/"I)G,V0HL:9!TX582 MR=!)6ZKN*Z]"IZG"J_RC"E-.:28C+@#"6,@N>M9X4=E%!$"OB M"!48E2^%LDNO/7-W!K\'(WYDP P=KJMB^)W!2I+;*;0_6?VD**/\J4]!3]*? M$BH$4@51#XUJB$@#"Z'I'0:A2 DALXF:N5&SX]E1L[N A^_>O18V_N?>BG\ M]'X1KD??YOJXW06((&^W[?U/@365N\?'[DMJQ]S:!>KN9WB[.HOSX:@[0'I@@9#(ND+9MY( MSFKA[RQ?J.] (^+T=S4RQ-0RZWEM82BT'X&/YK*X178UQX M5+#UITH.1T4<^MH<= F\G,^_% &C.3#6*>J,*Q1%R0VM!,R, ):05>PCN\7H[>H(X*CP*Q44CO1J1J!5J)0 M)-()OP6,5C8[Y9B4FRQ7>=$Z:BDY^47-K6SVBB@#=0@3$0Q4E4IA3/K]2$/! MRG@ Y!^4@D:$D6.P<] Z3QE:&U,E4;L(336F\:+0I$C\3%#0H&0H3\<@>LB@ M[!97E3Q49\58^Y8-,2>3#P#YP72QX79\$$OVZN MAU)3BAM,9B7LHZ"L6*/6/K(7'-TEV3A!""_EX58PA_,F4- M[;587 \)_MKT$^!.!*C"8.4C7N4B@U/H1>A8_H[BFTBR\GQ]UOC3$>LLP^P% M>ZQV=Q[$8]797Q./UQ>>/7[Y] M.L6L].7]!T?KYC_HM$_;GMM.9-UN)72.1RD'DA'JT>MF_ KK2,,ERY0'"3)9 )[I:^P$L4'8M2I,+A>G7P-=):IH# M:7O@!\V!Z#V#5(PRUVB4Y?H:ZPO"#QR_DQOU(P79V(8M@_$*?ZJIM90QG*1N M)I9:R4G9>J7M*".%4)JP!8[&%U"CT-)#V#4,(6J&TL% 0Y-;AM=UEK%.#Z*7 MJ^CY,!R/E=E,OWE0A8"DB!OA?.$ 96 #:>I(N^6 'D)_8_9KL]> MGG)412&G3+@D"&X,S*>#V8! Q;%.B&#J7HO([Z%J>6,&5NL'J2()I0,X'.X$ M?VCA=2M)=\Y,3BP6V4030CU>KD4-4KA#O _8.9"=>*K)VLAY1_CNP54NLE0M#0]UF)YO3)!C 7/X]4090B M6,R4;2I_HXL1,IGBNH/;+D2!GQA:7 4W7V)[[)2AIXG M!D@#Y%X+"21U_@79JER/!O%$^Z>R.EBTBE/5)[GOA!D8VB93&S0/OUJ+NYDX MUDZ')95LJA_3#K?,P>3@@('PAI->&@98N?S=@OGREWS8^OWH:Z(*9X7&SYFP M=9>_KH<+5;9H2/6@25 T365,R#H@?8(7[I=AT MK8:T.2K1EWC1. 6#K2\9K+@RXH/!3; J4'OY%W;KE^)2KF*BLVRGFTCR5%*KG9BGZA?2@ >BX/0 C=Y?O*.608<^[=KE/ ME;JH[K*9;9 .$YX:7!5DTX#HC9\>I^U=2OET25DVX7.ER,Z("9:IG'2-A8=9 MQJ6#"N@FS$LI+(K/5?MOJF"TNJCJ*\KF-:;LJH"UJR7KF@>MUO))90@O$YBS M!ZHA=1W3KTF?1S%"(3_0R&)EB,,!@NQHDV(E]ZP.S/TY-\TU:%9RPQC7 MGM(6C$/$;<=DW:O$BAH.R@.;M BVN>8*3+<*GNB.BM4F+8;'?]BYROLP*],Q?BS1$= OVD0Q!R-]0B\\LZ>>40.=XZ#L&S8R>B79))[8K57Q'A>5R_0+LH#2;HE[ MCA#<-A1!C8@L2CD\P"$+NI3,H [HNK[4L*1/G8+0#1/)XL&*,O$;S$>Z4@X3J'G-$ M!N",+X8!B28J>PF_@[G]47#FZ>)D7PZLM5!]NX/CL126L7JETDX)00X-A-;4 MF',:'\X.Z_HB&WK]*+G9(._0!YF-0^4K-()C!-*&Y$35E8.(?$AWVJJ_6URW M"LNMNK@X#CP3"S613">0,Y^.*-YV,T2T?57F1 MZIIA>M["+8FI5*4!BZQ&KW%%S 7EQ$K'$5G$U./9-NVPJ]#X:B"1;*0P28T( M23@TYL96\68;PA^I)2G?Y0,2J M,87*L* .!]L*ZB,O/U'RF#CYOW>*0NLR=%>@&D&J!K52FV0IELNV5"9+%-E0 M#&FY**Y[O],=_0"DA 9+,F*MO8:&D'+@C-#]:VY_K'J(Z!U -U3Z3[/ /"1V M;($.)&-JV](W5X>-D2N:;*FMQV0$&%=RN@J>L8YAJ?8R+A6HV2CC2MX"\8 * MH[E+F;%E/Q=>I!F7'P=3[2S1_R1BH_(;>Z,8]3CMG'=4SWVMPN6.7X@T-) ] M^J[6J49!I6X(-.DB15BSE@%&M!@L4VY=A,)0P00QPA8-W,M'#<&%C=C,)L&R M*@9H"4IEAXP6H?62^IEP+R.,_F=E4G#/K(^I/ 00SX<\B,.<$LUNI+;QBEA+ MWZ1'<=A9[T,5GU:3:81VGB8,A: HU6K!/J''IAL9<:\3?K;&C"O&3(*1_K=R M>M5*.[;YP7@94V=*0D@T598YBC1MY#OWE07G=/-H3.K'+"]Z2R?YS%5DU=.< M]-$32E8J:5SAH;#,?.2EV262MRS$R85%C)7F+F,W$? MJD\:Q^JI5T=?1Q#^%"D[!AG#GG M!+1*34ZHGT-8J;RT(+9XEG$FJ_1&%&(SQ=BHGI$F-C,]S&G%6I_369L JK)F M)MR7Q6;H;8QH.ROI382*I2M_*7J5):BGY%QSSJC?F,>2"\K@D#H%C*YI^C$G MX@02%5562UGQBPD$L,!\8.Y:0]$[5+L&=#YIR+B#U=+#--CJWKO6+@6OH*4Q8S\ M")TQ1XY-S)8#:L]5<2+N42!2V_LY3WPJ&;5-@"-Q8WA%4:#*(B[_6-L#E-UD M,,"(38R+UHRBO8/P*T+/I8&IJ1ZSF[)%8$:HZ_ME\R6347_;&4L=7652+;?A MHBFM1) O]0ZG$[(=V]8[N@G'V%X2)J*#_>C]FSF06JM$1N3.NDZB&6V4G5;( M/GQI,:AQ6.V2,TH3:5P:5]1V="Z9,RW.S:=GG>L$J/N&/K,5T@Y"&K>2=K_> M'*%1DLY3F;VP WWNE563VZRI)\4W- M;37=&94*^K+LOIA*&G",3WRJCFAQ+CHR9'JWJ9Z42$]$8*I\"%W=9>!D-C=JF1K4XWM8'[8<-2HT"GWISDJ-M2K1Q>;@;1NY^G@;NM*YAJ5VG M*H16YD<>*78D9I:#,(OTV6OCD,-4ID5>X$:A#.>JCP7Y9 .2^5*E#I*GQNV. MAB.6_FVL7+S92,[#1$%2:3QRU?"T*HY4XHZ1(V:"O8F6\%;D.]+>W0TC7#BB M@ZFLMRHFXSY&8^ M7EHH?V-R,II.MH!B:$5PLRH&9Z2 M>6Q#FHN,^-TI ]0TSYMOTO]F;[[E?NV>HAY:Q+F4*&#"H8527.ZXL]94QMU2 M3NQL6.1H;+?,96L]XJV*]WDV7[S(X%7W01 8NITU06!X3J"!;MO[+<:VD%E. M('&7NK7D^1]4"W)IL8:1\W]CK>?^PC)B,543A5]4:($=B M#3RZA1_@1#"---Y62*Q?N;CQC<['I?QZBD.$*D4%,?%KG5/B=PQ6%0I[NSL[\H=:G*>IMDKB]#(QKX@/3$ M>TND.JRC=/!4]BFQ.U.ZB@7, $(M1K'WO\'_8153A50GODT_.BF?(MZ_A'[@8R"=%!325?AK>S6W=_AZSE/X MOT"_67W=IJ_>YL'T=]W#]M[.T[U+#SO]O?G?W2I2>[ MWS[L=-=EL@?M_>/EAGV&R1ZU=_8/%QKV+5$N4R_ZM(&-_OIJ]Y557JF7R;L= MKT."3(\WY]'N^!8?G@;YJC(4\])#2\?C'VFBQ+#_*_[/R/,?+VGC5M][T:OW M7_3J@_+J%Q0 S[RV'QN8M+BO!,5ZA]-=BR.[2K"JZ;-.X"('P"6;?5]UUM.3 M431VM9JY.4_IVEEL[TY5PM;7%/UA7T4XN^G9BLQX#(=,IUN;(7+O2>RWC_87 MF$>-WP_-F>W==J=&-\8L(QSAU?NM3C4%^N6)V$7X%:OD\/.O(J7@QE?5 8P^ M/(UC,%(Q5/65G !)RL\J'*H7?'M]$K?AJ!CIS=U2.W.*V8NWU"W=^T!V/GW\ M3VR9_@:W5VT_^M[I&_3)_4?FWL_2$:'XQ6\FD_/'6_^#JW,Z8M0[P/\]488I M\A-L.(6% T]OW;*B]XE=#'0:?R^BB==!Y\JN:CLPDS2[#[@M.U[-YE SZ97: M'?*B=$\8!;:Z,0])([0=.XMOQAQA<+_Y5*7-TH/^^+A7CA=>/]@)EQ?_$FE\ M;0B\$6\O6;P]Q9W_K$;V#$EW?+RK(Y#WTX=4!LTZJ3PZJ'AOI:=F[1O-^/5G M_:B\77GE4L*[.:;FF)ICNLLQW4_@;_1]IW2!=;KO+N4XYR03OO)V[F_GOQ@F MK3_NIU!G'\)>:8ZI.:;FF!8ZIOO)_(V^\M;0Q*/PS7UL.F7KJU2R[I2YWWB" M'F.SGEG_77"=2Q[ZRC')XN[N.Z]_\XE]Y8FYD7:-M'MP:[\T!BD2;RGU>ID. MLFK,;92+[SJFIRQV+H_S=]N=1TB[/VA7\V;J\NYGY\TLFC;S]+4"E=W<:>_M MXO;IU*DQI4Z-14AUS%QP9$KMN?>Y*IP@E+912/#VC]8H>L%:O)V]PW5KP;O? M]KBU^H4M!EVWJI,/MFX#D6BD-X*?##/5%==XDZJM<7\*;]_%2?P9@0U"G] % M@)^_R3[,?+OSRHO%"!8A_> =%I%T=GK[G=,TO4I'<1Y\C,3@E<<[!J1QF[_K MA[RT9JBB3MIE=YM8_ M[<.B_-I%(:*T:KNGFGK _FT[OT-T$(9 2@EN"2O<6Z872&D'2:3L[1SAJ_#E M%@GHHYY\[UJ-TY?M#ZP 5=5J,P""+I2J*GKA#23,8)Y$]M MCH4\_XOFGV7XH4'GA3YE%(O_]H.\.3"Z2?,-[".U)< MV6_QDZC5%B23U,FS3] #&Q1-H>CVCTY_TMV3MYV=CHBQN7!(:!/M83YZ]?[J MI[=B4]:"( TPT^368#6(V6!Y8AV3$*D#IGVXDL%9OUT34)'Z*J+SYA M"LSS"87=SD)"X;EBQXVP>%0&V^UT?)E@FW-"BV,&.]/_)&-:XZ(,0]D'%5[Z M!;'8%_9K5(!5L-C,H.%<*@"=W9VN?NQ2I#T1RVS[RVTD)^CCP&^Z.SO=]G(, MN$Y\UGW8R[?AFN?CFJ[?OP/7V,:W*\(U&W!M+<),S:6UF>S7Q3O+,. 2EQ9J MA/=@S>.=@^9" ]V\?7GVMQ6XTYYC]?_^^=NOWI6X3>)D- $*TYB#E_Y0CH3W M(?$+#%VT[Y=_MS(EGN2U*^B)Z.7)%6^?CMOI$J)!+XR MJ/]#W"_KSR>=G;U&IBRX5V?86]#[BDF3U#R8.EH!Y6#3EX_8K'0+G>I!H'IA MJ!S*"XI9>T2-@2(RU:W+PE'K(!UP[)L:"IS*I'WFIH;/FA!4F[BR,EE">P^3 M)62S6U>[U<3*;/SEQ2^?3Z]^O.\>Y> M2_T0FVZD.!0BY0>(WN:+(I.J+R-W]5,-O3(X,$F]@K&36T\.1=37?B/R/JD' M"$2_B!%@'\>SW0;:SY;!<[2_NTP&S]Y!^[C[\,DV73V?!QV5)KOW3!#?CX@@ M^RP%GW\[]\Y^_?+MR[^]LR^?OIY^_L\RRO[+W;^M;T:PO*G;N8H.T-FCQ;OK M/IZ_10\\SB;L^8?3J_-WM@/,CY"HUG.1/_]GPQ;T-GOK_2J*5'A?I?_]^:7, M0R+1/I_9Y>PHH?X2TC?8\-3QFPHI.IT3%= Z]:E[*Y90E*)=.K<:_L)&H5'D M)(?^R,IJ:B&FK9S]V5;.VUX23. _PWP4O?__4$L#!!0 ( *Z%85>'/V%$ M3PX #Z- 0 8VQX+3(P,C,P.3,P+GAS9.U=6W/B.!9^[U^AY65[JX9 M[I-4IZ<<8A)J"+! NJ>?IH0M@Z:-Q4AR$O;7KR3;P<;&LDDRZQUWOW1LZUR_ M(_GH2!:??GE>NN 148:)=]4X/&@W /(L8F-O?M5XF':;/S=^^?SAPZ=_-)N_ M78_[X(98_A)Y''0H@AS9X GS!> +!+X2^AT_0C!R(7<(73:;GQ59AZS6%,\7 M'!RUCXZC9M%3>GE^7%V=M&\.+0NG/.STYEE'?\T MOVRC(W1^>G;>/#H[.6N>G!PZ3?'$:4*G?7YT?G2,K'.DF#ZS2V8MT!("89K' M+I_956/!^>JRU7IZ>CIX.CX@=-XZ:KJ:2-LZV+O>Z+U\XRZ4?OC MEGP\@PQ%S2WW.=':<@DESP<66;:DK>V+XW;45#+".:RQQSCTK!?6-J=-OEXA M=IA-))ZWY',IJ-UL'S:/#E.D>LJC9ONX>7P85]+F+V1Q#4];P<,&@)Q3//,Y MZ@J0;Y #?5>0^-Z?/G2Q@Y$M(LA%,D82#6*/.:1SQ =PB=@*6DCKPL\? )"P MXN6*4 Z\%*$#V4PIRBA79 T0A$"?6)"KR)8M6613JGT+N9S)JZ:\.GAF=J-5 M7*K/FG,(5Z4DQVD"Z>&=,AK$XOGPXN*B]2P#-%N#S*!3[9ORS^;AD8B#$F)W M16]QV>*J&=&]A0Z;SEE.AXCNE3ID=LA=L:"C5-?LM6J\].[2:H24I=3('BT* M8A$12!!.RPADR#J8D\>617R/TW61/IA%$EV4Z7T)9C;"961'S>4?>\M$EEU& M9M1<_I$A$WH>X8I>W@GOK5;84RZC!CY$3OC=1[,V-44O]=0FI1 MXFJ&L-:*DA6B'",6?^/,VH_?#[RZ<'0A%HA8I_LE.+Q^W! ER M^QM#(EH9\%<-)OSOHL U%;9[15%9NP4)$V]F!?/_N_D6=,N:+T@LW_U;6&\C MIZSU@@1[> _C)?54/ ?8OFITB)@NC.!<*"?O/XQ[NQ(X)733/.(9<=VH\[FM M_AV"YF9^T02*$DC23ZUM@BU6/D/VT/NL_MX.\9 X;))#N!4F2;LTD"V]& M?LSUKF"4!?&"MP0\D@+GK3A 'B@$@Z$.)!0CX(% ?7U3X M5]V#Y!JZ,I6>+!#B[!7P)_EH@3TN!FS(%01L?V 5\_$(4F'> G$L%'XKX)), MM2B>[(,B^)B04OL>&!\X.Y MNBYY8F\](F M&'\;=B>]VT&OV^L8@ZG1Z0P?!M/>X'8T[/'G=$>0W(!B!U[X@9!AC7 9FY/I M^*$S%>X?W!J#F['9-Z;F360(;@O?##1,1?U^B- MOQC]!_/>-"8/8U/=+X9&*8Y:K ZWL7IA#V+\59>1$H 2 >(R:@1F;] 9WIM3 MX[>B.5><0 O%4;K;2&J@R&OD93% F,9X($;JR<@<3^Z,L6F."CI\!ZW6]\?; MOA>,0,0)"%9 \0(?!;>; =7%Q>G)RGII1%*\/@H^1F%KE6)O: MW13.W**XIX&/ I4Z>SZLRE8&B !\M-JD9B*9F54>\DH6H,@AE M4FHQ2BTHJ?7'[%I.'6%)3OY+]9$L2AT4/Z?6(K>*!W7$(#;K&T!*A3:/Z 9QB-WR M4\\4 RTBJ?I 8A+ZPD^\V$.6-85FXB^7D*Z)TR&,LS&RR-S#_T%VEY)E9SU# MPDT<6M_W!:XD>RVL^;6%4)K:U"?E@8U ("6"F,AZ(I^S%:D4Q 7X:+%,U2+R M=S;5$J^\FL]^HVHICEH,4[4+;3VIYD-OGOO'B''J6]RGV)M#SQXC5VY75D/9 MFV%<1(@6]E3%0PM[0JSZS"44'(S4/X)A&R?#LJ@/7?D&\RSL8J7JFT5!+G*7J*>D*\P\< @?\?O@*) 3Q#RS>O=R_ M7][S*@E:5%,%LCV6 &J>&94!2!YF9/LN(@Y?(--QD"6_&+M!%#\J#_8\F6VH M+[QN$,-S3V8:D-TA>R[2C\33=PJA-]=0&X*I(1AI+6?0\JBK4'%YN5$= MQ+0#&^4!9"!4/][B1S 7#Q6#,<3E)^A]#&'=D_XO;M@F.#:P4B-:V,-C9? M__G*'K$9DUC/6(Q]UE)RDI2BTR*<^U5,+;V?O;EBT\V^(GG4);*-1T3A' W\ MY0Q1XDP64)@]]+D\[\X.2DR&Q[&-75\.L<'S4GC^)9IH(Z34MSO)[AXI"$(- M0:"B?!0H 6):JE$AKF?8IIYC0,8FDG)+4;OIM8@7^DZHEJBD-Y)L>J/YIX_Y MNMQB4F%V6LP*?5^4[)V!A'IVKSS/=Q;0FXO9G6=8EK_T5;%^*":%-'$^U0#Q M/A'I3+DA_1WD:D,C?:*(-C1"50#V0$P9H+39.J9+Z ,^!AK]JYZQE+65:;]2 M72%.6KQ3A=9=VZ-J7G?+\K:,;>(%YS")8!?!+5?IB#-&'%-U";=/ 8R=.PY4[1"9H'@Y_\@8GR2__EV6JA3']P MN0WE1@P(Y8"8(/ #8-&#$)] %[$1HI:T:5XV;R[*30MGJN"5[IGB=:C8@QC_ MOSV(GUK)T^"#Z\2)\?*\^/"'/Q3$EOO\>\][%)>$KCL^E2>%&IX]()X57 A/ M-@"<,4ZAQ:\:#G3E@=?RS/NKAI[0PZXK.]55@U-?'I0M?V#E2].31_V^!K.&="UZ\4KM@]DN6LN(F!IH&%62WU-MD^50XOJ/[F5V0N M;;*$V--;T&/,EWX:.B(5%(9/.+&^=PDUERN7K!%2UR/A2JF]FO+M!G$/5F5< M\!?BFKF(-_%G?R"+3TF'>,I^'[KN^D9V,;EST/U>9^WWQ=+L:@"UF((=!"3OTP(W6(# M9QY%%2RZI4()X?U\*[9;54'S&VQ]%QD!\52.L;['U@+/H7F-R.?@5<$"9\U#0,[]VQ;M_9TSLR>T]^P2/ MQ.A],163?%?-X&PYG?"IM1"1O9F=1#,1S=AIEXZ% *::^6KJ+V3BFTD4S^65YBL]6JFO77.^(SM""N MK9GBIMI580SZ"EWA7S[A1,[J/4MCPZ[FU3!%]/PN=GD@*/_]N*-Q%>R0_7;H MW!)BRP%\@N@CMA";9 98\O6GHZN"=88KE+5A,"_KR-]G)]3#L,BDKA!I%6R< M4I_QX,N"+J$BVWKY(?H;Y"!*D?IA2_'^57JHU0A-OWL%QRHX)';8BR:&TPVK MD)JZ"'J9)90$2-O-JN#Y,,\W[#]$ "';O.Y-=YI2E/Q_GP"IC6_,6J E_/SA MOU!+ P04 " "NA6%7&?@S5OH< "6# $ % &-L>"TR,#(S,#DS,%]C M86PN>&ULY7U;OS]Y0^SS__S;7_[RUW\CY+]?'KU]]GH>+\]AUCY[ MU8!O(3W[.&G/GK5G\.R?\^;WR0?_[-W4MWG>G!/RM^Z?O9I??&XFIV?M,TZY MN/[8]6^;GXTTG&>:2$Q&$ DJ$*>U(XY%EXU6(4;Q'Z<_4^!@E#:$:ZF)E"P3 M_$TF/E/##1<0#71?.IW,?O^YO 2_@&D+3JEX?1M-^K?Q?7LP4^4G\CUQTAYBS!.!/OITR(] M_]M?GCU;#DIJ/FXQ=>B]\4\CWPS0WHL_ P_?SJ0]-"C'ES_2^G/L"T>W=\N2"GWE^,WS7S M/&G?SA>+L:64\AP\$2E2(KUU)&@EB8N)BT2-STY\/>I%Z 5*W1$I^T7HV'3U MU2^*/E[ M%U(_C3Y=E,%^"3/ KQYS&U)F(N(, M%P:%8D!<@$B83TE)G;44MK)0#T#Y6L(5+NTU\=F\2=#@HOG\V48=G7D_?J$R\6E^?GW9<29,SY];_/S?R\BMK;>?U17VH8!:A#@2+3 M&Y07)UL[F5WBO#J\@*8;D\5+P-T$;D##8O2I;3R._63FF\_[.&*+@SG^=M;B M8.)C3O=G+32P:,=,9ZFB9X0ZHX@LNX73*)_3UGO@7*H0>J%1+^*L0T7^A8H_ M#A.?7OG5V/QK@[(L!V=,J1JT,]=$R4YE]*X_?5I(C M^ "S2[C62^-C^T^T]%Y=+EI413/Z%*>7Q4C<6RP _T^HG'$,#)3RBB@E.%IR M3!*KN291:IEYM$J87%GB#6 ^ M+!U#\V$287$\GZ9Q8LH:;@UA3!<#WR=BDU:$HC,@N,U61ZC,GH?1/'*Q[7?? MK\622H/_0^S]G)D 7!IB; Q$.J%PY0^"@(TT!Q.SY/V8D#O8^[?;E\!HB23Q MQ HGBU+3[OZ#H5_M^?IIMJJ-C&/H1/F5W0,&C_% MM6(OG4]FDT5;AN4#7/D-8VL],VCC$288KD5H4!&K/"41'0B%ZY1+DE=FTGK( M!K5Z#Y5E/2BY&@'WT@=HVLD"\5WC8";3%#,@A(0X@*.?*@$(Y(#;D[?:QMK& MY5T4ZQ!+_-F)M:7RJI'H"!: 7W.&U'Z-]O%T?E&.[FX@@3>*&DV$1*-79J:( MUV!(L@R$9$AZ[JL[*]\ M ZUY)^=6O546M&(7Y3=^>OA3^ -HQB]$P MHQ)18)'"0GD4*7&BD@(IDK(4;KDM=X(H#W[Y.KS0?U9>U%%)Q7.2.R$EQ'*8 MR\&-S2"C4;B%NLQ1/&.(O#%$[F#RC?T.R"E)$(!<74\(Q8"8H(GY(QVENK:MN)E448DHM3NN[F*1K@?8FIF!U.@R1*:(SI=P5OBHK*$6XVF,8!*HO8B^!6 ;:59B2]F]!TM MC9+0Z'$SIQR(-4J3I'WRTH883.WCRH<2')YV*=Y?O4__/02QA%];#7?%^%&:%-G]])V?I/W9 M*W\Q:?UT!=P81?$E)D&4I0;)6/+#?% $@C!!0I0\NNKQI.^A>F1\Z4 MQ%@]5/0]5(^,%_U(5*FLDFI4.6G +RZ;SRNKFQ-H6@N62"HQ3>D%)R[C8N>= M$D(+9J*LO8K<13&H@$]E+FPYYO5VE"\<[,($]QP2%0?IY@ *'#/,2T685H3GE(F4P> ,CA%W M^Z2-0XM1Q]IG.BN/'Y+K594)M^?"ID->U0&;M-VMN;UR5ZY$>D]A%@L@FK)7 M*5,2M65$H@=(G/21*"^Y%28:D6MOG]^ ,R2WK%=.U%))O833._)M% 7DGG%I M="(BLJY69V^A9-;;C^_L_7,E(< MXB"D(> E;AIH>1,;'(XZ+7$#216#VHF2WT8TT*U[$T[O"&^C^ M7H,X?2FI)HL*G)5TOFLX07AEE(@$;0N.!@<.@ 7(^.*]!9%9BCUPYGXP ]V' M*S&D@@*J>@70Q$DY#L9%;TRYUL(I3CS@/BYEEL0SJ@@('AG^PBE5VW2[!6%( M!ZJ5=;_-8-=; 18+:!=C)V/BSGB2J,2=BV=+?(B4>#0>&%<[0#R5P"&9 1MH-D[J]/&@UN-G^^: M.% 41W^IR7+(3M5/POM M03Q#LF0J:+_:T%&^%$9QL/\?@&=L..L@V=,:B)<2&A],UNB3YID)A@X M3E. VI/_FX"&9+94H$.]P:]7V&4^3Q\GT^E89I-M+#Z7X271'"$$4>IG""=8 M-@K_K+T07#][2 9*!2UO-*15KEZ=-#[!N6]^+Q&@<;2<&PJ.^!P$D=Z5S4:A M-0S6!\DTND6W)O.]5ZZ^^M)'1F2'JJKM!JO>8EQB>/NSUL].)\6Y[00J:)QQ M,N3D2?%T)KFGC!&T?<'ZL'7 MCKI_+XU@:'G/O7/L^T&Q1ZFIVG3[;3*;-]T 7 EE S42[1P259>#@UN^R[CE M"RNH43IYX6L7T+R-84B>[@"HLI6*^HB$CH$"\X8+HAQEN-4XAHXZOJ!W9C)G M5AE6^^#VP32>*C%="+BO986#F0&(M%D2QS(E&2RH$&U.NL>TJP$>[VVJ[6]D M(FTRUO78.Y^=GD!S_AI"NV+A1"D"2UD0(\L5SO9L@^PHLYY"8.3"BF+9(2V&)TRX1Z[2U&05WO+:1]%U0 M0SKCJ\6*NIJHZVZNR+B"QTI1ZN92XCSZ0I(R1ZQ$>!R<5]Y&Q7+U9)@'T0SI M0+ :)>J,?34NO+ZZQG@3-U_%!NU8*%%BJ9: ";Y$)X#8* /Q E]!@G"I]@W9 M[T :TMEC+5;4U$+E@/:U*:,2"A,X)4&5 Q*(EMB,XEGEN>#:AYQK[QG?" AO MD)#A%Z6L7OFC^#8?_+1+#VY?^:;YC$OT\NZ-1!4R,!(GG4&#+0'Z+D%9=%-M M2BE#]E!;RK6 #WIP7=_(VJNNDXK7)" @(_=PR 6\2%$N=)8&F7(X&A=4I M$X]N*'JZ/C$J+'>^=L^#>X$,R82N1X?MQ[QBU M7-01I0N.X*(L,Y?",E][#UQ]_I LXWK*WGB$*R;$P(6?I*N"B+@.K40&;LB7 M@?*@@#"32[H.U<0K&4G2$;UW;4+DM:]&KP%K2(9Q/4;4UL>N:^^L=D\K6]J; MZ?SCHM=V=X;XG6Z5R/64+P">]:^8?)OAM+S^_7Q0#^<:GWHOMY,.5 MZ7[1''RI'1:+Q@JJ@<5&IO2VOCZYBK;A$HQ49M\(HP1;V2^*] M,L0*S6($$2C4#O0-ME9<']SX1B&YQPQ]1>?\HH$XZ48$_SZ%;KAG:>^\A&/^ MU;T_YD8KRTPB4>".*064C 4A2I>[1,$&B*'V>?XZN(9DHNZ(+M7552_1X,PW M\-)WB_IYV5ZOL*#1I8-3*&R22&H!) @M2FG9TO/.25F]N>;]2(9DXNZ(+!54 MTM\AX*W.F28%8())DA0M]5;5/1;X#:4@6\,Y6EWI*JAM* M*&?8. !+8%_ZZG"JLU9$%"-=1MPZ0XE_Z0Q,"LK!5B\0\R"80140VA%=ZFBF M9B^\4ND(7L/RS_W9RFG/&&PR(C%/E.'HU@F3B=AGHDS?6I42F2?[ M!R7-IAKJD317!TO7&^B]!TQCSG5DUK!2RQX=/*;0\&))DVQ%$MIZ+J%VGM=F M2->AF?W#TZRZ3GODWSK%"\:1)0^:X@RQY4ZHPU4V&,4)9^"R5(I%T3__UD&Z M#O_<'\OTWH%*Z_3TO9N&8,E")BD@D M+:56E$"KT*!I:'V4$G*0*O1OMS\&\5H,_(.=8N]0Q_7*I^"XW$H+.8)%VTQB M"^DJ;>3K-U8^^0Z:R3S=%?OJ+L/H4SSSLU,X\BV,ANY6P0DN;=:FJF,V19DE,8.@I6NM)H%#J5R<60:"G MF&JGD&X:C'OBWG/#Y?@]37+Z4'_-CDOWX2N^Z.(6OABDS"Y98AVN9#@>:)X9 MF4K"@N5,9J]4[2UK?71#"IK]^/3<5OU]T_/-9.9G\=;TD:"<+K?.@T,K$/=> MXK/-1$L01BB:7?5V<.NC&U*8[L>GY[;JKT;/I8B'>57LP]E6 SS67N2L(I#( MM22R)$W@>!EBE=+YN.S>=->WWL<:ZN8 MRMD3S\L-&,$3<2I8PF6F&>T_ZD5MRW\M8$,R^GMBU#V9:Y455B_M^@;,ZTD9 M@UE:K#;)BEH[S4JGZUQVP.0S<1K*R:EP*2891/6FT=]&-+2^ISNA3ST=53G8 MWE\L+DMWT,.\ N/-O!F=7TSGGP&ZGTMUQ<5U!&@,,C//'26F"U@[AY(#0F9, M&S @C12W:GO<>[S]^"%V?2(8//E]V2^%]&\:N#!XJ1C7S:'XAR[H,1R>T W&0?#>F9Y@B!S M[2[KZZ-[Y*;^),ORMN1Z:%FNK+OJ6SM._U4#Y*K8WMVQ,#)(<"H18:@G,@M& MG/&)0 !'N6,BL[X(MB;$'V'S[XME?6BQQSM9^P?_&!V<'![MCXX/1B>O2X_- MZ28MT.__GNWO5:V!;\N;4]UV?'VM\NK&'"X*7TI,=&%F':-PTBW+6DJ5T':+ M$H@U,6J%RA-2K&,7?>J:?OAV[F;#W\]%;*^SM]XJHD7)YZ(IHN&8!='>!VI]"%K7SY%Z MW$7LOJ,S.]3\(P=\UTO[F-5:W/&;>EK>;V/'1&)XLS2*5>^K)E[1$LH/G09;UP=$2])2''DG^2D-'1 M9N*%82A3$DG3ON;[P[!^F W@,4QXT E$"3=P%2V*RN!(:38DWT1 ;W48] Z '^8+:4*EZJKK#ZK M_CEO?B_9Y>CW+&X!8R$P860F698B7!J!E=I]R/F4O'.A1&[[XM+#L(9PW+@[ M!E523WW>O-U_MJT5'(\,7O=S M=K$[:FRJ@1[MUC?[!WL'K_;WWNX?')\>,G35<0[?5D@0]:7#:P^2''KI!M M;U<_R1A6*F%S%6?QTQ44]T 8"\YPRZ.>"!5QZ9)H4KDH$LD00"HGD/^UK90U MH6U?>&+>M.U5O/GF^\]',@1; MOD^VW*TZL;4^*E:=".W^;-$VE^6X^0L8H(QK8STQ(@"1X-#V8R$1SQ3P8*4# M5;OOS0-0AF"=[Y(=-312N?SL?2)F5?J#"T$$T^6FE.+$@@M$6^-X5E%I43O5 MZD$P-0S(1;N,M]PCJK32.MRT28FCH#9I)FC*NA*:3Y)#4"K67BB_C6A("V8= MAMQG4%;22-7K4'<+Y=X'+V6-QF^01$$YL?6V=+22B8 6,0J:\+4V8=8&-Z3E MM!_N]*.G7OK:>)%D+ U)N$CE;KPIX0$MB08O/#4L\^J536OVM5GIMS$6E@FA M="**JR)**&7YC"0FHV/)*$=[IK;!L/K\(2V)FVKX6_U,'C6^]9:\6SW=8XXR M6(NK+2W]X2,KJ2TNDRRD$*"IX+;VO:U;$(:T?-72\S:C7-G2&P>>!/4QD "\ M!!NM(,Y[0?!MD.B$&!UJ1W?OJZA2:W>^7<8>MY,L@T+#(=B2)J/+Q4@*))AH M5-(LLNH%/G[0U@*/8L)F/04>HXSJ9197"SZ6S+TKJ:,+W%"!&16'O\Z\'5OUD[29'K93C[ M\O>;'QCO!-;VI\6['[U*1\7W BO7+Q I#OXQA;)RDLMD!!L(E)D]%(L '* M$^,&J6Y3Y<7BD1"W72T?>-R=Y[STBTD<,Q:E0TL4QT.PDO*$:SED32#CQ+5" ME3Y\NQF/^P$.:9?MDVNW%]W^M%BW!E(Y[_'3JRLL';BO>]U^*==\E1Z]US3E M:FMW3C26WJ7LT 0/49EB-GOTYHT@WF;@N%-IENI'?+=%/:3M?9>4W+&^^VQ# MEK7J MDD5._*>-6EI'%V6RSA$?+26EJ2NQVFGB% 7\/[%8O>]791$J=B%1VHN0.1#6 M->1RN9PWX)J=E0K&LN@D_W-T(7E*EGVC5$#M4-ACV=;7=G?S!LDZ6R99Q<_GZ#)LO#QJ@U-]],5L=/_ M7BYCG#>C96C)LK66N*S1](Y6E(Q;3C(WP7N>#:WN0/4CR9!VB.H\?X(XM0O%I,\B?Y:-I0@(Z[\D8'K_O4N_FB;:"=+%W0J^8] MR_H8=^>A358XJ;I>0UA7XOTC\IHW?% MAQ[/'8Y/#E_]O[\?OGT].CH>_=?[_9/_^7+"_JJK^+:8E!+YE^?E49#N#@=* M5,9BFXA$#R"V/^?H>V0JG8^L-0&8,D)*1PD+I>5EN47LL]V>Y>KN,B?!)N60<22[@%J-X)#8#ODCO@>4$PM>.T6Z#]X>S MA1_#N<L[UJ7HG.8M1 MY>0RD8;%^'-/0E\M!=7,\;R%J;0F M+ 7--K/#U91#&:(#65ICJO(2<^GS3DKR]+#@NT[729L<)P6#P8FA-!T&4V)$XLQ[^E M1"/CR6(,HD?+$3*NCNSY/FT>_ENH>1Z/C]V]/ MCH_@ O&6G(=C.%T:P^@$+P=XB\/D1S^CPEGQ=G)5LO17XL7(R%?S63N974YF MIU>]W6X.R5::0XX^M8W'V3&9^>;S/G)Z\4#RB1>0C)2&V%*0H*LI[UVFA#(( M2F?D5O6>*#V*LTT#@RN=+D,ZD$8O]T_&UD;.C$D$H.2PNF1(D-P22%$II[E5 MWGZ'M@]\]9 \@:'P:[5GP;;:J%H^;!GB6XI_+=G>+%TWWAAGW-J3Y<-]8HG(P2H'/P&KG9=Z","B3?[A\VEQM=0_]4;@&2@&_KG?<$HVF6?!2 M:PC(HLWZH;*JBR(JAT%)V*K:7!4G7"+ + M@Q5_9W]9*K+[^S@ <$UU)$5R!,<=<2Y)0I.A,0)EWM0V*=>$M@[IU)^=='VH MN4J'L=>3TTFY$.8O;@IK(+QWS3Q=+CN=?![-SDJ?J^[@Y68%#M$&IAGQN%VC MAXR3)OA2Q0>R]LEY,)FO8<)O]/!U^*;_K'S;C4K7//2X>K^\!+^ O_WE_P!0 M2P,$% @ KH5A5\LD+Y$01 )/X" !0 !C;'@M,C R,S Y,S!?9&5F M+GAM;.U]67-;N9+F>_^*FIK7P2WLRXV^/2';_'Q[4^OQO'\#$:S MGUY.P,\@_?378/;II]DG^.F?X\F?@R_^IP]#/\OCR1DA_S;_?WLY_GPQ&9Q^ MFOW$*1>K7UO]Z^3O1AK.,TTD)B.(!!6(T]H1QZ++1JL0H_A?IW^GP,$H;0C7 M4A,I62;X+YGX3 TW7$ T,'_H<##Z\^_E/\%/X2=?GK7V_]_E]B_MO,.??+_%\O?W4ZN.L7 M\;'LE__W^]NC^ G./!F,IC,_BEGV>7_X[=HU"^+?\1?G0[^/IW__[\= M1S^;$_3@$GY:^QOE;V3U:Z3\B#!.!/O;UVGZ^=_^Y:>?%I+SDS@9#^$CY)^6 M?_SCXYO;2 >CV2]IBWZU MY )*%3C_LSSMEZTQ?4(@DW@>@.!/8514O"+&NYZ^/>;+9Y$$V9\/9Q41WWYV M5;SC,S^H*>!;CZZ =OX@<@9G 28UH5Y[[C''X\>#X^.#EO[_SDPE^\5_@%L,1@D6&\SJG<-QO/9+P[*]C2_Y&/H P_E/3\ZG MY-3[SR=_C,ZGYW[X?O)FE"?P7^=X +V9P1E"AO*_TQ-J1 ;0OIP)>(A0'HD- M/A$J@&G0SE'!;W,[7>E*]M,P9W?YPE^**'^!X6RZ^LE!Y?/CU,WX/*5+!Y/5:I=?WH:?9IZ,SQIJPFS<0.0+?G%9/_\TGB28_.-GNJTJK%GT MF]'T?%+,B@^3<01(TQ,;(9@(E"@7$BY>"F*IEX0)R:1+3GF1=_,9W,+VS%2E M"26W58H<0NL[5Q0E MI7 Q$"6\(5*'3&P,A@1JT*HR7GFGG[Z"7/.,'XU^]!!]1;U 1_7DY04:;GXV M\_'/W^=&W EHPZ4RC&1A,Y'29.*-SL1(SQD(Q"/\ P[OG0]^-%;G)D(?UY+8 M6I?D7W^Y(PBP=?3BZ/SLS$\NQOGE>#J;?H0X/AT-_AO2:Q36-PNI$MOH^:Z: MD8]MEKFKN(A1,5O&4,N$\VA]>$YLV3PJWX>W1NMU&$:@)_"LZM<8%):Q.1-BHB#;,D9.X( ZUE4)"X%=^Y M<]N+\A[.;1_1[]QGZ0+NAW/;F\9>SLLF'.S>N=5""N8RX1HXD9$*8B$*PJ,) MQGO':/9/7T&V<&[;Z4ML2-H[IRU!TY81J=!YM]DIPH0. M4FK((=+*'_4]<)Z=55!+]+>U@C?2BJ7R=P'7R"JX%]A^K()J-'93CRTX:& 5 MW _2)V=-4N@I2XF[)!YTQ.G(<*L4S$>7/?[;TU>0!ZR"_>A'']'7M@K&T]G[ M_.MXG*8'HW0$DR^#"-.C\3 MC[QLI'52>F(R39P(0X@B'^T^FO,$+39H@0#](9BGHZ6R3++0-HTR58:P73 MS"5"?;!$0D!Y\ 3$"\@ZV(C_XRKO";T /@>M:<_,VBVCXC7+T1\?/KS]CY>_ M';QY]_K-NX-W+]^\^_7#Q_>_?CSX??/[E X/W?KBI"_P2C?/P\','D] M&"W3LDXG_IMH:(@&71::B9*Z:%)$3P.R)5ZI6"H3$DA;^\N[']+6.\^=C__@ M+\IW=#Q 73_] )/!.)T$7Q;/$XE.>+33>8D$XU?DO HQHYGN8^W+]\[@=K_C MU-246WM.$TY:'%MW GT?AH/3^?[[\GPR0W;F%9K^1Y4<\>, M-W#".J[KA#JT%QPP$KTS1":.I@1%OP,4")>T"]&G_2CF=ZEGO?AH$.2Y&^8B MKB4-9&%D)LF)A(XI]<29F(@Q5B:K6 RL=H+!/7!V=:&\>Z7H+^U]7R=/)[.3 MCWYT"O, !LT>DC:4,,8SD2Q28AF7A''&P B;.>\4(L:G?J,C^+P"XP^<=TNI-9WNA^.W&XA_)OT;2&YAD2:;)P(Z,EK MJXI&6D#+NBBH35P%(V@2G>*N^R9P362U/G]]!%:9M]_]U\'9^=D2B*>*<,U9:1;)621KE;?*A G/77KH[XVLKL8]KR&P7Z<$?#X^./_[Q\AA_ M[]VO!^]>?3Q\>W!\^.KE^Z/CHPK5SKT>OW4L:_/%5(IJ?80IFC-Q=EZ2,4LH M_&"4\&2K2@9LUHJ4_N2 MMBNV[TM[-J>E14PI?H)T/H3W^1[$TV42C-(QR,R)\ 4J8B/.2D:"B)Q[;A1C MU>-*W>'M*GC07'5:4?*X(@HJ.:-30D5WHA1[18EZGP*AN%T:+@5*J)KOLM>( M0BLV[XPP])%J0\>T"XSG%V'H)?PU'NHFDFM)I( <7;)$F8 ::2PK3>QP6]-9 M\JA%AM3I+GG?!':*,%3AKX? :D<84%)7WK)"2Y110TERL=1$&4,<98Q$ Q84 M=5J+3J[20Q&&;U^ZOPA#+[&/:\BLHBE_5ZA#IIR")]HD-!]R0B Y6V(]6A+> M)M!5/KM'$A[:F+R-95;YR[N\23Z*,/*3P7B^G7@M.%?,XO%!49N .A*8"02" MPN/=0_#=S.4'2+SSY<_9VME>VA4O6>> ECC^&$W1LQOD :154E\'4!7MH+5 M=F\552!IW$K"M;_^M>"T#,[S:!!2N;)0'#5<M]!-N([=?C"40_G2U/'Q:55LKC&FF*!Z;C]ZT4?L#?3A\.SS<'P! M< 1?8-YB=WGP)6V\$+C." ;W2,D=01M*D"0I2T)YJ6WM%E=KH.S^9JX26>/Z MDMYW3LDUF?CK9VN;-),N;VR:>=)[R;M,1@D)K95Y#^4@T:WQIC17MO@?K1V3 MD+56M5M-/ZID%!#&,-IR.FH#-@MO @S:=4MB^FV24/OJR<3)* M#U):NTS? ONFUF91!OM^\G)\]GD"GXI]\ 46/[R[ZL91RT1VF@@3#)$B26(C MKBF!"C*&)'UJFO54:1W/72OW0?>>$V)\M(*Q;(@+$JT'AG:$+?=%;CZ^RZ,W MRZI7 #[1A)AMU*P5)?M.B.G2.<1R74(BBDBGT-0U*1%K&256&I95\L;ZVIO? M(^S-U$P#>K1JZL/$SCOP= 'WHU53;QI[M>+9A(.=*PJ>J1D4'J<9"E):^A-& MKXFS+/O@N8;JXY2>5JNF=OK11_2[;M5$#=?:^DA\L!J-+@@D@&8$@#JO6=9> MWLC&?!:MFGI1TJ=54Q]Y[KU5$Z/4EI;( MN U:G0DD86UR7FC7Y5BYYQ7/@>B:4EQ[K;VC2XJ#&"?G?EA&QXSB8#A8R*;) M[<2]KVIZ+=%]D;N\CS":::2WCW[< M&^G=DH36]PY+>"?6VN!<\(3K(!$3I<0E7+1P5@9>$M*J#SNY"\>>M6%;LCHH M0B])MS%3O]'^3WYR"M,3R<$*8?"4I*7GA)5X!CO.2]M2S7D@^E9)IL ^6X>Q@&*#O +<2R M*(B2,2CJ>%*A[0G[)//?>VE"S_SW/HSL-+VY"[ ?^>^]*>RJ(,*8 M0!7/).AYZ7W2Y>8DD<0#9!,,S;%V,N'3RG]OHQ=]Q+[#_/?@J.$02NC4.MPC M2T\D6X;HE7&N02JG<^W,VB>0_]Z+K([Y[WTDW2!N,X]Z7UOK:M2-MAJ]RA+M MSI1(A7:93]*A8Z&]B0IRYK4U8!V6YZ("562]BWDPRUDJ!V_?O"LA^-\/WQT? M';Q[]?K@S_#VC\/?#P^._OAX./]YA3Z;6[UNZVN&>HNM=-7P"B:#+_.W M7'E)D0GOT1-"']J@SGLT_M\ MC&?S;Y!.(;T9O?333Z^'X[_F?V6)XMP$;G04-[-A MMEYO9W"[WXZVU8B;&U$;'AJ<3E<+?S[%6 GW%:IB[3:TZ[ \?76H(N4&QND=:EKZ$PQ.EW,]XL4U;3WQ3GE< M>(FH^KD,%)[-U);F42I9GQU4SZ+J"?'IZTI+3AI<3=RST[T9S6""QMA'/X,; MNYX6P-&?LP2405=/*TZL=8S$;&R"Z)WE:G>GSWJ@SU*=*O/3X);C&II?46QO MQ]/I\?@%VM=QZ*?3>4.6?PYFGP:CX[]@^ 5^'X]FGZ8G!L],I[T@0L>$L#DE M+OI,N.#*<7 FT]H7(1M"??J*M0N.;JN6W":-[TH$;T;%1YS?\!V=A_^$.#L> MOT1\$X]^HQ\.+UX51DI0^[Q\))_]9';Q=N##8#B87:P&J+T=G UFT^5)[KD! M=%Q%F?^ 7TQV@;@ FD1@CM*8; 2$XY+9HV.)TX"8E#""SZ&&H'A^Z \715II9L;].MZ[E< MB]LR[F4 J@1ABB*6 @G2:L),M)E':7-B'0Z7 MKN_;UQWS5GR.&\NU>KG:PQ@O6PX^C/+NF^6-M6 ?U\?MF.NI&EN(?7]*DD6* M%B@E:$%'(H-TQ /#S\X("2:'K*!;=>-^E6/-%?)CTXT^TJZL$\?CF1]V@;J\ M^I(NZAC1O(D N20'2K1V/"51^Z1R<$D(TT$Q>KYV=Y9C2^;&NQ%[@[C^\<2/ MI@@'15ZN6N??13)4&VXIT:(,[($RHI#JDI8EO E!1ZFK)Z#2S-ISWD>TE<_^U;$S'>L2?US_ACWD"&TG^G%UN36]?[\*:WX<3/]<)$0JA<<2 M9X1K7*140I.0J2*1*RJ218"Z]BW9?7B>P\E=3=X-;KUN&Y-E!UNE-W? UN@T MOP_7?@[V>BRN58]*%#0X[._%:+,T+ B)+$K\4D,"I\T3P((BD29;>*8IH+:G) MSFJ1:I\D]P+:Y\72MMR-6PF^@7EQ&;"X 2OSJ)6SI<#",R*M8L1Q)0E"\]90 MGIRO73>\!LHSTH0:PGYLR>>KLK]QGGV"PYPASM"(OO,R_A5,\3LHI8!^6I)" MYOV2O_G7722O5X>[T^3WML*NGCS_S0M7^3]O+^]UO5<^!1:(LEX1B=\.<3D% M_ ;P([#,12-J!QN[(:M2SW-'I^_RDCMSHEY QB/B*BMJV8ASE([]UQ,(4CH. MG&0E\'P((9/@P1,K4Q 6SPQ??)6]6=]%G-S&8O% ME97D&"6(Y(BE>$+*X&R9O"")$D$E*3474'MF3SWT/S2U'KE-O=H[A/7B8GG& MS7L-(.SII\'G%Q=KVA2^N%CG 2[B1RH)QGVTA-)29WM[K=YW(U4^Y'JA+[SASK%.:@,3@5*",IE\XO7-G2GI,2D;CS"ET<6;U2 MYW&'CA^7"O6)2O>A[/8)^ZX"06[5A-&64QH!A.5*2=214JL M44 RVA:@HJ&6UFZC]+2BTLVTHX_D&VC%NI"8I<8)F37Q446"[A$C5EA'$H]< M<\-=_;Y:3R/^V(NOCO''/L)NX(#>'R!/Z'?0%!,Q*:&!&$-$MX-Z/#:CTL;A MBTLW$-OI03_!-1OA\4WQZ'1ED#@ZH)8(&3R2H0())@BB@,D3-HZI^ M6JQ'\XSTH9+(UR8O[OV*8E'?Y4=I5>XW@&D>3U[[P>3_^N$YK ^F[_9N8EN< M>[J4J"K>2K<1ER]?@#NX!NYW\-/S":3WHX]0!G-!W1,!@+URK8+E>VK!G5_.K7>M-^ CZ;9BM](Y"1XDY0HK6N XPJ+!^-X M3D3SY*.P4G!9.YG@3B _-&4;9EKD)%40SR*X9K,5@AN4A;*E-:A-)*2DT5WF MN)YDP=O:W:BJ@=]51/[Q*.-^>'\2<7D)FD&FK(S>=&B_2U<"/8YPGX1AGG,N M:O=U>(QQ^3UI2)^P>Q^F=AU/[8+M1]B]-XM] JN;4+#SVQG%K&39$Y=I)%(: M2[S@C@AM8U:2>M=PLWD*8?=FVM%'\CL,NROK'7?1DXS'>VDWR4@HO0)#CA9A M68HFXG<9=N_%5\>P>Q]AMP^[+X4E18UU163BFG< M%7F2N$EJII46RLEF4;![D7W?UFH#]AKT(;B$MI3+8HK:+;RK'CL=P#8R9'L! MW8]EVX+Q=4K5C*Z6^U@WT$8&YEE$>9>Q,E8I8IG51-'(/:3@A:MM]#P"W7K M+'Y\JM6#I98J]6;T^7PVG4N +4]M1YW.2@D";EZ_Y34)H"2))FN1 A>T^J"6 M>^#L,!),03$H%CZ20=B?08"/$,2&8Q6M2] M[H'SO2G()BRT-:Z_$H\TO,TO$I5""I@)DC$$G M5[U#23^(N]>G9G3?&NW2CJL&6]3A=#8X\S-XGSO(Q<7,I#% ,M6F%*3B?BU MS(?N28J?6V2U@]M]\#U?I6K&TM/-1[]:]F/+0+^-[)'FG#\@PD>996ZDI0RX M)IP7DY%!*LU'/B*<,L" D: @EHY\AH32 M@B+E#!JL8='7#HQ<1_#4\X;[Z-/-77D++IH8B=-/N-;R/X?_=3[XXH^\ A-S -.P#;O1YMP]X=X_SJBKY% M7M.=(.\X#$XT95KKB 8$#Z53M.1EBKS'KT.:;#(2S*IG.G4%]PSU9%L*&B0B MO((,DTD9 WCV&4;3>0^/#T,_6E;2R."B\MD2RBE:F"#1[?;H>\=D07,7T7&I MWY+@/D1/6BLJ"KM!++WT?)_.SM8I:C",&9J!>&-8N3C*N)^5=ITI>-"NW!Z) MRJIP/Z(GK0H5A7U;%38>_WI]H2?1@I.12Z*3M41R 2@.>JG$8)F*[RIG?_X M#+[R#81WF\*MQZ4N4-QYXCA-(_4:=4LB,'"4A. ,L=XJ-$]RX*'VH;\6S#,@ M>EL1W^9^Z]FIW[A)EPOESC.?I<%]1"5<**/$*Z:(B-'I:"5EU6\=[H#Q/3N1 MV[+2J (")G'@AQ_\9YB<".T,KH 1*LM >YH16(90^GH+QZF(V=4.,MR L'L% MV9J6.PH=-I5I XJ//HTGLQE,SEY!N I>GP0MO%=&$NY!XNFDT=0(D1%(44>G M1 J15F;Z;B1/G_ *$F[@V+T=CTZ/EZ!.F(HJ2J.)E*5K+5A>+B. @,^*4FX# MR[7;1WW[_J?/\<;2;#( *:.)MQXZ'1$INI0 _3ZTC1E-"* MU[X2ZP;MZ:M#"PX:N';ULH*Y!?1OG2,FT'**&4/$(,X@W0WQKM_NJJ8Z8"]4=W -KCW4TA02P?&>R;P ML2DA$S)8L(&8Y"FNP9;Q2#X3G:D7%J*@K/9%[.-3O@>*$!ZC[O7AK8'._3X> MP<7O?O(GS%Z?C](*%;4Z)B43@3P>7"TW>X-'/2T(**T%K7&UP$DCV.J O'(&' MVI[FW4B^(P6I0,4^N^$D](RC(BXD0Z3SD7@-F7 GC0<3*0J@E3?YS+OA;&.2 M-V#O$73#>1CLCVXX-1G?LAM.?[KVW@U'9:5L!"!4('(II2!.F8!_]<)P(QVG M/[KA[%VU^K"TXVXX@1H?51 D2U-*L] &L%)G @%/;079\>H6]A/NAM.+R![= MJ/;C@5 M:-ZB&<4F'.VK&PXD:73FGB0:,I$J!&)U# 2X8KA[EP8PM\M)QPH$!E,)$X74U%0D9FE^&W5SP5X3MUP^M"]93>\&'RI MR5T0-O+-'D:W'Y=L6Q[O58MJ)#29 /X@TAQX#GB:$H%L$ID=D, Y>AL ML1IJ7];O2TT><+QVKR5]9%]1.^+PZ\GQY'PZ6]8@CR>X=_[7N1\.\@#2NCX3 MJY2"K#U:7*O:\KO@*:D"9YDH[3VZ? :(E=F0[!FX M;$S64/O::J>*\( 5LD,]Z"'HRM;'N_$,YKOC& ^T#_ZB;'FK2U412V9B)IHZ MAB9L<[:'(CB M&ISW(7C^[8)MF:F1:>A&YB6GT475(TL@KL1[<<@ MV)ZQ!U1@"W$W, ?6H#.0E2YEKS26XGI#,_&61:*4CXIF'X6IW4M^ETKP@#&P M*QWH(^5&W*_.QU4M1+#2>9%)=)3B098HVCI&$<.S=DDI)G3+IC/[,A5J\'-/ M]YD-A+O62JC8^O_H^/W+?__M_=M7AQ^/#O_/'V^._^.J.WTIDYE=;-Z\O_NS MMVZ_O^$R*C70?SGTT^G[?#0;QS_?7K8-0+T)K/2!]4F@X^#0QO3ELE^647W9 M@%&T]G=T)Y#M(]EQ@K82O(+%_[X9S9__:3Q$G9PNI/MQ/!PNAX&?4,<5E\:C MFR2A).\*XIA51$4?8D@RVU [$M43XNXWE^TUY':,NQTK+8*6M\#A H;G"HQU>>E*@C/&)IV]&N#/#=%8DQFW9/KU2N IO(K%@(P&4 MEQ;26%\_0E$%^3Y"YPT5Y&:<8_?L-NJJ.5Y(Z>B31T3OSV?3F1^59: 9GJ26 MT1,KP)5T",0F)26,:_ IH5T8:W=INP_/\]:G:DPTR!V+E.DI[F9S3H;:*K 7SO/6C#@'WB/5.1-9KHJ]D)QP%K-GV6A7?2A?%US/ M6T>J,]/@8O;5X,L@H0.*VU9F&I>C"4O9E19SFEB3%<$?TB3!4IMJ^TR7+W_> M>K"9C!N$W'\?C,:3N66\L'97BW^-XGDUF"[,8Q3[=)UY_-M"/"?:1AD42ZBE MO&QTC*$T<,NC-"KP,2<::F\GM; _;U7;"\.W-=5L/8(D_>?Y12XRK7TMV7I-SUNS'Y5&W-9XNTU"Q-Q0 M.#S[/!Q? ,Q%.!_M%6=X<,R[%,\+8DZ<%DH5GT+8E$B1%G'>)!*UT2:D6-J( M=TB.Z/:VYZE-C:1]6Q]<2WU8.IH9<,U1>)*40X32O*H55( MH!UG91"'D^C#+QH/4?RKI $H9U)5GWC;.;1:,T!H#.,N9OP^'(M$QIB)M2D0 MZJWQ(1AP1E9>:,< X5:,7KI8>+C/'XZ;QA#_)YTX;P%BR9@2 C];BSNXI<@Q MCZ"889Z+ZM.*NN!Z#O=_U>7?(L]X>0>_7/B+B[D8%AEU!GP"Y7 #I!DMO@"\ M= 92N!^"-]:Z)%3M&97WP-G58(+Z>E!+QH]E9,#1S,_F3UP<5L67&(\N^T%' M[7G*C!)C!72/+5/2)NE4]6&V]P+:5V9K-=9O7>36DGZ+VO_KF)8) M6EU -# MC[4-RAVJPD-5+#O6A#[";INTL>I0PCEE"7<]:DH_"6VA-"=Q)'O'O7;%Z&GH M3NPK?;4".>LMS TDVR"';$W@<0E.YBB$BYH RQ9M71N(%8H3[[,,UL@LJL_% MNA?0A)O\.5_+!F](TB'?C)"M_UR,$/P(+Q#$]HQ-*:M5\1EEU%=@PG@ M=>*V=O.6NY$\!P6H(./=I&"M@/%(*564,+1[<:V(SD:+RNESI%I:*5QMKW(M MF.? ?QU)-TBT.HCQ_.Q\B*9.6I?IL:JX4%91DQ2ZU-XA/,V(93R0 "$G%W/2 MH78:?F=PST%%VC#1(%?K[LCVJ@F94]1*XPCN7J4N!WFWFUHSJHEY_\Z!2F@]&]JOX.YAF),&U3,+4AB*:5534$4ZD$ MJ\,N5$!4+-U9!PUNW1TZ]RJAY_[HMQ>P,YEJC@( _B M/!>CY"%UP/#R?#+!'6"1J;%*E;RINW^P^6/_5BYH&P8'[/K$7D,<3N"G$Y8]+6GA0-J24Y[,=413@+7%, M<9(#J*0E.KZT=NG&-GA_*.#NZ&X0S:@AS*O%>!X$,W,IBC(Q5VGB@0LBJ "' M"P2KXB,\GW\H\V-0B :!FON^S'D)CDA6NYB(\:#PXV.>!),M888*E[Q+(&O; MDP] ^J&!54G;5]4=)"-2CAD77/K71W#$>1^)$A ,SUSG4'LC?)Q5=T]*NS:B MKT7/U#LLVF1CXEP385)I^TMY&8A@T#T#+U,.G*7:52L/.1O-XB2+3"*6/0AE M-.$;&5_]]F&B1.7@%]'CB1]/A MW!&ZJFI>Y3G1K0R0.A"-1)B8#38I6KR[HANQ1WE9M0NUZ!:K% M2]L-YU>4W=)-?>FGGUX/QW_]!ND4/OC)%=Q$K^G\ "]X2AN/C_C%G%@5F%64$FY8203PNO0\ !)]:=Y@J$FA]@5/-?"[ MW]#J:]VMAFA[8;:!4;]NP[]CBT8CX(^1/RO]+O[[RC0XF RFN,A7YV78R_5[ MCA/*I*"*!:+*F!=I-2=!H6^D:)0R292VJ9U9U'(]SU&1'PW_.TY?^K ("QV, M%B;/A_%T-H'98#(/ 6VTZJMD >=Y9#D8$FW02(J5)/!HT8BA63%G)'.U1]+N M::G?TQ?QF+2F@1MU6[!',)LMKJVFMXZPD^""<,$DHJQ5Y;8DDY!5($:@[#4H MQ6SM6'$_A,]1-1MRU"!IZ39:_"H66C^(RY^^Q"_H)'J'$C"6V&+]2!M0\R$J MDG5V0&-01K4W;N_&]GUH405>&B0HW<;YLE1"K?J_OKA8=KR;G+CH(NHS)<.>_9**LL,@,"!N]+H MBQN8SS--)'BN$:SU3HD4K:B]#_4"N*M4G?8*U(Z7QY*@\_'2+"QKNII]B"(+ MT04B@8?25LJ0H'%E8(5%"1H35.WH\]U(]M]SJSKSM[LN;,M FWX;-U"MQIAV MP-4H'V<=IOVDY-3@[4%5V$+HNU2*G#7:6F70@H32\%2Q<@G"":/61FJE1+!/ M6AD>2,K9I2[TD76K8-7Z@,+UW?*R@TSBG&9.0@ \AP,SQ%&!UI63.L?H4Z2J M1:"I'\Q]).O7X/BNN%!#@AH$]V\P_P9^./OT9C GRWV7P7<6Z4$29ZC M5\?0M?. "AX%,Q 2RU!]%M>W[W_^MNO&TFX0&%YA62I]%S2-[-3K2/9CG6[. MS!J*MQ!KP\]\B2J U8QY1:@MLV25,<0JPTA*,B7F:09=.\J_"Y(?L#I;<=Q' MFA6Y+1-"KLZP:_E<0LL$LHP(2J*,TE !MR=<)G7":>U=O'6+<^?\E;N?OON3 M>AMYCZL*JZ(Q=QW1TC;PDQ4J\ JM$),)1%6.F6A0/T7 L\8[J8)Q.9I>%-Y\ MPS.@<2NA-??WCSZ/1]/QY.UX45D\WW4HY3DX']"6+#,GM ?$AGBMC-98&V(* MM9/H'P3U_,VNNKPTN%*]%^#R<^D"<2>!Q#OA/8:8XM;$]E&;+5C9]7)S\<73"C8RNC"D !XB E18UG$7"RA!H:KRT]VX%4XA_.QU_^67YQ 75 MR[]8*8 MM ,KE.A6D_VX:%]CO.V2]3Z";<3VZ_$$HK_L":]P;<;X9 MS*Q;JMKWK4TJ6;=:^FX+705 L)R2D%.Q-+0AOG0W2*Y<3EFG8DC[DJ_#%7&@%;'>TLB#%$;4SE.Y']&C3C]Z-E$2W,IB>*AF 5VN*!$Y\SLXH1J.*[?6J&];O0\<:\+:3TLB#167G//;W/A?@T\5TGA,5 MP>M2;L=9*8VP D6C628Q"FJ!B9AW4!>Y%M[WH55UV-EG1:2C3N-.&HGFOMPJ MY$0AKWO4@[V7;8H,UH+V M1,UG\IEF[V8[U:VV8>!75;H=<'U/9=M]N*M:ZG>)D+?J5+D MJ'PL839M<(_EQA(GT4QD(%V*6L=(VU=Y/YJTJ<:ZT$/6CZ1LDU.!^R*/Q"6.$3.*JO'TR[;[,5QA;+-/@0UB)5?JS\Q667I0\E^+_:: M3J',>Q>$92DD_I,3M+:R/+U:NVT,CHVEW;[6K@N:[Z76KAS8XY!K#Y-XXD4:/4BZ^$"K3Z2;E.@):W+EI?AT4F@Q:R4)J$8 M2T: 5=9Z9NYM$/#=\>'AT>;YVMW?/#6*=F;+*!2UG5)ZRFMAP>C4QC% 7PS M/MI:JBT%]"#GS;DL[(NQ]2ZX'DV%&6>3;\\-8+3Q+7VC$1B2FW]]+J,C!+X[DG0(-,AMI8^RZ\*[;=[QV5M... M06;UR:C>,.8,TF!^]"VR/] .RKC+L42D+.,EE$SH48,G3J'+%0(W!KJ%'VX\ M^,G3NKVX*L>/?O=?!V?G9X=?/\_=YC]&:3DO"M(B"4W[$%C&8RM85"MA,G&. M,F*RX 841]M&=&#R@=<\"UYKBK)BN+] .QK,X&JU%P>G$X"$RA?+9G(*[W,! M>/3)EU$Q)\I(:XO)*IRVJ(U.$.>Y(=EI%J2G+(#L0'F?=SX+_IL)N6+HJ.!\ M"[,93!#.!+>AV8OQ9#+^"R&]])]]',PN3@Q+0@6))XGU:/)"R=>R#$C43BGA M!>>N"_\/O.994%Y3E U2>!?PIBM\[\]GTYG';6ET>G!6-J83GI7D02?"_7SX M4W D)"6)9%)+%M&]";6]]X

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

    JO&$.0;6/V"HC_/EV 3I^LFP14TZ5[AZURD7L$"P/"JB= _!\ MNOA'?#BI8Z$MVND#54*0"AV6!\56&>$/,.AT$N]7"D;WN;T99J;N&+)*)-$0 M%/>+IBWQ'?3V\EB=O?)_N<4V._]6*?K MPZ [K(LT$:P(K_?6O'HS3RZ]E?VC_> MQDE,H\7\%%0X^,%.=&CJM6*(7-NB!*BQL9VL)_SQYGLN)@D+6/;XN"MCNQWW MQ4ZD:.JB:I!DV_' 2IIX>X;MA&]35UN'9=0>B(7]Z,UA.X'8U%W781DU]"HP MC7/P"[_&?]^.9@]ZI8Q2[O&93B W=?757X:M1@%]^7&J"*"G(Q>)_MDSV0*1 M/U_LW=]R_Y1E(-G$Q]*!/UW&'["O03C#8WT>!JGVX-H#A9]WY.;J:S\(_1'] M[6+T([X#-7$]G=T-#AW9/F(]F#;E/>VX^-H7R>/QYO1&L5 0R>Z!ZT5?[85B MVD\NE:'[$J<%<'H';H^G(U4+H]JW.[8NMC8 X_'#M,ILC1CWPZ3,7CL\ M>CT5>!R6G>556V?&./ME-KW]_G$^ORV(Z+YQJT7G'JM'#\NHMD;]9B?7,3Q, MM!2*^\:M%I=[K'8]+*/J>W%Z.5W8<8EWX,VQJH7;'KWGMLJB/D)O_ (\\?'= M%SL*A8#:-F2UP-KC\=HCF=J.!I";SFSGS1$21"WC5TO3K4 EGN$U8(J?9AJ<86Z M<^1Z$:9#].HA0=6.K/CW[6AQ]S<[OEV)$MR;F^_+=.U1@LE$6&TI='M^JE[ MZ9%P'R?*VF[CAIKYVWQYB%Q\ RGE9HEQ]G51RI/L]ZEZL:I'W]T=(\KF\#^/ MBX\3/[TI=(?>Z0/U0E:+8;U;;,TA_.R2^51([_E0)\2;NCLZ0HR5D=^B?O+* MUY=?94#O^HU.>+=T^]13>,UM\L^+;[G3T4GW]_9O=(*ZI8NKGL*KO:NMNQW; MV:?1?%'PJ7OWJ)W@;.DZZZ" :@/X7+,,O0G9,62G:(66+K/VBZ;ZS?^]\B\/ MX*&Q.R'9TE561V$U4"3\P7#_-)WOB]\52W=C8L[Z'; M;^N G>!JZ0)JGUAJISIG@RJOJ!!@V\;KA%=+%T9[A-+"%7^1\I@_#]0)H)9N M>;:)H;H1,AT<*GD_1B<\6KJ#V5A\&V'>@^'H&Z]*6[HF:3!,=3KY!0R7]<3> MQ[F?C9;/,(7B5 \/WPG$EBY NHNL^KD41GE>=LPQ_?&XNE+/SX=&[X1L2WTM@^+)QOSD$1J:]K[^16LV[UKS'I)ZKW1:K(< M]_WLOL!G%[.;2?@PMM=%D'HZ8K5DJMXX;95$(RCE'?]N,@^SHH M[?=<%HT ]>OT/X_S*ZL!=PQ=+2NJ-W#[95/;,;\_4T-62X7J#%T'J;2P\>;OP$R.E].'Z99[X^XR?K4DJ7Y;L)N4FL7S1##62YDJ M@%XCH-4M>70ZIVR_S/\J@O17$:0A002K_0__^,"F.2:(X.G8=9WE3KMHKU : M &L9C?+6SN,R1S5.YFOYS7)V>"Y"/'][]_AOOMB[9:^0O)C'%4W"E[&=Y&>/ M]],;.YH4QOPD4ZRRO?>38?IRR#1 O+.;[^/I78P7"S#2/G]?-7@[H,J/8<_N M[U31'B^"[K2GJ!N@PW)N;[[#Y_UH*8JOH^MOB_G%FZ\7)Z'%X>]5N>&K08_. MHJ]M]VT[=$MT^M@[<+4"!L/RRG^/LDS,9WUQ?1W\Y&BU$>P0U+2 M'H9[FWND#;^CWSI@Q>O%0U@\24+;(XS:J8,/4QM\.;\Q5#5L]DI[*RJ-W":N M;Z6WZ)(RU_.[!VX JSW7] <%\O_U ]=)[,>N>^BOIZV_GK;Z1=(L9N/+.+N9 M?TZ7LP#\*A.(L6?8:GNHGXUP6##5+84\JQ(WA4]'JA8#VM>&V[+\5B"Y'"T& MF]=/AJH6\'DD*$\$4!F5K[?C2+ 3)%LU8?I]$8?'Y>X:LUI\9S^<#HBD?G[? M*3#;,VRUV,Y^L!T63!,*<#FO7!73+DHHP2?#58O>/$81;A-$0\KP'FB/4>A(_1 MACODT016[V]GRXD5 .EAJ'HOPL>@LRF!)F#Y*83@^OK-#SL:#ZZCMV?<>L_# MQP"V5S:OXY7QRW0\\K" +[.I/^$KXY//G."56;?,\GR[64RUSC=S]*XW<*@_$ M>8_\3J_1UW^1?W%V'O_W__I_4$L#!!0 ( *Z%85?V5*IP@1< &RE > M 8VQX<3%F>3(T97@Q,#%A;FYU86QI;F-E;G0N:'1M[5U;<]LXEG[?7X%- MU\[85;3;M]PSJ?+&[EIO=3NIQ-V]\[0%D9"$-D5H"-"*YM?/N0 @*-&)G4N; M&KL?.K)$ B!P[N<[AZ^F;E:^?C55LGC]'Z_^REV-GQ5[TQ\V6M)U,G#O8.#L7OIK[45Y)_=]J5ZG48Y]6/_/>K'VF2 M5R-3+%^_*O25T,7?'NF]@Z/#O9$Z&C]]+(\.BN?R/!G] M_^'A([@7KN>;K%N6ZF^/9KK:F2IOQJ9R M,%L--_-''F-M)*<^NAU9ZDGU@A[H$=\:?LY-:>H7/^S1?R_QEYVQG.ER^>*O M%WJFK#A7"_'>S&3UU\S*RNY85>LQ7VCU/Q6L"99'?RYXO4]AG%)7*JQ__P 7 M??IQJD?:B?V]W?WNBOO7FL/6JOJ.%GOQ/Z?BS<]OW[_]/_'F[2_OCL__+@:_ MYN/S\U^/?Q9GYV].SR_.?CL5[WX^/K_UJGLHZD]]UH,;/6L\C>^[T4?]&VW% M,3!^ :)#5H5XKZPC.7(Z'JOFZLVKW- MKJ9[>+LM_*8T= &4,N?E(S'AGV]@9O,1=.=L+JNE.*ZJ1I;BK$):1SIZ5\JJ M0V+X12 LH:UP1DCG:ID[8JU:.:DK@3>,@,N$O)*ZE*,2)E:U-56E2C$VM8 U M:*=-151MFQ$P)$P(4]?*SN%K4#RE=DL:$Z:8U^9*%PK^%#JN#<=1LWEIEDK9 M_@?*A!0GJI0+62N1&WCT6N*TG4?RU\:GPCFUL[0L76A9:QC>+Z16N9E4L.?^ M:6%@^'Z*.QJ7\B>1;/\9BSL5M'0"[7;N/WUIA?JH\@8/##813D&!+-5($+"; M2M:5L%-3NQV0K#.12SM-#AB/K;"B <:I89.!VI#Z;L5Y0Y-G!X.39R=JK"OF MQ=V[)YZQ*4NS0.L>"<**A2Y+,95 #*[SZTS)"O\E6<(BC40 7L4BZO&SEU], M*&B_?R>RZ'_T+;E]=SO???:#P]VGQ!5>.MX=O8+=A@+@+DG2ZP0B-Q!?8F2J MQHJYU* A*A9703JIKQ1.?S[-C1YHKF=;_ML,BN:0L&A)*-U.--@?SM11U'E= MNTE4EP^'ZHYV#X\&0G5OIEJ-Q6DPE<3;\5CGJAX6'>:TR&C/ 1'2(C>8&(OA M$.. 1" 3XSMEYN5 *;&?\EKGL63OT/6X(],&UH-7FJ;.88TS<%_!-=PU7@)I1+,55E(49+&K!ETM]@#>(=7*31FQ [HK-QZ""^\2ZG$L?C ML=0@N-]N/,^H!Y[IXQE3J&'QR!E&*RM9BO?J2E4-TEI!<9_]Y\^>9$*"/ M9.NICZP.A[K1V." =@C[1E(,M@@0+_[S(021-TK'3Q_HL#GVR22U<,AV:>[2%"#(-E?=+'S=R5K\4[6 M3N<:#M\-AV;AT#BE!Y2E"\P\(MF.%! @I=Q$D/P"!"T(U"0[ +1^L"TXUALV " MG\VD1&C1U#@Y&24T( R]I?DAXE+!:[S2IK'@-G[1),%QI0G":D&+J'\T[(S. M:S,S..KJDY:4;XH'1W&":B,MS3^^D[B\";$,5UQ^=REY,UX*4O(N M&2H8NBVO?)$TVV*N@]/.HF3KXU,I^E35]B:QU.5P+) !93;>*Z=KQ;#;H=@= MB"W0%'Q =9-K8&H3*%>X40;QL M@(3A3.G4E!%TXXKJVOI,403@H*! 2@4H1_QUEHYDP4/',PCO!>W)TZ1 MP;P3L!1+^"%,AYC0I@61)(=(2\;< @UOUA:W-0 V^\T3A]_S ?#:-EG'A]OB M8 \_S0S8Y)&65Y:[26*^'(Z8'Y#E] &!QR 9C_:>'P^ ^+R@3U?5AD *3LYQ MQI#%(8@#%(PL?FHOFR:--U/0/6C*"5VY*@S(^PKS>,OHU]T/N^)$H4U$6L7/ M?(':HV$9UINAV4!NF V'&_9W]_:'P@TQZCL<7D!R3R'0.OBW'7.G((A1232* M<1G^*X,[*U>;THK'>QCYSHFLO53WY.V, UK.S6P$*RG$E2$)/S<+3G>C#9*7 MTGK[Q#J37UY/Z6DE5?#'7Q"W@KY?JZT*=WG&V&MOD2.PCQJW?LMGRK'X_],Z MC#P'^VQG! Q\N4,VW0M9+N32/OI.)6##8_1J.(P^H)1 %P(R(&;W&@WH5Y98 MP5 D?GP^5453I+YF)R<P>1<@P4B=]JBM;B4!3G1 'J-/0C>UFTU!18>WOJ-14:"86M78AG3A3 M;FHHN-V:Q3Z=2*-WXV<\KG0T\%]^>/S\92A2+#+Z(5OS%#OK"OGYOJBW77TZ M#N 5BN.6ZG/+#5YIFU?]Q"/XK?&YQ#C6DE8W!?N_$!PZHP09XP;G\U+G&("C M/ZT!;P*_]MBKFFQT2E1*<(OIPF[J5M>$,5#@6P?_.(G!QNG ?E^;+Z838*F* MO'2X'*V.^/ST7&V*-CPX#(E W.*A.M,3U4PN8UTMIS67X3"0VGRB,^@.WEJ? MV:C#0* ML\L<7%@.RA![I0&>>WRR9[ S(%:98]S7'G/*93(R3GIGYU*&'EWYGRC7@0-S MWJ3-M-@5-E\Y7=3 >8F7@"_XBC80F%,9EH06!0SK-#]K[VP[P/'/E-./*:W47^! U,_)GUA*EKJ SSB_(*NB;?$%N)R)M-]O5U@YE MB7[6OAMS%D- MH)"J".>7C(J?M0&]%.(VO.A5\(^_PP;8E27O55<-0[RC!\+,YJ?I!*WZYPT@ M (]B[UZ2UQI&TY([)B7BVTUKTTRF[9W V^G>\W; \\:'&C=U0+ YY Z0"^RK M(0U+SX*R;/>2(F_$,YT-GTKKD?D(@BLTLJ)%L2-!(6&$!R-!RN'9.8JM;:HO M-<#ZYJ2MEC>]4+!-35FT])?Z]=$T0"@*!\J/: MJ%CV N"SU8B(IB+I8:3:?1DM1!K#%Q4Y;X#7E,ZBN*"'JO)_L(N!2@/2@', M:FI_#37 PO,?U[(I&+'A$(1)EMI,6Y!419,["J)&=;52--NV24B=[[8"=^5' MLDFPP@4VD! =J8P@&;.07@QUE;I'HPKCNP-*JTD-3.45-_2BP*_ZF"N%8@L- M#S1H.F+1 ?DI']1?EZ@V$;LLQ?ZWJ3!3C9TR]YYY$\;D>5.GL2#&).*0?$%[ M$O'0V-KQIWB?(\AG2,TE(7H2>?,95;TP#4@7:N(V4LK;:7WF+-_;S#V)A/U> MYXWLD_2[DC% BLW"?.HC,@BNF*XF7IB8*U43U91R0Y1OL\;QL&$B"D'=2\=3)!!X-Q0S>N9KWFL(28"\Y 28JI;WE$87EMPCDVO05&35!A-N!FMFC'QK1=/K>S:JN\,[!%2_&>2BAP M<6] <(YD?HFRH>T=G/;X8(D=>@C3_:%,(".1ZRDFZ 8ZR-4UMH4L04#KRCIP M1@(=Y&$=23$)DHU,GX9GI\..3E+BKCPEH]F,'Z"I7PA-'0!(Z&AP(*&+;L79 M:4R#;F(?\5,P.^9.D)V_)';TQCH%;U*F KW-CFCJ"[1B2R+S=Z(MS.%DL52@ M37!2JLD.XW2[K7)M/VCZD,]M;8!TT(!+S3TNY1,M6[#O]X>T[S>LTWL1W*E\ M&*7V=VD1_#X%2S+&I%#\>]E]+3B+(DVE;=NXAUA4ZR;+O@.[Y3GU&X,QV(S& M2+9&&[@VH*(QV*I\NGUV>*3#=D R;;Y5[]\!B,S'@Q.9QPF+82LXGQ5,+AGB'V^_?<9V MN]4 M:J=GMUXJW6$!]+9+Q@L8!)E94,GW>"O[@#FEPDI383'5@K18$E 2-5[+"V![ M$80#K"[%87Y4I^:3H(T.(*O;W3=%_%$R@6))A Y)V8]X)R:G;X!N1BV^VH&, M^PO 2KP3S5CLM!'MV_TFX$KYI$%D.OX.MS!C8X]QQ M\]7#H[3YZET27]8QRWW*KRK\BWGP]!%NXKR ;'/G";5&.W!7O,=,HN)PFUFY ME&R]D %@&[_&R[^"9-<(D")^>?"PN'%H'?WM?W;AI1!P:5G[#R#W'NK?I]B2I&>/D/6@YO(W! MYIPM2"TH"@@5AF.($8[B->V)*8J= MGV O+L7OJ$ ^N%J!P_<>\5PSWSR\LLT,AGY7&^?U")E7 ;:79/?@2>^QQC[G MC!P0S+(+# JTU@*$UDQ!F:13^ AC^L7Y]S!+:A#($;R))AQ'K:WB+IJ?#J1Y MUUNE%4%H6'LBGQA3^,QSM,+CCXA!=G7#;SI-G/C("*'S%UBOV (!+]D6"0YJ M A35V^YMHX7TL\$):7KI;JCI7$F!Q#C* &S:CDNS)MR '<#)J(J,<$\(R2,\.#YS#9N>ASXVC M_.,ZQ*/E(6H/FKRN(SI\$>+5O37M0[!>G5XM0SPC33[>8P,S1:;CV]+JJU#M ML6[IX36=WKB.OB(5&Q+YOK]NU8-^4A\Q!^.[1G]>W3Z@= 8O'/>'*!R/+8(. M-U4DMM"<5$.W#G;7,^8JTH#FS0)Z.0LHX@Q=0#U#TX]#R\WFM-:B ^NS-) MQ (*CBU4%2<6R+[!]=NP[A";ZWL.^)8?/\?>(UGL$(NOAP1KC409I8ZYI?0T MY!JBJ59A#VJJ3C3Z/B.&3]K2"K Z%8GW]?W.N@5+/BS!FTDAUE"/%L(1R;WW M>',_"PN^-D''NSBO3:Z*IE:4S]-.%."+I. '?EM.RAAP /&%>_@*])9)N"[8 MS)+B,NMK#B@6OPP(BFXY5)<08FR(&@AMMK5_,#R%1I*5Q%*;G]U@Q;; @&6B MV[" )JH*@H##2+!B9H5YV:!OW7W]#_F>L%'4'37D@.(7Z]?R(/=8YAR37>Z) MI^-B49PW9'(3JUSXRI_T6N-U,NI-"C;0VVBCHK9^%,?H>S(Y? "B[[*N#"?/:.HLS)CUS),EV.9/Y#R2U<=W3'S%K)LM^X;3 MF#/(O@]8B^:;T6VBR#MC78GM%%8ZK5]?WA+?^>+]:6_OIZR5O ]&5]1)(Q.Z M1.0&]>]H*E6!$9"K"'_T+U97N9>J= ^][H9N(C@:-M8,M_GN?V-?8#CS+[CI M7;1'KG7[$"6+ME$@M#:_7]/"\R>]]85]!SV;2ZYLQYM&RWLLM"]6X%:=6')R M7)3$T^/0,/1S]! /D?I!5,AA5.R+:;\">[]@+\% 9Q%@T4<#G6/E*_!DZ4T^ M-!^ODM_IL^;TQ5/W:O\V*S<$ZL(@GB4)T6DD>,^AO6<5.&VJB0BZ6^RK9]66 MWD F*P*0PK*<+PZBJLZ$2+B_I#\8["#B4[8HS+AC#Q(!4*Z9Z3R^X0)N:TT.)8Q$NP='H M7()_W1L(&W5P-_A--P)G0UD"AY3F2+#8KMD'OCB[A]N%M#D! YQJG6K!>73T M;5JHL?)08YL0>XC];38A#ZS@0Z=9M3/K286ZSU+=N:3D4.N]@3SIM]!V_ MU,=Q<,-WO@LN0\A]>)SJ.E@037ZPYB)\[E.]_>ZQ-8V1L]8$35KRY+*QJA,; M^Q0T$X3$6.J2S 1JJ;CL-D_L%LVS\X2]M-A:;D"6E#&,15W%VL-+QPDOE)41 MM1>-"%<;Z>&6U_=1^M*&?X^NS6K?@,G >)]4+U!@JOJN0M/G)^+M3^+D[9M? M?SD]OQ@X(N''D2F6\,_4S#,Q,6-E;V-EAV>&8L:9+_+K<4927?]K_.]N5WPR25U0Z45B27I2HG:ZG(CO M%;D'T>VV4C>FFEL]R;PXZY\-Q/?&/NBI;,:]]CE=+^89GS;/X].PR#@V:GX] M5GHJM/IPI,^B=_W^H)\,^_+R?$CG,KY(+M-A-(S2M'_Q[OR'Z BJ$&]TG)_G M].&HT&4W(UY_='[6NQA6_FJFE<]&4;__GZ--46DGD(Z-]Z8874*R?>--%1X] M/?JNS/6D' 6/H)X:^-_J)R8W=O2F'_Y=\4@WE87.YZ-O[G5!3GRFF?AB"EE^ MTW&R=%U'5J>-H-,_$TS"(N%QUEA\@7ER7=+"@^B,;;Y]S'2LO1A$O6A\RO(+ MOY][OX=+"5) ]A_RZ>;VR_W=MW#=IOT_ MUL[K=/Z7.W"^U8&[COB?+I447ZA4.75$0I;-$3Z3_NV;X>75OEYA-F1DU(V0 MIW_(J:BW,/KO7_UJ(RQ1OS?D,-R)3$Y)6)IJFH%R?*:=^*F6%M#-YWA?&>N% M*<6WQA8BZG?_+TPJ[C,2-S#:/(*.BDJ62_TB$/B'@Q%P^E MF>6D)H!_2$R;#F5@0FE0*+""U*5 D1=>EL3/$#I"%4$>9*BP)/5,A>I3/#* M"E. Z;QIY)X)E)20<]+.6:20#X1UU^9T>*=@#);,0PG"&BR0:(N2 [$2ZK!$ MD16S3">9<#7_6.G/R%(["3M0:)>C-G&9FVF?P4%741(,Y'DKF&84W)Q"38EX MOAZ&0X7729Y+7"G #*6L8Z M )EF6JF09X8H0S?/5QALT^^>+ V8*\T3=UBBSB$ X!F@(RSG@CV)=)E(*K[.7QV^[C>2\?;-Y5ET<>5:!+5U MG2G I*G&8TC3G9"6 B"08!WGQ(D3!!3&N789B[-8 ?IC"N1GI5V2&U=#CXG1 MFKQ!1F5-0@JOG3@&$!0!64VV;Q^33)83$A_!.5_J'!+10':CX3&=!-5HJ)JG MYE%S1UH^^9WC^BB!Y+$_$ M)W+H*A&.4!)^.U<=KE:)K-WN*EPV8D+2B1)N!2-6M1 :365=;PCP6TPL""Z# M/JD]N.MU 25^"I2=M]PSO.R^67>&#: VU8K1()TI);.2=$ 2]ST,$6G5(ET MD):QSK6?Q]US0=L:G]RQ;LPG!R*4W<4:6_W?2*>-&K!8Q3$PG8 M$_+)"QQB3A5V?1.NYV'GLTU;/,/(UMSNL=>9\DV2U):#N\:O6V8MC/-XSQ]R M,)=+,%%[-!;'+ZBD0 EVX1/IUG"TJ!2.97QB*^NE72>-59ETRV+$^S>@BE0@ MMA"/EG3F.'P]4-Z>T9[(=_YPB/9$TJOJ?8=?2>\;/LJHQ9;HK'8]D] Z+%<$ MP,#:HU@^ZVN6IDGT-MY8MZQ/X06F+ KM/=&O4&QL4 %Y7&G8%R8Y!GC!:(X9 M$_]SA[78"@7H?L(7V@6Y]J],MIVA>#'[;<\"%:00K46G MJ5@.YOM%N:UH%Z/8WN] MEY8/[6XK$ ,89+M(22XK1Z/%+U?@K"J7\Y$N0V"#TM7FK0E?&4V9^% AVZN& MD/IFN+U-&KSO]0=#OE#RL-.KQ<+M75,OW#6=>O5\[/UE[WW_Y>%^+UJ.G8:Y MF_GA@:MD^>%H 8VQX<3%F>3(T97@S M,3)C9F]C97)T:69I8V$N:'1MW5I=;]LX%GW?7\%-L9T$L!W+B=O$<0-TTA3( M+M#9+8*=QP4E75G<2**&I.QX?OV>2\I?L3/C8'9FXO8AC<1+WJ_#729R& _.WETF41:?)5F:_2]/V_*Q[I9K)4Q7ST MW;TJR8HO-!-?=2FK[SI65K9KR:@L"%KU,T$CE/O'66L0UBE410L#HP&;),:G M+/1[*W^_4_GM8ZYBY<19U!LL[ @QW8ZL-!,$-];.Z7)T@>7;-T[7_G$MG@G2 M2^9W#^ANGVYNO][??;Z[^7A_]\.73:=V9_^_C74JFP<'5)7"^-'9N_K/ L1= M1_R#IJH2W_?$WV6B8TM51R1DV$CAOAE>7#WK62W3%!NS6U 6_-APK!M= M_&F>1;T_!NN[M%]MA"7J]X8MX9I.H6;4TQ+13Q? M#\.A0N[L<"!'(E,5DLKX6"6Q [Q!',-F;5Q5&2A".H5U5)4438HU 92UC'4 M,L6T4B//#%&&;E&L,-BFWSY1#9BGBA?NL$130 # TT"'5V>]/8FTN<@*/;,+ M5!J:*.N,A"+)+X/=L+*S!BZ[,&;+VD/%U_FKP]?]1C+>OKD81.^O;(N@MJXS M!>@L4WCT:;H3TI '!!*LXH(X<8* PKA0-F=Q%BM!?TR!_)PJFQ3:-IC'Q&AT M$9!1&YU0BM=6' ,(*0%9(=NWCTDNJPF)C^"A,=J/A,9WXJ=$P#4_A M47%75P5$\OJ"B6D-J $X;,O>BK(-11D4L9]/X0L)KM,OZ'N&YZ\(DL?R1'PB MBUX3X? EX==SU>%JE]M^L>\,&4)NJE-$@K:XDLY*T0!+W/0P1:=)%N@ @ M)6-5*#?G>K1++8/79]8G+>!N0W2M;_+D]]@Z5#>F!FBLKY])HDWJ#? =U(0J ME,4"V,$(U0Q*%D%W&/ !\*H:_'.P"$E.Q.U4%HW?;QP^RC+T#&H*Q^V.VK\L M-WOP1WCL&_>\!?LPG%Q*$W=4V:\WO2)>]&H>XQ0B 7M\ M/EG!(>8TQ:X/X=H..Y]MVN+I1W;F]@5[G2E?)TEC.+AK_+ICU5);A_?\,0=K MV00+M4=C*MCG%SD&>,%HEAD3 M_W.'M=AQ]%.C8+[?74V5^*/0B&5W+;S 2!1A-BWM679:LY( M/G"Q"#7 @ZY&Z$$_HNAD!L#O(*[D]RHRX[]8M2GL!,Y6 MU5074V+BKN2D_?!FVNU-95WH.6%TENNPI^4&0)#0_TM5Z^U/U6U0K\>QN7YV MUO95QR:WA>0XWP"W4V) A4P722ID;6FT^.4*+%87O]TZ=>GVV.5%[[+__'"_ M%RW'3OW:87UX8&M9?3@Z.WH2S=&@?A31YHT/!^:I$\'^/Q[&WME/ *HG4_$% ML"EC("?J^#O)9=K7/%Y8MUAB&#+\BU'HXG3[8[GVT_X+/Q'$+&P_Y B\INB<$B.WCY2TO Y5?P;O:;X)\Z@BLNM MZ(J;7%$F/B]+RP^A'=V.Q*DG\'UJQEZ5YLF?*M3:^@_]H_#];4K/_O%"JZ>_ MFB)C0+!QST]Y[GY^AX4;/\/?99SZOP?Y'U!+ P04 " "NA6%7>I7/$Y,$ M " %0 '@ &-L>'$Q9GDR-&5X,S)C96]C9F]C97)T:69I+FAT;>U845/C M-A!^[Z_8ABG'S<2)'2>$.(&9*P[6KWV]U/:XU2DV=GHY01>O;%Z$O/@X\RGN5,&(@5(X91F&DN MIO"9,GT'GE>M.I?%4O%I:J#C=T+X+-4=GY-2;KC)V%EM9]0NGT=MM\EH(NGR M;$3Y'#@];?!^?Q#V^L0/DS#IDGA CI-^M\M"?Y!,!G'/_SEHH"HN+W6T66;L MM)%SX:7,[A]U.ZU^KS##!:^.1C$]%Y!Q&:2(QO$HL=C#H6)G7\8 M7WVZWO3Y!=YBGM79$ZW7CJ3[;"17 F(I!(L-EP(6W*1@4@8%6I.4QZ!8(94! MF< 87Y^C4_(>"SPOB%C"D5UZ>'#2Z?C#ZIU["H;O :U=2I5#X'L_0"+5FEE@ M@F+OW++"L'S"%(1^T[5*LP;EKT6B\R(DX'4V?UD:B(:$9PC**@.W+)XI;CCN M002%B_LX)6+*+/8YU]IF:QW^&Y>G&OTF+%@3ON."$KA!M#-\.D\Y2] .VC5\ MSN!3DO 8PR7!+'S[?HW59%(12)'XO8XF)PF-,L>MUQ!L1B;S@I'A]*GV^D(Z"]V]7 MQ\,-7(Y;8=?B8'-2EBPGF?"%2:Z0)*P*6U:,=5K*B#C1(N3-M:0A7 MS;*R(B0>'6Y/_8A6P#9VQ2$E56X>-AKWQH/,3FNMG7K];9(^3CEREF-(Z[1% M(L6J%]+ A%D>MA'JU()9O@/*L&]HLSX(W#%2G0.[G";[ ,Y'S*(C;;B6\W)T M",K)84?GC>6/VON)5)0I#X/(2*%95/\SI%P7&5E&7#A7G-(P)VJ* _9$&B/S MR [7A3V>"D-?"W MB_U6L)*UG6U5+ZAQ=/M#[7XW9J%50;P@WJHXC"PB#-<.)YQ"[?H^@?%' =BG M&+>,N/_6< \/@F-_^']T^QG= S<]^=KZ3Q+4GT)AGP+=_4OZ*1)M-XSL^-7Z MZ%(0/ZW=J!TIEA'KS]9KPFK8\1]4R 0+;6:VJ^QP][7Q6]Z MMW-ZV]02P$" M% ,4 " "NA6%7LH(&HOH> 0!G4A$ $ @ $ 8VQX M+3(P,C,P.3,P+FAT;5!+ 0(4 Q0 ( *Z%85>'/V%$3PX #Z- 0 M " 2@? 0!C;'@M,C R,S Y,S N>'-D4$L! A0#% @ KH5A M5QGX,U;Z' E@P! !0 ( !I2T! &-L>"TR,#(S,#DS,%]C M86PN>&UL4$L! A0#% @ KH5A5\LD+Y$01 )/X" !0 M ( !T4H! &-L>"TR,#(S,#DS,%]D968N>&UL4$L! A0#% @ KH5A5]N& MQ8/F-P FCH !, ( !$X\! &-L>"TR,#(S,#DS,%]G,2YJ M<&=02P$"% ,4 " "NA6%7M\ %#:+0 #&A@@ % @ $J MQP$ 8VQX+3(P,C,P.3,P7VQA8BYX;6Q02P$"% ,4 " "NA6%7!.8:.D-\ M #7IP4 % @ '^EP( 8VQX+3(P,C,P.3,P7W!R92YX;6Q0 M2P$"% ,4 " "NA6%7]E2J<($7 !LI0 '@ @ %S% , M8VQX<3%F>3(T97@Q,#%A;FYU86QI;F-E;G0N:'1M4$L! A0#% @ KH5A M5U5L24%"!P 92$ !X ( !,"P# &-L>'$Q9GDR-&5X,S$Q M8V5O8V5R=&EF:6-A+FAT;5!+ 0(4 Q0 ( *Z%85<8QEXM:0< !8B > M " :XS P!C;'AQ,69Y,C1E>#,Q,F-F;V-EI7/$Y,$ " %0 '@ @ %3 M.P, 8VQX<3%F>3(T97@S,F-E;V-F;V-E